• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of microrevMicrobiol Mol Biol Rev ArchivePermissionsJournals.ASM.orgMMBR ArticleJournal InfoAuthorsReviewers
Microbiol Rev. Mar 1993; 57(1): 183–289.
PMCID: PMC372905

Pathogenesis of human immunodeficiency virus infection.

Abstract

The lentivirus human immunodeficiency virus (HIV) causes AIDS by interacting with a large number of different cells in the body and escaping the host immune response against it. HIV is transmitted primarily through blood and genital fluids and to newborn infants from infected mothers. The steps occurring in infection involve an interaction of HIV not only with the CD4 molecule on cells but also with other cellular receptors recently identified. Virus-cell fusion and HIV entry subsequently take place. Following virus infection, a variety of intracellular mechanisms determine the relative expression of viral regulatory and accessory genes leading to productive or latent infection. With CD4+ lymphocytes, HIV replication can cause syncytium formation and cell death; with other cells, such as macrophages, persistent infection can occur, creating reservoirs for the virus in many cells and tissues. HIV strains are highly heterogeneous, and certain biologic and serologic properties determined by specific genetic sequences can be linked to pathogenic pathways and resistance to the immune response. The host reaction against HIV, through neutralizing antibodies and particularly through strong cellular immune responses, can keep the virus suppressed for many years. Long-term survival appears to involve infection with a relatively low-virulence strain that remains sensitive to the immune response, particularly to control by CD8+ cell antiviral activity. Several therapeutic approaches have been attempted, and others are under investigation. Vaccine development has provided some encouraging results, but the observations indicate the major challenge of preventing infection by HIV. Ongoing research is necessary to find a solution to this devastating worldwide epidemic.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (27M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Abrams DI. Alternative therapies in HIV infection. AIDS. 1990 Dec;4(12):1179–1187. [PubMed]
  • Abrams DI, Lewis BJ, Beckstead JH, Casavant CA, Drew WL. Persistent diffuse lymphadenopathy in homosexual men: endpoint or prodrome? Ann Intern Med. 1984 Jun;100(6):801–808. [PubMed]
  • Abrignani S, Montagna D, Jeannet M, Wintsch J, Haigwood NL, Shuster JR, Steimer KS, Cruchaud A, Staehelin T. Priming of CD4+ T cells specific for conserved regions of human immunodeficiency virus glycoprotein gp120 in humans immunized with a recombinant envelope protein. Proc Natl Acad Sci U S A. 1990 Aug;87(16):6136–6140. [PMC free article] [PubMed]
  • Adachi A, Koenig S, Gendelman HE, Daugherty D, Gattoni-Celli S, Fauci AS, Martin MA. Productive, persistent infection of human colorectal cell lines with human immunodeficiency virus. J Virol. 1987 Jan;61(1):209–213. [PMC free article] [PubMed]
  • Adams LE, Donovan-Brand R, Friedman-Kien A, el Ramahi K, Hess EV. Sperm and seminal plasma antibodies in acquired immune deficiency (AIDS) and other associated syndromes. Clin Immunol Immunopathol. 1988 Mar;46(3):442–449. [PubMed]
  • Children born to women with HIV-1 infection: natural history and risk of transmission. European Collaborative Study. Lancet. 1991 Feb 2;337(8736):253–260. [PubMed]
  • Agy MB, Frumkin LR, Corey L, Coombs RW, Wolinsky SM, Koehler J, Morton WR, Katze MG. Infection of Macaca nemestrina by human immunodeficiency virus type-1. Science. 1992 Jul 3;257(5066):103–106. [PubMed]
  • Ahmad N, Maitra RK, Venkatesan S. Rev-induced modulation of Nef protein underlies temporal regulation of human immunodeficiency virus replication. Proc Natl Acad Sci U S A. 1989 Aug;86(16):6111–6115. [PMC free article] [PubMed]
  • Ahmad N, Venkatesan S. Nef protein of HIV-1 is a transcriptional repressor of HIV-1 LTR. Science. 1988 Sep 16;241(4872):1481–1485. [PubMed]
  • Albert J, Bredberg U, Chiodi F, Böttiger B, Fenyö EM, Norrby E, Biberfeld G. A new human retrovirus isolate of West African origin (SBL-6669) and its relationship to HTLV-IV, LAV-II, and HTLV-IIIB. AIDS Res Hum Retroviruses. 1987 Spring;3(1):3–10. [PubMed]
  • Albert J, Wahlberg J, Lundeberg J, Cox S, Sandström E, Wahren B, Uhlén M. Persistence of azidothymidine-resistant human immunodeficiency virus type 1 RNA genotypes in posttreatment sera. J Virol. 1992 Sep;66(9):5627–5630. [PMC free article] [PubMed]
  • Albrecht MA, DeLuca NA, Byrn RA, Schaffer PA, Hammer SM. The herpes simplex virus immediate-early protein, ICP4, is required to potentiate replication of human immunodeficiency virus in CD4+ lymphocytes. J Virol. 1989 May;63(5):1861–1868. [PMC free article] [PubMed]
  • Aldovini A, Young RA. Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines. Nature. 1991 Jun 6;351(6326):479–482. [PubMed]
  • Alesi DR, Ajello F, Lupo G, Vitale F, Portera M, Spadaro F, Romano N. Neutralizing antibody and clinical status of human immunodeficiency virus (HIV)-infected individuals. J Med Virol. 1989 Jan;27(1):7–12. [PubMed]
  • Alizon M, Sonigo P, Barré-Sinoussi F, Chermann JC, Tiollais P, Montagnier L, Wain-Hobson S. Molecular cloning of lymphadenopathy-associated virus. Nature. 1984 Dec 20;312(5996):757–760. [PubMed]
  • Allan JS, Strauss J, Buck DW. Enhancement of SIV infection with soluble receptor molecules. Science. 1990 Mar 2;247(4946):1084–1088. [PubMed]
  • Alonso A, Derse D, Peterlin BM. Human chromosome 12 is required for optimal interactions between Tat and TAR of human immunodeficiency virus type 1 in rodent cells. J Virol. 1992 Jul;66(7):4617–4621. [PMC free article] [PubMed]
  • Amadori A, de Rossi A, Giaquinto C, Faulkner-Valle G, Zacchello F, Chieco-Bianchi L. In-vitro production of HIV-specific antibody in children at risk of AIDS. Lancet. 1988 Apr 16;1(8590):852–854. [PubMed]
  • Amerongen HM, Weltzin R, Farnet CM, Michetti P, Haseltine WA, Neutra MR. Transepithelial transport of HIV-1 by intestinal M cells: a mechanism for transmission of AIDS. J Acquir Immune Defic Syndr. 1991;4(8):760–765. [PubMed]
  • Amirhessami-Aghili N, Spector SA. Human immunodeficiency virus type 1 infection of human placenta: potential route for fetal infection. J Virol. 1991 May;65(5):2231–2236. [PMC free article] [PubMed]
  • Ammann AJ, Levy J. Laboratory investigation of pediatric acquired immunodeficiency syndrome. Clin Immunol Immunopathol. 1986 Jul;40(1):122–127. [PubMed]
  • Ammann AJ, Cowan MJ, Wara DW, Weintrub P, Dritz S, Goldman H, Perkins HA. Acquired immunodeficiency in an infant: possible transmission by means of blood products. Lancet. 1983 Apr 30;1(8331):956–958. [PubMed]
  • Anand R, Siegal F, Reed C, Cheung T, Forlenza S, Moore J. Non-cytocidal natural variants of human immunodeficiency virus isolated from AIDS patients with neurological disorders. Lancet. 1987 Aug 1;2(8553):234–238. [PubMed]
  • Ancelle R, Bletry O, Baglin AC, Brun-Vezinet F, Rey MA, Godeau P. Long incubation period for HIV-2 infection. Lancet. 1987 Mar 21;1(8534):688–689. [PubMed]
  • Anderson DJ, O'Brien TR, Politch JA, Martinez A, Seage GR, 3rd, Padian N, Horsburgh CR, Jr, Mayer KH. Effects of disease stage and zidovudine therapy on the detection of human immunodeficiency virus type 1 in semen. JAMA. 1992 May 27;267(20):2769–2774. [PubMed]
  • Anderson DJ, Politch JA, Martinez A, Van Voorhis BJ, Padian NS, O'Brien TR. White blood cells and HIV-1 in semen from vasectomised seropositive men. Lancet. 1991 Aug 31;338(8766):573–574. [PubMed]
  • Archibald DW, Cole GA. In vitro inhibition of HIV-1 infectivity by human salivas. AIDS Res Hum Retroviruses. 1990 Dec;6(12):1425–1432. [PubMed]
  • Ardman B, Sikorski MA, Settles M, Staunton DE. Human immunodeficiency virus type 1-infected individuals make autoantibodies that bind to CD43 on normal thymic lymphocytes. J Exp Med. 1990 Oct 1;172(4):1151–1158. [PMC free article] [PubMed]
  • Arendrup M, Nielsen C, Hansen JE, Pedersen C, Mathiesen L, Nielsen JO. Autologous HIV-1 neutralizing antibodies: emergence of neutralization-resistant escape virus and subsequent development of escape virus neutralizing antibodies. J Acquir Immune Defic Syndr. 1992;5(3):303–307. [PubMed]
  • Arthos J, Deen KC, Chaikin MA, Fornwald JA, Sathe G, Sattentau QJ, Clapham PR, Weiss RA, McDougal JS, Pietropaolo C, et al. Identification of the residues in human CD4 critical for the binding of HIV. Cell. 1989 May 5;57(3):469–481. [PubMed]
  • Arthur LO, Bess JW, Jr, Sowder RC, 2nd, Benveniste RE, Mann DL, Chermann JC, Henderson LE. Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. Science. 1992 Dec 18;258(5090):1935–1938. [PubMed]
  • Arthur LO, Bess JW, Jr, Waters DJ, Pyle SW, Kelliher JC, Nara PL, Krohn K, Robey WG, Langlois AJ, Gallo RC, et al. Challenge of chimpanzees (Pan troglodytes) immunized with human immunodeficiency virus envelope glycoprotein gp120. J Virol. 1989 Dec;63(12):5046–5053. [PMC free article] [PubMed]
  • Ashkenazi A, Smith DH, Marsters SA, Riddle L, Gregory TJ, Ho DD, Capon DJ. Resistance of primary isolates of human immunodeficiency virus type 1 to soluble CD4 is independent of CD4-rgp120 binding affinity. Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):7056–7060. [PMC free article] [PubMed]
  • Ashorn P, Moss B, Weinstein JN, Chaudhary VK, FitzGerald DJ, Pastan I, Berger EA. Elimination of infectious human immunodeficiency virus from human T-cell cultures by synergistic action of CD4-Pseudomonas exotoxin and reverse transcriptase inhibitors. Proc Natl Acad Sci U S A. 1990 Nov;87(22):8889–8893. [PMC free article] [PubMed]
  • Asjö B, Albert J, Chiodi F, Fenyö EM. Improved tissue culture technique for production of poorly replicating human immunodeficiency virus strains. J Virol Methods. 1988 Mar-Apr;19(3-4):191–196. [PubMed]
  • Asjö B, Morfeldt-Månson L, Albert J, Biberfeld G, Karlsson A, Lidman K, Fenyö EM. Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet. 1986 Sep 20;2(8508):660–662. [PubMed]
  • Attanasio R, Allan JS, Anderson SA, Chanh TC, Kennedy RC. Anti-idiotypic antibody response to monoclonal anti-CD4 preparations in nonhuman primate species. J Immunol. 1991 Jan 15;146(2):507–514. [PubMed]
  • Attanasio R, Kennedy RC. Idiotypic cascades associated with the CD4-HIV gp120 interaction: principles for idiotype-based vaccines. Int Rev Immunol. 1990;7(1):109–119. [PubMed]
  • Autiero M, Abrescia P, Dettin M, Di Bello C, Guardiola J. Binding to CD4 of synthetic peptides patterned on the principal neutralizing domain of the HIV-1 envelope protein. Virology. 1991 Dec;185(2):820–828. [PubMed]
  • Autran B, Plata F, Debre P. MHC-restricted cytotoxicity against HIV. J Acquir Immune Defic Syndr. 1991;4(4):361–367. [PubMed]
  • Baba M, Pauwels R, Balzarini J, Arnout J, Desmyter J, De Clercq E. Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro. Proc Natl Acad Sci U S A. 1988 Aug;85(16):6132–6136. [PMC free article] [PubMed]
  • Bachelerie F, Alcami J, Hazan U, Israël N, Goud B, Arenzana-Seisdedos F, Virelizier JL. Constitutive expression of human immunodeficiency virus (HIV) nef protein in human astrocytes does not influence basal or induced HIV long terminal repeat activity. J Virol. 1990 Jun;64(6):3059–3062. [PMC free article] [PubMed]
  • Bagasra O, Hauptman SP, Lischner HW, Sachs M, Pomerantz RJ. Detection of human immunodeficiency virus type 1 provirus in mononuclear cells by in situ polymerase chain reaction. N Engl J Med. 1992 May 21;326(21):1385–1391. [PubMed]
  • Ballem PJ, Belzberg A, Devine DV, Lyster D, Spruston B, Chambers H, Doubroff P, Mikulash K. Kinetic studies of the mechanism of thrombocytopenia in patients with human immunodeficiency virus infection. N Engl J Med. 1992 Dec 17;327(25):1779–1784. [PubMed]
  • Banda NK, Bernier J, Kurahara DK, Kurrle R, Haigwood N, Sekaly RP, Finkel TH. Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J Exp Med. 1992 Oct 1;176(4):1099–1106. [PMC free article] [PubMed]
  • Barboza A, Castro BA, Whalen M, Moore CC, Parkin JS, Miller WL, Gonzalez-Scarano F, Levy JA. Infection of cultured human adrenal cells by different strains of HIV. AIDS. 1992 Dec;6(12):1437–1443. [PubMed]
  • Barnett SW, Barboza A, Wilcox CM, Forsmark CE, Levy JA. Characterization of human immunodeficiency virus type 1 strains recovered from the bowel of infected individuals. Virology. 1991 Jun;182(2):802–809. [PubMed]
  • Barnett SW, Quiroga M, Werner A, Dina D, Levy JA. Distinguishing features of an infectious molecular clone of the highly divergent and noncytopathic human immunodeficiency virus type 2 UC1 strain. J Virol. 1993 Feb;67(2):1006–1014. [PMC free article] [PubMed]
  • Barré-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, Dauguet C, Axler-Blin C, Vézinet-Brun F, Rouzioux C, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science. 1983 May 20;220(4599):868–871. [PubMed]
  • Barrett AD, Gould EA. Antibody-mediated early death in vivo after infection with yellow fever virus. J Gen Virol. 1986 Nov;67(Pt 11):2539–2542. [PubMed]
  • Bartholomew C, Blattner W, Cleghorn F. Progression to AIDS in homosexual men co-infected with HIV and HTLV-I in Trinidad. Lancet. 1987 Dec 19;2(8573):1469–1469. [PubMed]
  • Baucke RB, Spear PG. Membrane proteins specified by herpes simplex viruses. V. Identification of an Fc-binding glycoprotein. J Virol. 1979 Dec;32(3):779–789. [PMC free article] [PubMed]
  • Bauer FA, Wear DJ, Angritt P, Lo SC. Mycoplasma fermentans (incognitus strain) infection in the kidneys of patients with acquired immunodeficiency syndrome and associated nephropathy: a light microscopic, immunohistochemical, and ultrastructural study. Hum Pathol. 1991 Jan;22(1):63–69. [PubMed]
  • Becherer PR, Smiley ML, Matthews TJ, Weinhold KJ, McMillan CW, White GC., 2nd Human immunodeficiency virus-1 disease progression in hemophiliacs. Am J Hematol. 1990 Jul;34(3):204–209. [PubMed]
  • Bednarik DP, Mosca JD, Raj NB. Methylation as a modulator of expression of human immunodeficiency virus. J Virol. 1987 Apr;61(4):1253–1257. [PMC free article] [PubMed]
  • Status report on the acquired immunodeficiency syndrome. Human T-cell lymphotropic virus type III testing. Council on Scientific Affairs. JAMA. 1985 Sep 13;254(10):1342–1345. [PubMed]
  • Benjouad A, Gluckman JC, Rochat H, Montagnier L, Bahraoui E. Influence of carbohydrate moieties on the immunogenicity of human immunodeficiency virus type 1 recombinant gp160. J Virol. 1992 Apr;66(4):2473–2483. [PMC free article] [PubMed]
  • Benn S, Rutledge R, Folks T, Gold J, Baker L, McCormick J, Feorino P, Piot P, Quinn T, Martin M. Genomic heterogeneity of AIDS retroviral isolates from North America and Zaire. Science. 1985 Nov 22;230(4728):949–951. [PubMed]
  • Benveniste RE, Arthur LO, Tsai CC, Sowder R, Copeland TD, Henderson LE, Oroszlan S. Isolation of a lentivirus from a macaque with lymphoma: comparison with HTLV-III/LAV and other lentiviruses. J Virol. 1986 Nov;60(2):483–490. [PMC free article] [PubMed]
  • Berger EA, Lifson JD, Eiden LE. Stimulation of glycoprotein gp120 dissociation from the envelope glycoprotein complex of human immunodeficiency virus type 1 by soluble CD4 and CD4 peptide derivatives: implications for the role of the complementarity-determining region 3-like region in membrane fusion. Proc Natl Acad Sci U S A. 1991 Sep 15;88(18):8082–8086. [PMC free article] [PubMed]
  • Berger EA, Sisler JR, Earl PL. Human immunodeficiency virus type 1 envelope glycoprotein molecules containing membrane fusion-impairing mutations in the V3 region efficiently undergo soluble CD4-stimulated gp120 release. J Virol. 1992 Oct;66(10):6208–6212. [PMC free article] [PubMed]
  • Berger JR, Levy JA. The human immunodeficiency virus, type 1: the virus and its role in neurologic disease. Semin Neurol. 1992 Mar;12(1):1–9. [PubMed]
  • Bergeron L, Sodroski J. Dissociation of unintegrated viral DNA accumulation from single-cell lysis induced by human immunodeficiency virus type 1. J Virol. 1992 Oct;66(10):5777–5787. [PMC free article] [PubMed]
  • Bergeron L, Sullivan N, Sodroski J. Target cell-specific determinants of membrane fusion within the human immunodeficiency virus type 1 gp120 third variable region and gp41 amino terminus. J Virol. 1992 Apr;66(4):2389–2397. [PMC free article] [PubMed]
  • Berman PW, Gregory T, Crase D, Lasky LA. Protection from genital herpes simplex virus type 2 infection by vaccination with cloned type 1 glycoprotein D. Science. 1985 Mar 22;227(4693):1490–1492. [PubMed]
  • Berman PW, Gregory TJ, Riddle L, Nakamura GR, Champe MA, Porter JP, Wurm FM, Hershberg RD, Cobb EK, Eichberg JW. Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160. Nature. 1990 Jun 14;345(6276):622–625. [PubMed]
  • Berman PW, Matthews TJ, Riddle L, Champe M, Hobbs MR, Nakamura GR, Mercer J, Eastman DJ, Lucas C, Langlois AJ, et al. Neutralization of multiple laboratory and clinical isolates of human immunodeficiency virus type 1 (HIV-1) by antisera raised against gp120 from the MN isolate of HIV-1. J Virol. 1992 Jul;66(7):4464–4469. [PMC free article] [PubMed]
  • Besansky NJ, Butera ST, Sinha S, Folks TM. Unintegrated human immunodeficiency virus type 1 DNA in chronically infected cell lines is not correlated with surface CD4 expression. J Virol. 1991 May;65(5):2695–2698. [PMC free article] [PubMed]
  • Bettaieb A, Fromont P, Louache F, Oksenhendler E, Vainchenker W, Duédari N, Bierling P. Presence of cross-reactive antibody between human immunodeficiency virus (HIV) and platelet glycoproteins in HIV-related immune thrombocytopenic purpura. Blood. 1992 Jul 1;80(1):162–169. [PubMed]
  • Bhat S, Spitalnik SL, Gonzalez-Scarano F, Silberberg DH. Galactosyl ceramide or a derivative is an essential component of the neural receptor for human immunodeficiency virus type 1 envelope glycoprotein gp120. Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):7131–7134. [PMC free article] [PubMed]
  • Binninger D, Ennen J, Bonn D, Norley SG, Kurth R. Mutational analysis of the simian immunodeficiency virus SIVmac nef gene. J Virol. 1991 Oct;65(10):5237–5243. [PMC free article] [PubMed]
  • Bisaccia E, Berger C, Klainer AS. Extracorporeal photopheresis in the treatment of AIDS-related complex: a pilot study. Ann Intern Med. 1990 Aug 15;113(4):270–275. [PubMed]
  • Bjork RL., Jr HIV-1: seven facets of functional molecular mimicry. Immunol Lett. 1991 May;28(2):91–99. [PubMed]
  • Björling E, Broliden K, Bernardi D, Utter G, Thorstensson R, Chiodi F, Norrby E. Hyperimmune antisera against synthetic peptides representing the glycoprotein of human immunodeficiency virus type 2 can mediate neutralization and antibody-dependent cytotoxic activity. Proc Natl Acad Sci U S A. 1991 Jul 15;88(14):6082–6086. [PMC free article] [PubMed]
  • Blackburn R, Clerici M, Mann D, Lucey DR, Goedert J, Golding B, Shearer GM, Golding H. Common sequence in HIV 1 GP41 and HLA class II beta chains can generate crossreactive autoantibodies with immunosuppressive potential early in the course of HIV 1 infection. Adv Exp Med Biol. 1991;303:63–69. [PubMed]
  • Blanche S, Rouzioux C, Moscato ML, Veber F, Mayaux MJ, Jacomet C, Tricoire J, Deville A, Vial M, Firtion G, et al. A prospective study of infants born to women seropositive for human immunodeficiency virus type 1. HIV Infection in Newborns French Collaborative Study Group. N Engl J Med. 1989 Jun 22;320(25):1643–1648. [PubMed]
  • Blumberg RS, Schooley RT. Lymphocyte markers and infectious diseases. Semin Hematol. 1985 Apr;22(2):81–114. [PubMed]
  • Bloom EJ, Abrams DI, Rodgers G. Lupus anticoagulant in the acquired immunodeficiency syndrome. JAMA. 1986 Jul 25;256(4):491–493. [PubMed]
  • Boeri E, Giri A, Lillo F, Ferrari G, Varnier OE, Ferro A, Sabbatani S, Saxinger WC, Franchini G. In vivo genetic variability of the human immunodeficiency virus type 2 V3 region. J Virol. 1992 Jul;66(7):4546–4550. [PMC free article] [PubMed]
  • Boettiger D. Animal virus pseudotypes. Prog Med Virol. 1979;25:37–68. [PubMed]
  • Bollinger RC, Jr, Kline RL, Francis HL, Moss MW, Bartlett JG, Quinn TC. Acid dissociation increases the sensitivity of p24 antigen detection for the evaluation of antiviral therapy and disease progression in asymptomatic human immunodeficiency virus-infected persons. J Infect Dis. 1992 May;165(5):913–916. [PubMed]
  • Bolognesi DP. Prospects for prevention of and early intervention against HIV. JAMA. 1989 May 26;261(20):3007–3013. [PubMed]
  • Bonavida B, Katz J, Gottlieb M. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. I. Defective trigger on NK cells for NKCF production by target cells, and partial restoration by IL 2. J Immunol. 1986 Aug 15;137(4):1157–1163. [PubMed]
  • Borzy MS, Connell RS, Kiessling AA. Detection of human immunodeficiency virus in cell-free seminal fluid. J Acquir Immune Defic Syndr. 1988;1(5):419–424. [PubMed]
  • Bosch V, Pfeiffer T. HIV-1-induced cytopathogenicity in cell culture despite very decreased amounts of fusion-competent viral glycoprotein. AIDS Res Hum Retroviruses. 1992 Oct;8(10):1815–1821. [PubMed]
  • Böttiger B, Ljunggren K, Karlsson A, Krohn K, Fenyö EM, Jondal M, Biberfeld G. Neutralizing antibodies in relation to antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus type I. Clin Exp Immunol. 1988 Sep;73(3):339–342. [PMC free article] [PubMed]
  • Boue F, Wallon C, Goujard C, Barre-Sinoussi F, Galanaud P, Delfraissy JF. HIV induces IL-6 production by human B lymphocytes. Role of IL-4. J Immunol. 1992 Jun 15;148(12):3761–3767. [PubMed]
  • Bourinbaiar AS, Phillips DM. Transmission of human immunodeficiency virus from monocytes to epithelia. J Acquir Immune Defic Syndr. 1991;4(1):56–63. [PubMed]
  • Bowman MR, MacFerrin KD, Schreiber SL, Burakoff SJ. Identification and structural analysis of residues in the V1 region of CD4 involved in interaction with human immunodeficiency virus envelope glycoprotein gp120 and class II major histocompatibility complex molecules. Proc Natl Acad Sci U S A. 1990 Nov;87(22):9052–9056. [PMC free article] [PubMed]
  • Boyer JC, Bebenek K, Kunkel TA. Unequal human immunodeficiency virus type 1 reverse transcriptase error rates with RNA and DNA templates. Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):6919–6923. [PMC free article] [PubMed]
  • Boyer V, Desgranges C, Trabaud MA, Fischer E, Kazatchkine MD. Complement mediates human immunodeficiency virus type 1 infection of a human T cell line in a CD4- and antibody-independent fashion. J Exp Med. 1991 May 1;173(5):1151–1158. [PMC free article] [PubMed]
  • Brack-Werner R, Kleinschmidt A, Ludvigsen A, Mellert W, Neumann M, Herrmann R, Khim MC, Burny A, Müller-Lantzsch N, Stavrou D, et al. Infection of human brain cells by HIV-1: restricted virus production in chronically infected human glial cell lines. AIDS. 1992 Mar;6(3):273–285. [PubMed]
  • Breen EC, Rezai AR, Nakajima K, Beall GN, Mitsuyasu RT, Hirano T, Kishimoto T, Martinez-Maza O. Infection with HIV is associated with elevated IL-6 levels and production. J Immunol. 1990 Jan 15;144(2):480–484. [PubMed]
  • Brenneman DE, Westbrook GL, Fitzgerald SP, Ennist DL, Elkins KL, Ruff MR, Pert CB. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature. 1988 Oct 13;335(6191):639–642. [PubMed]
  • Brenner BG, Gryllis C, Wainberg MA. Role of antibody-dependent cellular cytotoxicity and lymphokine-activated killer cells in AIDS and related diseases. J Leukoc Biol. 1991 Dec;50(6):628–640. [PubMed]
  • Brighty DW, Rosenberg M, Chen IS, Ivey-Hoyle M. Envelope proteins from clinical isolates of human immunodeficiency virus type 1 that are refractory to neutralization by soluble CD4 possess high affinity for the CD4 receptor. Proc Natl Acad Sci U S A. 1991 Sep 1;88(17):7802–7805. [PMC free article] [PubMed]
  • Brinchmann JE, Albert J, Vartdal F. Few infected CD4+ T cells but a high proportion of replication-competent provirus copies in asymptomatic human immunodeficiency virus type 1 infection. J Virol. 1991 Apr;65(4):2019–2023. [PMC free article] [PubMed]
  • Brinchmann JE, Gaudernack G, Vartdal F. CD8+ T cells inhibit HIV replication in naturally infected CD4+ T cells. Evidence for a soluble inhibitor. J Immunol. 1990 Apr 15;144(8):2961–2966. [PubMed]
  • Brinchmann JE, Gaudernack G, Vartdal F. In vitro replication of HIV-1 in naturally infected CD4+ T cells is inhibited by rIFN alpha 2 and by a soluble factor secreted by activated CD8+ T cells, but not by rIFN beta, rIFN gamma, or recombinant tumor necrosis factor-alpha. J Acquir Immune Defic Syndr. 1991;4(5):480–488. [PubMed]
  • Broder CC, Berger EA. CD4 molecules with a diversity of mutations encompassing the CDR3 region efficiently support human immunodeficiency virus type 1 envelope glycoprotein-mediated cell fusion. J Virol. 1993 Feb;67(2):913–926. [PMC free article] [PubMed]
  • Brodsky MH, Warton M, Myers RM, Littman DR. Analysis of the site in CD4 that binds to the HIV envelope glycoprotein. J Immunol. 1990 Apr 15;144(8):3078–3086. [PubMed]
  • Broliden PA, Mäkitalo B, Akerblom L, Rosen J, Broliden K, Utter G, Jondal M, Norrby E, Wahren B. Identification of amino acids in the V3 region of gp120 critical for virus neutralization by human HIV-1-specific antibodies. Immunology. 1991 Aug;73(4):371–376. [PMC free article] [PubMed]
  • Broliden PA, von Gegerfelt A, Clapham P, Rosen J, Fenyö EM, Wahren B, Broliden K. Identification of human neutralization-inducing regions of the human immunodeficiency virus type 1 envelope glycoproteins. Proc Natl Acad Sci U S A. 1992 Jan 15;89(2):461–465. [PMC free article] [PubMed]
  • Brookmeyer R. Reconstruction and future trends of the AIDS epidemic in the United States. Science. 1991 Jul 5;253(5015):37–42. [PubMed]
  • Bryant ML, Yamamoto J, Luciw P, Munn R, Marx P, Higgins J, Pedersen N, Levine A, Gardner MB. Molecular comparison of retroviruses associated with human and simian AIDS. Hematol Oncol. 1985 Jul-Sep;3(3):187–197. [PubMed]
  • Budhraja M, Levendoglu H, Kocka F, Mangkornkanok M, Sherer R. Duodenal mucosal T cell subpopulation and bacterial cultures in acquired immune deficiency syndrome. Am J Gastroenterol. 1987 May;82(5):427–431. [PubMed]
  • Bukrinsky MI, Sharova N, Dempsey MP, Stanwick TL, Bukrinskaya AG, Haggerty S, Stevenson M. Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proc Natl Acad Sci U S A. 1992 Jul 15;89(14):6580–6584. [PMC free article] [PubMed]
  • Bukrinsky MI, Stanwick TL, Dempsey MP, Stevenson M. Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. Science. 1991 Oct 18;254(5030):423–427. [PubMed]
  • Buonaguro L, Barillari G, Chang HK, Bohan CA, Kao V, Morgan R, Gallo RC, Ensoli B. Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines. J Virol. 1992 Dec;66(12):7159–7167. [PMC free article] [PubMed]
  • Burgard M, Mayaux MJ, Blanche S, Ferroni A, Guihard-Moscato ML, Allemon MC, Ciraru-Vigneron N, Firtion G, Floch C, Guillot F, et al. The use of viral culture and p24 antigen testing to diagnose human immunodeficiency virus infection in neonates. The HIV Infection in Newborns French Collaborative Study Group. N Engl J Med. 1992 Oct 22;327(17):1192–1197. [PubMed]
  • Burger H, Weiser B, Flaherty K, Gulla J, Nguyen PN, Gibbs RA. Evolution of human immunodeficiency virus type 1 nucleotide sequence diversity among close contacts. Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11236–11240. [PMC free article] [PubMed]
  • Butera ST, Perez VL, Wu BY, Nabel GJ, Folks TM. Oscillation of the human immunodeficiency virus surface receptor is regulated by the state of viral activation in a CD4+ cell model of chronic infection. J Virol. 1991 Sep;65(9):4645–4653. [PMC free article] [PubMed]
  • Butler KM, Husson RN, Balis FM, Brouwers P, Eddy J, el-Amin D, Gress J, Hawkins M, Jarosinski P, Moss H, et al. Dideoxyinosine in children with symptomatic human immunodeficiency virus infection. N Engl J Med. 1991 Jan 17;324(3):137–144. [PubMed]
  • Byars NE, Allison AC. Adjuvant formulation for use in vaccines to elicit both cell-mediated and humoral immunity. Vaccine. 1987 Sep;5(3):223–228. [PubMed]
  • Byers VS, Levin AS, Waites LA, Starrett BA, Mayer RA, Clegg JA, Price MR, Robins RA, Delaney M, Baldwin RW. A phase I/II study of trichosanthin treatment of HIV disease. AIDS. 1990 Dec;4(12):1189–1196. [PubMed]
  • Byrne JA, Oldstone MB. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus in vivo. J Virol. 1984 Sep;51(3):682–686. [PMC free article] [PubMed]
  • Cai Q, Huang XL, Rappocciolo G, Rinaldo CR., Jr Natural killer cell responses in homosexual men with early HIV infection. J Acquir Immune Defic Syndr. 1990;3(7):669–676. [PubMed]
  • Calabrese LH, Kelley DM, Myers A, O'Connell M, Easley K. Rheumatic symptoms and human immunodeficiency virus infection. The influence of clinical and laboratory variables in a longitudinal cohort study. Arthritis Rheum. 1991 Mar;34(3):257–263. [PubMed]
  • Camerini D, Seed B. A CD4 domain important for HIV-mediated syncytium formation lies outside the virus binding site. Cell. 1990 Mar 9;60(5):747–754. [PubMed]
  • Cameron DW, Simonsen JN, D'Costa LJ, Ronald AR, Maitha GM, Gakinya MN, Cheang M, Ndinya-Achola JO, Piot P, Brunham RC, et al. Female to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men. Lancet. 1989 Aug 19;2(8660):403–407. [PubMed]
  • Cameron PU, Freudenthal PS, Barker JM, Gezelter S, Inaba K, Steinman RM. Dendritic cells exposed to human immunodeficiency virus type-1 transmit a vigorous cytopathic infection to CD4+ T cells. Science. 1992 Jul 17;257(5068):383–387. [PubMed]
  • Canivet M, Hoffman AD, Hardy D, Sernatinger J, Levy JA. Replication of HIV-1 in a wide variety of animal cells following phenotypic mixing with murine retroviruses. Virology. 1990 Oct;178(2):543–551. [PubMed]
  • Cann AJ, Churcher MJ, Boyd M, O'Brien W, Zhao JQ, Zack J, Chen IS. The region of the envelope gene of human immunodeficiency virus type 1 responsible for determination of cell tropism. J Virol. 1992 Jan;66(1):305–309. [PMC free article] [PubMed]
  • Cann AJ, Zack JA, Go AS, Arrigo SJ, Koyanagi Y, Green PL, Koyanagi Y, Pang S, Chen IS. Human immunodeficiency virus type 1 T-cell tropism is determined by events prior to provirus formation. J Virol. 1990 Oct;64(10):4735–4742. [PMC free article] [PubMed]
  • Cantrill HL, Henry K, Jackson B, Erice A, Ussery FM, Balfour HH., Jr Recovery of human immunodeficiency virus from ocular tissues in patients with acquired immune deficiency syndrome. Ophthalmology. 1988 Oct;95(10):1458–1462. [PubMed]
  • Cao YZ, Dieterich D, Thomas PA, Huang YX, Mirabile M, Ho DD. Identification and quantitation of HIV-1 in the liver of patients with AIDS. AIDS. 1992 Jan;6(1):65–70. [PubMed]
  • Cao YZ, Friedman-Kien AE, Huang YX, Li XL, Mirabile M, Moudgil T, Zucker-Franklin D, Ho DD. CD4-independent, productive human immunodeficiency virus type 1 infection of hepatoma cell lines in vitro. J Virol. 1990 Jun;64(6):2553–2559. [PMC free article] [PubMed]
  • Capon DJ, Ward RH. The CD4-gp120 interaction and AIDS pathogenesis. Annu Rev Immunol. 1991;9:649–678. [PubMed]
  • Carlson JR, McGraw TP, Keddie E, Yee JL, Rosenthal A, Langlois AJ, Dickover R, Donovan R, Luciw PA, Jennings MB, et al. Vaccine protection of rhesus macaques against simian immunodeficiency virus infection. AIDS Res Hum Retroviruses. 1990 Nov;6(11):1239–1246. [PubMed]
  • Carne CA, Tedder RS, Smith A, Sutherland S, Elkington SG, Daly HM, Preston FE, Craske J. Acute encephalopathy coincident with seroconversion for anti-HTLV-III. Lancet. 1985 Nov 30;2(8466):1206–1208. [PubMed]
  • Carrigan DR, Knox KK, Tapper MA. Suppression of human immunodeficiency virus type 1 replication by human herpesvirus-6. J Infect Dis. 1990 Oct;162(4):844–851. [PubMed]
  • Casareale D, Fiala M, Chang CM, Cone LA, Mocarski ES. Cytomegalovirus enhances lysis of HIV-infected T lymphoblasts. Int J Cancer. 1989 Jul 15;44(1):124–130. [PubMed]
  • Castro BA, Barnett SW, Evans LA, Moreau J, Odehouri K, Levy JA. Biologic heterogeneity of human immunodeficiency virus type 2 (HIV-2) strains. Virology. 1990 Oct;178(2):527–534. [PubMed]
  • Castro BA, Cheng-Mayer C, Evans LA, Levy JA. HIV heterogeneity and viral pathogenesis. AIDS. 1988;2 (Suppl 1):S17–S27. [PubMed]
  • Castro BA, Walker CM, Tateno M, Cheng-Mayer C, Heberling R, Eichberg JW, Levy JA. Human immunodeficiency virus (HIV) from experimentally infected chimpanzees: isolation and characterization. J Med Primatol. 1989;18(3-4):337–342. [PubMed]
  • Castro BA, Homsy J, Lennette E, Murthy KK, Eichberg JW, Levy JA. HIV-1 expression in chimpanzees can be activated by CD8+ cell depletion or CMV infection. Clin Immunol Immunopathol. 1992 Dec;65(3):227–233. [PubMed]
  • Castro BA, Nepomuceno M, Lerche NW, Eichberg JW, Levy JA. Persistent infection of baboons and rhesus monkeys with different strains of HIV-2. Virology. 1991 Sep;184(1):219–226. [PubMed]
  • Cauda R, Tumbarello M, Ortona L, Kanda P, Kennedy RC, Chanh TC. Inhibition of normal human natural killer cell activity by human immunodeficiency virus synthetic transmembrane peptides. Cell Immunol. 1988 Aug;115(1):57–65. [PubMed]
  • Cavard C, Zider A, Vernet M, Bennoun M, Saragosti S, Grimber G, Briand P. In vivo activation by ultraviolet rays of the human immunodeficiency virus type 1 long terminal repeat. J Clin Invest. 1990 Oct;86(4):1369–1374. [PMC free article] [PubMed]
  • Celada F, Cambiaggi C, Maccari J, Burastero S, Gregory T, Patzer E, Porter J, McDanal C, Matthews T. Antibody raised against soluble CD4-rgp120 complex recognizes the CD4 moiety and blocks membrane fusion without inhibiting CD4-gp120 binding. J Exp Med. 1990 Oct 1;172(4):1143–1150. [PMC free article] [PubMed]
  • Pneumocystis carinii pneumonia among persons with hemophilia A. MMWR Morb Mortal Wkly Rep. 1982 Jul 16;31(27):365–367. [PubMed]
  • Chad DA, Smith TW, Blumenfeld A, Fairchild PG, DeGirolami U. Human immunodeficiency virus (HIV)-associated myopathy: immunocytochemical identification of an HIV antigen (gp 41) in muscle macrophages. Ann Neurol. 1990 Oct;28(4):579–582. [PubMed]
  • Chams V, Jouault T, Fenouillet E, Gluckman JC, Klatzmann D. Detection of anti-CD4 autoantibodies in the sera of HIV-infected patients using recombinant soluble CD4 molecules. AIDS. 1988 Oct;2(5):353–361. [PubMed]
  • Chandwani S, Greco MA, Mittal K, Antoine C, Krasinski K, Borkowsky W. Pathology and human immunodeficiency virus expression in placentas of seropositive women. J Infect Dis. 1991 May;163(5):1134–1138. [PubMed]
  • Chanh TC, Dreesman GR, Kanda P, Linette GP, Sparrow JT, Ho DD, Kennedy RC. Induction of anti-HIV neutralizing antibodies by synthetic peptides. EMBO J. 1986 Nov;5(11):3065–3071. [PMC free article] [PubMed]
  • Chanh TC, Kennedy RC, Kanda P. Synthetic peptides homologous to HIV transmembrane glycoprotein suppress normal human lymphocyte blastogenic response. Cell Immunol. 1988 Jan;111(1):77–86. [PubMed]
  • Chapel A, Bensussan A, Vilmer E, Dormont D. Differential human immunodeficiency virus expression in CD4+ cloned lymphocytes: from viral latency to replication. J Virol. 1992 Jun;66(6):3966–3970. [PMC free article] [PubMed]
  • Charbit A, Molla A, Ronco J, Clément JM, Favier V, Bahraoui EM, Montagnier L, Leguern A, Hofnung M. Immunogenicity and antigenicity of conserved peptides from the envelope of HIV-1 expressed at the surface of recombinant bacteria. AIDS. 1990 Jun;4(6):545–551. [PubMed]
  • Charman HP, Bladen S, Gilden RV, Coggins L. Equine infectious anemia virus: evidence favoring classification as a retravirus. J Virol. 1976 Sep;19(3):1073–1079. [PMC free article] [PubMed]
  • Chayt KJ, Harper ME, Marselle LM, Lewin EB, Rose RM, Oleske JM, Epstein LG, Wong-Staal F, Gallo RC. Detection of HTLV-III RNA in lungs of patients with AIDS and pulmonary involvement. JAMA. 1986 Nov 7;256(17):2356–2359. [PubMed]
  • Chehimi J, Bandyopadhyay S, Prakash K, Perussia B, Hassan NF, Kawashima H, Campbell D, Kornbluth J, Starr SE. In vitro infection of natural killer cells with different human immunodeficiency virus type 1 isolates. J Virol. 1991 Apr;65(4):1812–1822. [PMC free article] [PubMed]
  • Chehimi J, Starr SE, Frank I, Rengaraju M, Jackson SJ, Llanes C, Kobayashi M, Perussia B, Young D, Nickbarg E, et al. Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients. J Exp Med. 1992 Mar 1;175(3):789–796. [PMC free article] [PubMed]
  • Cheng-Mayer C, Homsy J, Evans LA, Levy JA. Identification of human immunodeficiency virus subtypes with distinct patterns of sensitivity to serum neutralization. Proc Natl Acad Sci U S A. 1988 Apr;85(8):2815–2819. [PMC free article] [PubMed]
  • Cheng-Mayer C, Iannello P, Shaw K, Luciw PA, Levy JA. Differential effects of nef on HIV replication: implications for viral pathogenesis in the host. Science. 1989 Dec 22;246(4937):1629–1632. [PubMed]
  • Cheng-Mayer C, Levy JA. Distinct biological and serological properties of human immunodeficiency viruses from the brain. Ann Neurol. 1988;23 (Suppl):S58–S61. [PubMed]
  • Cheng-Mayer C, Levy JA. Human immunodeficiency virus infection of the CNS: characterization of "neurotropic" strains. Curr Top Microbiol Immunol. 1990;160:145–156. [PubMed]
  • Cheng-Mayer C, Quiroga M, Tung JW, Dina D, Levy JA. Viral determinants of human immunodeficiency virus type 1 T-cell or macrophage tropism, cytopathogenicity, and CD4 antigen modulation. J Virol. 1990 Sep;64(9):4390–4398. [PMC free article] [PubMed]
  • Cheng-Mayer C, Rutka JT, Rosenblum ML, McHugh T, Stites DP, Levy JA. Human immunodeficiency virus can productively infect cultured human glial cells. Proc Natl Acad Sci U S A. 1987 May;84(10):3526–3530. [PMC free article] [PubMed]
  • Cheng-Mayer C, Seto D, Levy JA. Altered host range of HIV-1 after passage through various human cell types. Virology. 1991 Mar;181(1):288–294. [PubMed]
  • Cheng-Mayer C, Seto D, Tateno M, Levy JA. Biologic features of HIV-1 that correlate with virulence in the host. Science. 1988 Apr 1;240(4848):80–82. [PubMed]
  • Cheng-Mayer C, Shioda T, Levy JA. Host range, replicative, and cytopathic properties of human immunodeficiency virus type 1 are determined by very few amino acid changes in tat and gp120. J Virol. 1991 Dec;65(12):6931–6941. [PMC free article] [PubMed]
  • Cheng-Mayer C, Weiss C, Seto D, Levy JA. Isolates of human immunodeficiency virus type 1 from the brain may constitute a special group of the AIDS virus. Proc Natl Acad Sci U S A. 1989 Nov;86(21):8575–8579. [PMC free article] [PubMed]
  • Chermann JC, Donker G, Yahi N, Salaun D, Guettari N, Gayet O, Hirsh I. Discrepancies in AIDS virus data. Nature. 1991 May 23;351(6324):277–278. [PubMed]
  • Chesebro B, Buller R, Portis J, Wehrly K. Failure of human immunodeficiency virus entry and infection in CD4-positive human brain and skin cells. J Virol. 1990 Jan;64(1):215–221. [PMC free article] [PubMed]
  • Chesebro B, Nishio J, Perryman S, Cann A, O'Brien W, Chen IS, Wehrly K. Identification of human immunodeficiency virus envelope gene sequences influencing viral entry into CD4-positive HeLa cells, T-leukemia cells, and macrophages. J Virol. 1991 Nov;65(11):5782–5789. [PMC free article] [PubMed]
  • Cheingsong-Popov R, Callow D, Beddows S, Shaunak S, Wasi C, Kaleebu P, Gilks C, Petrascu IV, Garaev MM, Watts DM, et al. Geographic diversity of human immunodeficiency virus type 1: serologic reactivity to env epitopes and relationship to neutralization. J Infect Dis. 1992 Feb;165(2):256–261. [PubMed]
  • Chiodi F, Fuerstenberg S, Gidlund M, Asjö B, Fenyö EM. Infection of brain-derived cells with the human immunodeficiency virus. J Virol. 1987 Apr;61(4):1244–1247. [PMC free article] [PubMed]
  • Chirmule N, Oyaizu N, Kalyanaraman VS, Pahwa S. Inhibition of normal B-cell function by human immunodeficiency virus envelope glycoprotein, gp120. Blood. 1992 Mar 1;79(5):1245–1254. [PubMed]
  • Chiu IM, Yaniv A, Dahlberg JE, Gazit A, Skuntz SF, Tronick SR, Aaronson SA. Nucleotide sequence evidence for relationship of AIDS retrovirus to lentiviruses. Nature. 317(6035):366–368. [PubMed]
  • Cianciolo GJ, Copeland TD, Oroszlan S, Snyderman R. Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins. Science. 1985 Oct 25;230(4724):453–455. [PubMed]
  • Cichutek K, Merget H, Norley S, Linde R, Kreuz W, Gahr M, Kurth R. Development of a quasispecies of human immunodeficiency virus type 1 in vivo. Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7365–7369. [PMC free article] [PubMed]
  • Cichutek K, Norley S, Linde R, Kreuz W, Gahr M, Löwer J, von Wangenheim G, Kurth R. Lack of HIV-1 V3 region sequence diversity in two haemophiliac patients infected with a putative biologic clone of HIV-1. AIDS. 1991 Oct;5(10):1185–1187. [PubMed]
  • Clapham PR, Blanc D, Weiss RA. Specific cell surface requirements for the infection of CD4-positive cells by human immunodeficiency virus types 1 and 2 and by Simian immunodeficiency virus. Virology. 1991 Apr;181(2):703–715. [PubMed]
  • Clapham PR, McKnight A, Weiss RA. Human immunodeficiency virus type 2 infection and fusion of CD4-negative human cell lines: induction and enhancement by soluble CD4. J Virol. 1992 Jun;66(6):3531–3537. [PMC free article] [PubMed]
  • Clapham PR, Weber JN, Whitby D, McIntosh K, Dalgleish AG, Maddon PJ, Deen KC, Sweet RW, Weiss RA. Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells. Nature. 1989 Jan 26;337(6205):368–370. [PubMed]
  • Clark SJ, Saag MS, Decker WD, Campbell-Hill S, Roberson JL, Veldkamp PJ, Kappes JC, Hahn BH, Shaw GM. High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. N Engl J Med. 1991 Apr 4;324(14):954–960. [PubMed]
  • Clavel F, Guétard D, Brun-Vézinet F, Chamaret S, Rey MA, Santos-Ferreira MO, Laurent AG, Dauguet C, Katlama C, Rouzioux C, et al. Isolation of a new human retrovirus from West African patients with AIDS. Science. 1986 Jul 18;233(4761):343–346. [PubMed]
  • Clavel F, Mansinho K, Chamaret S, Guetard D, Favier V, Nina J, Santos-Ferreira MO, Champalimaud JL, Montagnier L. Human immunodeficiency virus type 2 infection associated with AIDS in West Africa. N Engl J Med. 1987 May 7;316(19):1180–1185. [PubMed]
  • Clayton LK, Hussey RE, Steinbrich R, Ramachandran H, Husain Y, Reinherz EL. Substitution of murine for human CD4 residues identifies amino acids critical for HIV-gp120 binding. Nature. 1988 Sep 22;335(6188):363–366. [PubMed]
  • Clements GJ, Price-Jones MJ, Stephens PE, Sutton C, Schulz TF, Clapham PR, McKeating JA, McClure MO, Thomson S, Marsh M, et al. The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion? AIDS Res Hum Retroviruses. 1991 Jan;7(1):3–16. [PubMed]
  • Clerici M, Giorgi JV, Chou CC, Gudeman VK, Zack JA, Gupta P, Ho HN, Nishanian PG, Berzofsky JA, Shearer GM. Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1. J Infect Dis. 1992 Jun;165(6):1012–1019. [PubMed]
  • Clerici M, Lucey DR, Zajac RA, Boswell RN, Gebel HM, Takahashi H, Berzofsky JA, Shearer GM. Detection of cytotoxic T lymphocytes specific for synthetic peptides of gp160 in HIV-seropositive individuals. J Immunol. 1991 Apr 1;146(7):2214–2219. [PubMed]
  • Clerici M, Roilides E, Via CS, Pizzo PA, Shearer GM. A factor from CD8 cells of human immunodeficiency virus-infected patients suppresses HLA self-restricted T helper cell responses. Proc Natl Acad Sci U S A. 1992 Sep 15;89(18):8424–8428. [PMC free article] [PubMed]
  • Cloyd MW, Lynn WS. Perturbation of host-cell membrane is a primary mechanism of HIV cytopathology. Virology. 1991 Apr;181(2):500–511. [PubMed]
  • Cloyd MW, Moore BE. Spectrum of biological properties of human immunodeficiency virus (HIV-1) isolates. Virology. 1990 Jan;174(1):103–116. [PubMed]
  • Coffin J, Haase A, Levy JA, Montagnier L, Oroszlan S, Teich N, Temin H, Toyoshima K, Varmus H, Vogt P, et al. Human immunodeficiency viruses. Science. 1986 May 9;232(4751):697–697. [PubMed]
  • Coffin JM. Superantigens and endogenous retroviruses: a confluence of puzzles. Science. 1992 Jan 24;255(5043):411–413. [PubMed]
  • Cohen AH, Sun NC, Shapshak P, Imagawa DT. Demonstration of human immunodeficiency virus in renal epithelium in HIV-associated nephropathy. Mod Pathol. 1989 Mar;2(2):125–128. [PubMed]
  • Cohen DI, Tani Y, Tian H, Boone E, Samelson LE, Lane HC. Participation of tyrosine phosphorylation in the cytopathic effect of human immunodeficiency virus-1. Science. 1992 Apr 24;256(5056):542–545. [PubMed]
  • Cohen JH, Geffriaud C, Caudwell V, Kazatchkine MD. Genetic analysis of CR1 (the C3b complement receptor, CD35) expression on erythrocytes of HIV-infected individuals. AIDS. 1989 Jun;3(6):397–399. [PubMed]
  • Cohen JJ, Duke RC, Fadok VA, Sellins KS. Apoptosis and programmed cell death in immunity. Annu Rev Immunol. 1992;10:267–293. [PubMed]
  • Collier AC, Bozzette S, Coombs RW, Causey DM, Schoenfeld DA, Spector SA, Pettinelli CB, Davies G, Richman DD, Leedom JM, et al. A pilot study of low-dose zidovudine in human immunodeficiency virus infection. N Engl J Med. 1990 Oct 11;323(15):1015–1021. [PubMed]
  • Collman R, Godfrey B, Cutilli J, Rhodes A, Hassan NF, Sweet R, Douglas SD, Friedman H, Nathanson N, Gonzalez-Scarano F. Macrophage-tropic strains of human immunodeficiency virus type 1 utilize the CD4 receptor. J Virol. 1990 Sep;64(9):4468–4476. [PMC free article] [PubMed]
  • Conant M, Hardy D, Sernatinger J, Spicer D, Levy JA. Condoms prevent transmission of AIDS-associated retrovirus. JAMA. 1986 Apr 4;255(13):1706–1706. [PubMed]
  • Coombs RW, Collier AC, Allain JP, Nikora B, Leuther M, Gjerset GF, Corey L. Plasma viremia in human immunodeficiency virus infection. N Engl J Med. 1989 Dec 14;321(24):1626–1631. [PubMed]
  • Cooney EL, Collier AC, Greenberg PD, Coombs RW, Zarling J, Arditti DE, Hoffman MC, Hu SL, Corey L. Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein. Lancet. 1991 Mar 9;337(8741):567–572. [PubMed]
  • Cooper DA, Gold J, Maclean P, Donovan B, Finlayson R, Barnes TG, Michelmore HM, Brooke P, Penny R. Acute AIDS retrovirus infection. Definition of a clinical illness associated with seroconversion. Lancet. 1985 Mar 9;1(8428):537–540. [PubMed]
  • Corbeau P, Benkirane M, Weil R, David C, Emiliani S, Olive D, Mawas C, Serre A, Devaux C. Ig CDR3-like region of the CD4 molecule is involved in HIV-induced syncytia formation but not in viral entry. J Immunol. 1993 Jan 1;150(1):290–301. [PubMed]
  • Corboy JR, Buzy JM, Zink MC, Clements JE. Expression directed from HIV long terminal repeats in the central nervous system of transgenic mice. Science. 1992 Dec 11;258(5089):1804–1808. [PubMed]
  • Cordonnier A, Montagnier L, Emerman M. Single amino-acid changes in HIV envelope affect viral tropism and receptor binding. Nature. 1989 Aug 17;340(6234):571–574. [PubMed]
  • Cordonnier A, Rivière Y, Montagnier L, Emerman M. Effects of mutations in hyperconserved regions of the extracellular glycoprotein of human immunodeficiency virus type 1 on receptor binding. J Virol. 1989 Oct;63(10):4464–4468. [PMC free article] [PubMed]
  • Courgnaud V, Lauré F, Brossard A, Bignozzi C, Goudeau A, Barin F, Bréchot C. Frequent and early in utero HIV-1 infection. AIDS Res Hum Retroviruses. 1991 Mar;7(3):337–341. [PubMed]
  • Cowan MJ, Walker C, Culver K, Weintrub PS, Wara DW, Levy JA. Maternally transmitted HIV infection in children. AIDS. 1988 Dec;2(6):437–441. [PubMed]
  • Crise B, Buonocore L, Rose JK. CD4 is retained in the endoplasmic reticulum by the human immunodeficiency virus type 1 glycoprotein precursor. J Virol. 1990 Nov;64(11):5585–5593. [PMC free article] [PubMed]
  • Crise B, Rose JK. Human immunodeficiency virus type 1 glycoprotein precursor retains a CD4-p56lck complex in the endoplasmic reticulum. J Virol. 1992 Apr;66(4):2296–2301. [PMC free article] [PubMed]
  • Crowe S, Mills J, McGrath MS. Quantitative immunocytofluorographic analysis of CD4 surface antigen expression and HIV infection of human peripheral blood monocyte/macrophages. AIDS Res Hum Retroviruses. 1987 Summer;3(2):135–145. [PubMed]
  • Crumpacker CS., 2nd Molecular targets of antiviral therapy. N Engl J Med. 1989 Jul 20;321(3):163–172. [PubMed]
  • Cullen BR, Greene WC. Functions of the auxiliary gene products of the human immunodeficiency virus type 1. Virology. 1990 Sep;178(1):1–5. [PubMed]
  • Curtis BM, Scharnowske S, Watson AJ. Sequence and expression of a membrane-associated C-type lectin that exhibits CD4-independent binding of human immunodeficiency virus envelope glycoprotein gp120. Proc Natl Acad Sci U S A. 1992 Sep 1;89(17):8356–8360. [PMC free article] [PubMed]
  • Cvetkovich TA, Lazar E, Blumberg BM, Saito Y, Eskin TA, Reichman R, Baram DA, del Cerro C, Gendelman HE, del Cerro M, et al. Human immunodeficiency virus type 1 infection of neural xenografts. Proc Natl Acad Sci U S A. 1992 Jun 1;89(11):5162–5166. [PMC free article] [PubMed]
  • Daar ES, Li XL, Moudgil T, Ho DD. High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates. Proc Natl Acad Sci U S A. 1990 Sep;87(17):6574–6578. [PMC free article] [PubMed]
  • Daar ES, Moudgil T, Meyer RD, Ho DD. Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. N Engl J Med. 1991 Apr 4;324(14):961–964. [PubMed]
  • Dahl K, Martin K, Miller G. Differences among human immunodeficiency virus strains in their capacities to induce cytolysis or persistent infection of a lymphoblastoid cell line immortalized by Epstein-Barr virus. J Virol. 1987 May;61(5):1602–1608. [PMC free article] [PubMed]
  • Dahl KE, Burrage T, Jones F, Miller G. Persistent nonproductive infection of Epstein-Barr virus-transformed human B lymphocytes by human immunodeficiency virus type 1. J Virol. 1990 Apr;64(4):1771–1783. [PMC free article] [PubMed]
  • Dai LC, West K, Littaua R, Takahashi K, Ennis FA. Mutation of human immunodeficiency virus type 1 at amino acid 585 on gp41 results in loss of killing by CD8+ A24-restricted cytotoxic T lymphocytes. J Virol. 1992 May;66(5):3151–3154. [PMC free article] [PubMed]
  • Dalgleish AG, Beverley PC, Clapham PR, Crawford DH, Greaves MF, Weiss RA. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature. 1984 Dec 20;312(5996):763–767. [PubMed]
  • Dalgleish AG, Chanh TC, Kennedy RC, Kanda P, Clapham PR, Weiss RA. Neutralization of diverse HIV-1 strains by monoclonal antibodies raised against a gp41 synthetic peptide. Virology. 1988 Jul;165(1):209–215. [PubMed]
  • Dalgleish AG, Thomson BJ, Chanh TC, Malkovsky M, Kennedy RC. Neutralisation of HIV isolates by anti-idiotypic antibodies which mimic the T4 (CD4) epitope: a potential AIDS vaccine. Lancet. 1987 Nov 7;2(8567):1047–1050. [PubMed]
  • Dalgleish AG, Wilson S, Gompels M, Ludlam C, Gazzard B, Coates AM, Habeshaw J. T-cell receptor variable gene products and early HIV-1 infection. Lancet. 1992 Apr 4;339(8797):824–828. [PubMed]
  • Daniel MD, Kirchhoff F, Czajak SC, Sehgal PK, Desrosiers RC. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science. 1992 Dec 18;258(5090):1938–1941. [PubMed]
  • Daniel MD, Letvin NL, King NW, Kannagi M, Sehgal PK, Hunt RD, Kanki PJ, Essex M, Desrosiers RC. Isolation of T-cell tropic HTLV-III-like retrovirus from macaques. Science. 1985 Jun 7;228(4704):1201–1204. [PubMed]
  • da Silva M, Shevchuk MM, Cronin WJ, Armenakas NA, Tannenbaum M, Fracchia JA, Ioachim HL. Detection of HIV-related protein in testes and prostates of patients with AIDS. Am J Clin Pathol. 1990 Feb;93(2):196–201. [PubMed]
  • Davis BR, Schwartz DH, Marx JC, Johnson CE, Berry JM, Lyding J, Merigan TC, Zander A. Absent or rare human immunodeficiency virus infection of bone marrow stem/progenitor cells in vivo. J Virol. 1991 Apr;65(4):1985–1990. [PMC free article] [PubMed]
  • Davis D, Stephens DM, Willers C, Lachmann PJ. Glycosylation governs the binding of antipeptide antibodies to regions of hypervariable amino acid sequence within recombinant gp120 of human immunodeficiency virus type 1. J Gen Virol. 1990 Dec;71(Pt 12):2889–2898. [PubMed]
  • Davis MG, Kenney SC, Kamine J, Pagano JS, Huang ES. Immediate-early gene region of human cytomegalovirus trans-activates the promoter of human immunodeficiency virus. Proc Natl Acad Sci U S A. 1987 Dec;84(23):8642–8646. [PMC free article] [PubMed]
  • Dayton AI, Sodroski JG, Rosen CA, Goh WC, Haseltine WA. The trans-activator gene of the human T cell lymphotropic virus type III is required for replication. Cell. 1986 Mar 28;44(6):941–947. [PubMed]
  • Dean NC, Golden JA, Evans LA, Warnock ML, Addison TE, Hopewell PC, Levy JA. Human immunodeficiency virus recovery from bronchoalveolar lavage fluid in patients with AIDS. Chest. 1988 Jun;93(6):1176–1179. [PubMed]
  • De Clercq E. New acquisitions in the development of anti-HIV agents. Antiviral Res. 1989 Aug;12(1):1–19. [PubMed]
  • De Clercq E. Basic approaches to anti-retroviral treatment. J Acquir Immune Defic Syndr. 1991;4(3):207–218. [PubMed]
  • Dedieu JF, Ronco J, van der Werf S, Hogle JM, Henin Y, Girard M. Poliovirus chimeras expressing sequences from the principal neutralization domain of human immunodeficiency virus type 1. J Virol. 1992 May;66(5):3161–3167. [PMC free article] [PubMed]
  • De Jong JJ, De Ronde A, Keulen W, Tersmette M, Goudsmit J. Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution. J Virol. 1992 Nov;66(11):6777–6780. [PMC free article] [PubMed]
  • de Jong JJ, Goudsmit J, Keulen W, Klaver B, Krone W, Tersmette M, de Ronde A. Human immunodeficiency virus type 1 clones chimeric for the envelope V3 domain differ in syncytium formation and replication capacity. J Virol. 1992 Feb;66(2):757–765. [PMC free article] [PubMed]
  • de la Monte SM, Gabuzda DH, Ho DD, Brown RH, Jr, Hedley-Whyte ET, Schooley RT, Hirsch MS, Bhan AK. Peripheral neuropathy in the acquired immunodeficiency syndrome. Ann Neurol. 1988 May;23(5):485–492. [PubMed]
  • Delassus S, Cheynier R, Wain-Hobson S. Evolution of human immunodeficiency virus type 1 nef and long terminal repeat sequences over 4 years in vivo and in vitro. J Virol. 1991 Jan;65(1):225–231. [PMC free article] [PubMed]
  • De Maria A, Pantaleo G, Schnittman SM, Greenhouse JJ, Baseler M, Orenstein JM, Fauci AS. Infection of CD8+ T lymphocytes with HIV. Requirement for interaction with infected CD4+ cells and induction of infectious virus from chronically infected CD8+ cells. J Immunol. 1991 Apr 1;146(7):2220–2226. [PubMed]
  • de Ronde A, Klaver B, Keulen W, Smit L, Goudsmit J. Natural HIV-1 NEF accelerates virus replication in primary human lymphocytes. Virology. 1992 May;188(1):391–395. [PubMed]
  • De Rossi A, Franchini G, Aldovini A, Del Mistro A, Chieco-Bianchi L, Gallo RC, Wong-Staal F. Differential response to the cytopathic effects of human T-cell lymphotropic virus type III (HTLV-III) superinfection in T4+ (helper) and T8+ (suppressor) T-cell clones transformed by HTLV-I. Proc Natl Acad Sci U S A. 1986 Jun;83(12):4297–4301. [PMC free article] [PubMed]
  • De Rossi A, Ometto L, Mammano F, Zanotto C, Giaquinto C, Chieco-Bianchi L. Vertical transmission of HIV-1: lack of detectable virus in peripheral blood cells of infected children at birth. AIDS. 1992 Oct;6(10):1117–1120. [PubMed]
  • Desai K, Loewenstein PM, Green M. Isolation of a cellular protein that binds to the human immunodeficiency virus Tat protein and can potentiate transactivation of the viral promoter. Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):8875–8879. [PMC free article] [PubMed]
  • Desrosiers RC, Wyand MS, Kodama T, Ringler DJ, Arthur LO, Sehgal PK, Letvin NL, King NW, Daniel MD. Vaccine protection against simian immunodeficiency virus infection. Proc Natl Acad Sci U S A. 1989 Aug;86(16):6353–6357. [PMC free article] [PubMed]
  • Dewhurst S, Sakai K, Bresser J, Stevenson M, Evinger-Hodges MJ, Volsky DJ. Persistent productive infection of human glial cells by human immunodeficiency virus (HIV) and by infectious molecular clones of HIV. J Virol. 1987 Dec;61(12):3774–3782. [PMC free article] [PubMed]
  • de Wolf F, Meloen RH, Bakker M, Barin F, Goudsmit J. Characterization of human antibody-binding sites on the external envelope of human immunodeficiency virus type 2. J Gen Virol. 1991 Jun;72(Pt 6):1261–1267. [PubMed]
  • de Wolf F, Lange JM, Houweling JT, Coutinho RA, Schellekens PT, van der Noordaa J, Goudsmit J. Numbers of CD4+ cells and the levels of core antigens of and antibodies to the human immunodeficiency virus as predictors of AIDS among seropositive homosexual men. J Infect Dis. 1988 Sep;158(3):615–622. [PubMed]
  • Diamond DC, Sleckman BP, Gregory T, Lasky LA, Greenstein JL, Burakoff SJ. Inhibition of CD4+ T cell function by the HIV envelope protein, gp120. J Immunol. 1988 Dec 1;141(11):3715–3717. [PubMed]
  • Dimitrov DS, Willey RL, Martin MA, Blumenthal R. Kinetics of HIV-1 interactions with sCD4 and CD4+ cells: implications for inhibition of virus infection and initial steps of virus entry into cells. Virology. 1992 Apr;187(2):398–406. [PubMed]
  • Dimmock NJ. Review article initial stages in infection with animal viruses. J Gen Virol. 1982 Mar;59(Pt 1):1–22. [PubMed]
  • Doherty PC, Knowles BB, Wettstein PJ. Immunological surveillance of tumors in the context of major histocompatibility complex restriction of T cell function. Adv Cancer Res. 1984;42:1–65. [PubMed]
  • Dolei A, Serra C, Arca MV, Toniolo A. Acute HIV-1 infection of CD4+ human lung fibroblasts. AIDS. 1992 Feb;6(2):232–234. [PubMed]
  • Dolin R, Graham BS, Greenberg SB, Tacket CO, Belshe RB, Midthun K, Clements ML, Gorse GJ, Horgan BW, Atmar RL, et al. The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans. NIAID AIDS Vaccine Clinical Trials Network. Ann Intern Med. 1991 Jan 15;114(2):119–127. [PubMed]
  • Donahue RE, Johnson MM, Zon LI, Clark SC, Groopman JE. Suppression of in vitro haematopoiesis following human immunodeficiency virus infection. Nature. 1987 Mar 12;326(6109):200–203. [PubMed]
  • Dorsett BH, Cronin W, Ioachim HL. Presence and prognostic significance of antilymphocyte antibodies in symptomatic and asymptomatic human immunodeficiency virus infection. Arch Intern Med. 1990 May;150(5):1025–1028. [PubMed]
  • Douglas GC, Fry GN, Thirkill T, Holmes E, Hakim H, Jennings M, King BF. Cell-mediated infection of human placental trophoblast with HIV in vitro. AIDS Res Hum Retroviruses. 1991 Sep;7(9):735–740. [PubMed]
  • Dournon E, Matheron S, Rozenbaum W, Gharakhanian S, Michon C, Girard PM, Perronne C, Salmon D, De Truchis P, Leport C, et al. Effects of zidovudine in 365 consecutive patients with AIDS or AIDS-related complex. Lancet. 1988 Dec 3;2(8623):1297–1302. [PubMed]
  • Dragic T, Charneau P, Clavel F, Alizon M. Complementation of murine cells for human immunodeficiency virus envelope/CD4-mediated fusion in human/murine heterokaryons. J Virol. 1992 Aug;66(8):4794–4802. [PMC free article] [PubMed]
  • Dreesman GR, Kennedy RC. Anti-idiotypic antibodies: implications of internal image-based vaccines for infectious diseases. J Infect Dis. 1985 May;151(5):761–765. [PubMed]
  • Dreyer EB, Kaiser PK, Offermann JT, Lipton SA. HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science. 1990 Apr 20;248(4953):364–367. [PubMed]
  • Dreyer GB, Metcalf BW, Tomaszek TA, Jr, Carr TJ, Chandler AC, 3rd, Hyland L, Fakhoury SA, Magaard VW, Moore ML, Strickler JE, et al. Inhibition of human immunodeficiency virus 1 protease in vitro: rational design of substrate analogue inhibitors. Proc Natl Acad Sci U S A. 1989 Dec;86(24):9752–9756. [PMC free article] [PubMed]
  • Drysdale CM, Pavlakis GN. Rapid activation and subsequent down-regulation of the human immunodeficiency virus type 1 promoter in the presence of Tat: possible mechanisms contributing to latency. J Virol. 1991 Jun;65(6):3044–3051. [PMC free article] [PubMed]
  • D'Souza MP, Durda P, Hanson CV, Milman G. Evaluation of monoclonal antibodies to HIV-1 by neutralization and serological assays: an international collaboration. Collaborating Investigators. AIDS. 1991 Sep;5(9):1061–1070. [PubMed]
  • Duh EJ, Maury WJ, Folks TM, Fauci AS, Rabson AB. Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. Proc Natl Acad Sci U S A. 1989 Aug;86(15):5974–5978. [PMC free article] [PubMed]
  • Duke RC, Cohen JJ. IL-2 addiction: withdrawal of growth factor activates a suicide program in dependent T cells. Lymphokine Res. 1986 Fall;5(4):289–299. [PubMed]
  • Earl PL, Doms RW, Moss B. Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein. Proc Natl Acad Sci U S A. 1990 Jan;87(2):648–652. [PMC free article] [PubMed]
  • Earl PL, Doms RW, Moss B. Multimeric CD4 binding exhibited by human and simian immunodeficiency virus envelope protein dimers. J Virol. 1992 Sep;66(9):5610–5614. [PMC free article] [PubMed]
  • Edwards JR, Ulrich PP, Weintrub PS, Cowan MJ, Levy JA, Wara DW, Vyas GN. Polymerase chain reaction compared with concurrent viral cultures for rapid identification of human immunodeficiency virus infection among high-risk infants and children. J Pediatr. 1989 Aug;115(2):200–203. [PubMed]
  • Ehrnst A, Lindgren S, Dictor M, Johansson B, Sönnerborg A, Czajkowski J, Sundin G, Bohlin AB. HIV in pregnant women and their offspring: evidence for late transmission. Lancet. 1991 Jul 27;338(8761):203–207. [PubMed]
  • Ehrnst A, Sönnerborg A, Bergdahl S, Strannegård O. Efficient isolation of HIV from plasma during different stages of HIV infection. J Med Virol. 1988 Sep;26(1):23–32. [PubMed]
  • Emau P, McClure HM, Isahakia M, Else JG, Fultz PN. Isolation from African Sykes' monkeys (Cercopithecus mitis) of a lentivirus related to human and simian immunodeficiency viruses. J Virol. 1991 Apr;65(4):2135–2140. [PMC free article] [PubMed]
  • Embretson J, Zupancic M, Beneke J, Till M, Wolinsky S, Ribas JL, Burke A, Haase AT. Analysis of human immunodeficiency virus-infected tissues by amplification and in situ hybridization reveals latent and permissive infections at single-cell resolution. Proc Natl Acad Sci U S A. 1993 Jan 1;90(1):357–361. [PMC free article] [PubMed]
  • Emini EA, Schleif WA, Nunberg JH, Conley AJ, Eda Y, Tokiyoshi S, Putney SD, Matsushita S, Cobb KE, Jett CM, et al. Prevention of HIV-1 infection in chimpanzees by gp120 V3 domain-specific monoclonal antibody. Nature. 1992 Feb 20;355(6362):728–730. [PubMed]
  • Epstein LG, Kuiken C, Blumberg BM, Hartman S, Sharer LR, Clement M, Goudsmit J. HIV-1 V3 domain variation in brain and spleen of children with AIDS: tissue-specific evolution within host-determined quasispecies. Virology. 1991 Feb;180(2):583–590. [PubMed]
  • Escaich S, Ritter J, Rougier P, Lepot D, Lamelin JP, Sepetjan M, Trepo C. Plasma viraemia as a marker of viral replication in HIV-infected individuals. AIDS. 1991 Oct;5(10):1189–1194. [PubMed]
  • Espinoza LR, Aguilar JL, Espinoza CG, Berman A, Gutierrez F, Vasey FB, Germain BF. HIV associated arthropathy: HIV antigen demonstration in the synovial membrane. J Rheumatol. 1990 Sep;17(9):1195–1201. [PubMed]
  • Evans DJ, McKeating J, Meredith JM, Burke KL, Katrak K, John A, Ferguson M, Minor PD, Weiss RA, Almond JW. An engineered poliovirus chimaera elicits broadly reactive HIV-1 neutralizing antibodies. Nature. 1989 Jun 1;339(6223):385–340. [PubMed]
  • Evans LA, Levy JA. Characteristics of HIV infection and pathogenesis. Biochim Biophys Acta. 1989 Dec 27;989(3):237–254. [PubMed]
  • Evans LA, McHugh TM, Stites DP, Levy JA. Differential ability of human immunodeficiency virus isolates to productively infect human cells. J Immunol. 1987 May 15;138(10):3415–3418. [PubMed]
  • Evans LA, Moreau J, Odehouri K, Legg H, Barboza A, Cheng-Mayer C, Levy JA. Characterization of a noncytopathic HIV-2 strain with unusual effects on CD4 expression. Science. 1988 Jun 10;240(4858):1522–1525. [PubMed]
  • Evans LA, Moreau J, Odehouri K, Seto D, Thomson-Honnebier G, Legg H, Barboza A, Cheng-Mayer C, Levy JA. Simultaneous isolation of HIV-1 and HIV-2 from an AIDS patient. Lancet. 1988 Dec 17;2(8625):1389–1391. [PubMed]
  • Evatt BL, Ramsey RB, Lawrence DN, Zyla LD, Curran JW. The acquired immunodeficiency syndrome in patients with hemophilia. Ann Intern Med. 1984 Apr;100(4):499–504. [PubMed]
  • Everall IP, Luthert PJ, Lantos PL. Neuronal loss in the frontal cortex in HIV infection. Lancet. 1991 May 11;337(8750):1119–1121. [PubMed]
  • Eyster ME, Gail MH, Ballard JO, Al-Mondhiry H, Goedert JJ. Natural history of human immunodeficiency virus infections in hemophiliacs: effects of T-cell subsets, platelet counts, and age. Ann Intern Med. 1987 Jul;107(1):1–6. [PubMed]
  • Ezekowitz RA, Kuhlman M, Groopman JE, Byrn RA. A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus. J Exp Med. 1989 Jan 1;169(1):185–196. [PMC free article] [PubMed]
  • Fahey JL, Taylor JM, Detels R, Hofmann B, Melmed R, Nishanian P, Giorgi JV. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N Engl J Med. 1990 Jan 18;322(3):166–172. [PubMed]
  • Falk LA, Jr, Paul D, Landay A, Kessler H. HIV isolation from plasma of HIV-infected persons. N Engl J Med. 1987 Jun 11;316(24):1547–1548. [PubMed]
  • Fantini J, Yahi N, Baghdiguian S, Chermann JC. Human colon epithelial cells productively infected with human immunodeficiency virus show impaired differentiation and altered secretion. J Virol. 1992 Jan;66(1):580–585. [PMC free article] [PubMed]
  • Fantini J, Yahi N, Chermann JC. Human immunodeficiency virus can infect the apical and basolateral surfaces of human colonic epithelial cells. Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):9297–9301. [PMC free article] [PubMed]
  • Farzadegan H, Polis MA, Wolinsky SM, Rinaldo CR, Jr, Sninsky JJ, Kwok S, Griffith RL, Kaslow RA, Phair JP, Polk BF, et al. Loss of human immunodeficiency virus type 1 (HIV-1) antibodies with evidence of viral infection in asymptomatic homosexual men. A report from the Multicenter AIDS Cohort Study. Ann Intern Med. 1988 Jun;108(6):785–790. [PubMed]
  • Feinberg MB, Jarrett RF, Aldovini A, Gallo RC, Wong-Staal F. HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA. Cell. 1986 Sep 12;46(6):807–817. [PubMed]
  • Feinberg MB, Trono D. Intracellular immunization: trans-dominant mutants of HIV gene products as tools for the study and interruption of viral replication. AIDS Res Hum Retroviruses. 1992 Jun;8(6):1013–1022. [PubMed]
  • Feizi T, Larkin M. AIDS and glycosylation. Glycobiology. 1990 Sep;1(1):17–23. [PubMed]
  • Fenyö EM, Morfeldt-Månson L, Chiodi F, Lind B, von Gegerfelt A, Albert J, Olausson E, Asjö B. Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates. J Virol. 1988 Nov;62(11):4414–4419. [PMC free article] [PubMed]
  • Fermin CD, Garry RF. Membrane alterations linked to early interactions of HIV with the cell surface. Virology. 1992 Dec;191(2):941–946. [PubMed]
  • Fernandez-Larsson R, Srivastava KK, Lu S, Robinson HL. Replication of patient isolates of human immunodeficiency virus type 1 in T cells: a spectrum of rates and efficiencies of entry. Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2223–2226. [PMC free article] [PubMed]
  • Fields AP, Bednarik DP, Hess A, May WS. Human immunodeficiency virus induces phosphorylation of its cell surface receptor. Nature. 1988 May 19;333(6170):278–280. [PubMed]
  • Fischl MA, Richman DD, Grieco MH, Gottlieb MS, Volberding PA, Laskin OL, Leedom JM, Groopman JE, Mildvan D, Schooley RT, et al. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med. 1987 Jul 23;317(4):185–191. [PubMed]
  • Fisher AG, Ratner L, Mitsuya H, Marselle LM, Harper ME, Broder S, Gallo RC, Wong-Staal F. Infectious mutants of HTLV-III with changes in the 3' region and markedly reduced cytopathic effects. Science. 1986 Aug 8;233(4764):655–659. [PubMed]
  • Fleming SC, Kapembwa MS, MacDonald TT, Griffin GE. Direct in vitro infection of human intestine with HIV-1. AIDS. 1992 Oct;6(10):1099–1104. [PubMed]
  • Fleury S, Lamarre D, Meloche S, Ryu SE, Cantin C, Hendrickson WA, Sekaly RP. Mutational analysis of the interaction between CD4 and class II MHC: class II antigens contact CD4 on a surface opposite the gp120-binding site. Cell. 1991 Sep 6;66(5):1037–1049. [PubMed]
  • Folks T, Powell DM, Lightfoote MM, Benn S, Martin MA, Fauci AS. Induction of HTLV-III/LAV from a nonvirus-producing T-cell line: implications for latency. Science. 1986 Feb 7;231(4738):600–602. [PubMed]
  • Bednarik DP, Folks TM. Mechanisms of HIV-1 latency. AIDS. 1992 Jan;6(1):3–16. [PubMed]
  • Folks TM, Clouse KA, Justement J, Rabson A, Duh E, Kehrl JH, Fauci AS. Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proc Natl Acad Sci U S A. 1989 Apr;86(7):2365–2368. [PMC free article] [PubMed]
  • Folks TM, Justement J, Kinter A, Dinarello CA, Fauci AS. Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. Science. 1987 Nov 6;238(4828):800–802. [PubMed]
  • Folks TM, Kessler SW, Orenstein JM, Justement JS, Jaffe ES, Fauci AS. Infection and replication of HIV-1 in purified progenitor cells of normal human bone marrow. Science. 1988 Nov 11;242(4880):919–922. [PubMed]
  • Folks TM, Powell D, Lightfoote M, Koenig S, Fauci AS, Benn S, Rabson A, Daugherty D, Gendelman HE, Hoggan MD, et al. Biological and biochemical characterization of a cloned Leu-3- cell surviving infection with the acquired immune deficiency syndrome retrovirus. J Exp Med. 1986 Jul 1;164(1):280–290. [PMC free article] [PubMed]
  • Fomsgaard A, Hirsch VM, Allan JS, Johnson PR. A highly divergent proviral DNA clone of SIV from a distinct species of African green monkey. Virology. 1991 May;182(1):397–402. [PubMed]
  • Fontana A, Fierz W, Wekerle H. Astrocytes present myelin basic protein to encephalitogenic T-cell lines. Nature. 1984 Jan 19;307(5948):273–276. [PubMed]
  • Fontana L, Sirianni MC, de Sanctis G, Carbonari M, Ensoli B, Aiuti F. Deficiency of natural killer activity, but not of natural killer binding, in patients with lymphoadenopathy syndrome positive for antibodies to HTLV-III. Immunobiology. 1986 Jul;171(4-5):425–435. [PubMed]
  • Forrest BD. Women, HIV, and mucosal immunity. Lancet. 1991 Apr 6;337(8745):835–836. [PubMed]
  • Forster SM, Osborne LM, Cheingsong-Popov R, Kenny C, Burnell R, Jeffries DJ, Pinching AJ, Harris JR, Weber JN. Decline of anti-p24 antibody precedes antigenaemia as correlate of prognosis in HIV-1 infection. AIDS. 1987 Dec;1(4):235–240. [PubMed]
  • Fouchier RA, Groenink M, Kootstra NA, Tersmette M, Huisman HG, Miedema F, Schuitemaker H. Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. J Virol. 1992 May;66(5):3183–3187. [PMC free article] [PubMed]
  • Fox CH, Kotler D, Tierney A, Wilson CS, Fauci AS. Detection of HIV-1 RNA in the lamina propria of patients with AIDS and gastrointestinal disease. J Infect Dis. 1989 Mar;159(3):467–471. [PubMed]
  • Fox CH, Tenner-Rácz K, Rácz P, Firpo A, Pizzo PA, Fauci AS. Lymphoid germinal centers are reservoirs of human immunodeficiency virus type 1 RNA. J Infect Dis. 1991 Dec;164(6):1051–1057. [PubMed]
  • Franza BR, Jr, Josephs SF, Gilman MZ, Ryan W, Clarkson B. Characterization of cellular proteins recognizing the HIV enhancer using a microscale DNA-affinity precipitation assay. Nature. 330(6146):391–395. [PubMed]
  • Freed EO, Delwart EL, Buchschacher GL, Jr, Panganiban AT. A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity. Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):70–74. [PMC free article] [PubMed]
  • Freed EO, Myers DJ. Identification and characterization of fusion and processing domains of the human immunodeficiency virus type 2 envelope glycoprotein. J Virol. 1992 Sep;66(9):5472–5478. [PMC free article] [PubMed]
  • Freed EO, Myers DJ, Risser R. Identification of the principal neutralizing determinant of human immunodeficiency virus type 1 as a fusion domain. J Virol. 1991 Jan;65(1):190–194. [PMC free article] [PubMed]
  • Freedman AR, Gibson FM, Fleming SC, Spry CJ, Griffin GE. Human immunodeficiency virus infection of eosinophils in human bone marrow cultures. J Exp Med. 1991 Dec 1;174(6):1661–1664. [PMC free article] [PubMed]
  • Fujikawa LS, Salahuddin SZ, Palestine AG, Masur H, Nussenblatt RB, Gallo RC. Isolation of human T-lymphotropic virus type III from the tears of a patient with the acquired immunodeficiency syndrome. Lancet. 1985 Sep 7;2(8454):529–530. [PubMed]
  • Fujino T, Fujiyoshi T, Yashiki S, Sonoda S, Otsuka H, Nagata Y. HTLV-I transmission from mother to fetus via placenta. Lancet. 1992 Nov 7;340(8828):1157–1157. [PubMed]
  • Fultz PN, McClure HM, Daugharty H, Brodie A, McGrath CR, Swenson B, Francis DP. Vaginal transmission of human immunodeficiency virus (HIV) to a chimpanzee. J Infect Dis. 1986 Nov;154(5):896–900. [PubMed]
  • Fultz PN, Gluckman JC, Muchmore E, Girard M. Transient increases in numbers of infectious cells in an HIV-infected chimpanzee following immune stimulation. AIDS Res Hum Retroviruses. 1992 Feb;8(2):313–317. [PubMed]
  • Fultz PN, McClure HM, Anderson DC, Switzer WM. Identification and biologic characterization of an acutely lethal variant of simian immunodeficiency virus from sooty mangabeys (SIV/SMM). AIDS Res Hum Retroviruses. 1989 Aug;5(4):397–409. [PubMed]
  • Fultz PN, Nara P, Barre-Sinoussi F, Chaput A, Greenberg ML, Muchmore E, Kieny MP, Girard M. Vaccine protection of chimpanzees against challenge with HIV-1-infected peripheral blood mononuclear cells. Science. 1992 Jun 19;256(5064):1687–1690. [PubMed]
  • Fung MS, Sun CR, Gordon WL, Liou RS, Chang TW, Sun WN, Daar ES, Ho DD. Identification and characterization of a neutralization site within the second variable region of human immunodeficiency virus type 1 gp120. J Virol. 1992 Feb;66(2):848–856. [PMC free article] [PubMed]
  • Funke I, Hahn A, Rieber EP, Weiss E, Riethmüller G. The cellular receptor (CD4) of the human immunodeficiency virus is expressed on neurons and glial cells in human brain. J Exp Med. 1987 Apr 1;165(4):1230–1235. [PMC free article] [PubMed]
  • Gabuzda DH, Lever A, Terwilliger E, Sodroski J. Effects of deletions in the cytoplasmic domain on biological functions of human immunodeficiency virus type 1 envelope glycoproteins. J Virol. 1992 Jun;66(6):3306–3315. [PMC free article] [PubMed]
  • Gaines H, Albert J, von Sydow M, Sönnerborg A, Chiodi F, Ehrnst A, Strannegård O, Asjö B. HIV antigenaemia and virus isolation from plasma during primary HIV infection. Lancet. 1987 Jun 6;1(8545):1317–1318. [PubMed]
  • Gaines H, von Sydow M, Parry JV, Forsgren M, Pehrson PO, Sönnerborg A, Mortimer PP, Strannegård O. Detection of immunoglobulin M antibody in primary human immunodeficiency virus infection. AIDS. 1988 Feb;2(1):11–15. [PubMed]
  • Gaines H, von Sydow M, Sönnerborg A, Albert J, Czajkowski J, Pehrson PO, Chiodi F, Moberg L, Fenyö EM, Asjö B, et al. Antibody response in primary human immunodeficiency virus infection. Lancet. 1987 May 30;1(8544):1249–1253. [PubMed]
  • Gallaher WR. Detection of a fusion peptide sequence in the transmembrane protein of human immunodeficiency virus. Cell. 1987 Jul 31;50(3):327–328. [PubMed]
  • Gallo P, Frei K, Rordorf C, Lazdins J, Tavolato B, Fontana A. Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: an evaluation of cytokines in cerebrospinal fluid. J Neuroimmunol. 1989 Jul;23(2):109–116. [PubMed]
  • Gallo RC, Salahuddin SZ, Popovic M, Shearer GM, Kaplan M, Haynes BF, Palker TJ, Redfield R, Oleske J, Safai B, et al. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science. 1984 May 4;224(4648):500–503. [PubMed]
  • Gallo RC, Sarin PS, Gelmann EP, Robert-Guroff M, Richardson E, Kalyanaraman VS, Mann D, Sidhu GD, Stahl RE, Zolla-Pazner S, et al. Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS). Science. 1983 May 20;220(4599):865–867. [PubMed]
  • Gao F, Yue L, White AT, Pappas PG, Barchue J, Hanson AP, Greene BM, Sharp PM, Shaw GM, Hahn BH. Human infection by genetically diverse SIVSM-related HIV-2 in west Africa. Nature. 1992 Aug 6;358(6386):495–499. [PubMed]
  • Gao Q, Gu ZX, Parniak MA, Li XG, Wainberg MA. In vitro selection of variants of human immunodeficiency virus type 1 resistant to 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine. J Virol. 1992 Jan;66(1):12–19. [PMC free article] [PubMed]
  • Garcia JA, Wu FK, Mitsuyasu R, Gaynor RB. Interactions of cellular proteins involved in the transcriptional regulation of the human immunodeficiency virus. EMBO J. 1987 Dec 1;6(12):3761–3770. [PMC free article] [PubMed]
  • Garcia JV, Miller AD. Serine phosphorylation-independent downregulation of cell-surface CD4 by nef. Nature. 1991 Apr 11;350(6318):508–511. [PubMed]
  • Gardner MB, Luciw PA. Animal models of AIDS. FASEB J. 1989 Dec;3(14):2593–2606. [PubMed]
  • Garry RF. Potential mechanisms for the cytopathic properties of HIV. AIDS. 1989 Nov;3(11):683–694. [PubMed]
  • Garry RF. Extensive antigenic mimicry by retrovirus capsid proteins. AIDS Res Hum Retroviruses. 1990 Dec;6(12):1361–1362. [PubMed]
  • Garry RF, Koch G. Tat contains a sequence related to snake neurotoxins. AIDS. 1992 Dec;6(12):1541–1542. [PubMed]
  • Garry RF, Kort JJ, Koch-Nolte F, Koch G. Similarities of viral proteins to toxins that interact with monovalent cation channels. AIDS. 1991 Nov;5(11):1381–1384. [PubMed]
  • Gartner S, Markovits P, Markovitz DM, Betts RF, Popovic M. Virus isolation from and identification of HTLV-III/LAV-producing cells in brain tissue from a patient with AIDS. JAMA. 1986 Nov 7;256(17):2365–2371. [PubMed]
  • Gartner S, Markovits P, Markovitz DM, Kaplan MH, Gallo RC, Popovic M. The role of mononuclear phagocytes in HTLV-III/LAV infection. Science. 1986 Jul 11;233(4760):215–219. [PubMed]
  • Gattegno L, Ramdani A, Jouault T, Saffar L, Gluckman JC. Lectin-carbohydrate interactions and infectivity of human immunodeficiency virus type 1 (HIV-1). AIDS Res Hum Retroviruses. 1992 Jan;8(1):27–37. [PubMed]
  • Gaynor R. Cellular transcription factors involved in the regulation of HIV-1 gene expression. AIDS. 1992 Apr;6(4):347–363. [PubMed]
  • Gelderblom HR, Ozel M, Pauli G. Morphogenesis and morphology of HIV. Structure-function relations. Arch Virol. 1989;106(1-2):1–13. [PubMed]
  • Gendelman HE, Orenstein JM, Baca LM, Weiser B, Burger H, Kalter DC, Meltzer MS. The macrophage in the persistence and pathogenesis of HIV infection. AIDS. 1989 Aug;3(8):475–495. [PubMed]
  • Gendelman HE, Orenstein JM, Martin MA, Ferrua C, Mitra R, Phipps T, Wahl LA, Lane HC, Fauci AS, Burke DS, et al. Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J Exp Med. 1988 Apr 1;167(4):1428–1441. [PMC free article] [PubMed]
  • Gendelman HE, Phelps W, Feigenbaum L, Ostrove JM, Adachi A, Howley PM, Khoury G, Ginsberg HS, Martin MA. Trans-activation of the human immunodeficiency virus long terminal repeat sequence by DNA viruses. Proc Natl Acad Sci U S A. 1986 Dec;83(24):9759–9763. [PMC free article] [PubMed]
  • Genesca J, Wang RY, Alter HJ, Shih JW. Clinical correlation and genetic polymorphism of the human immunodeficiency virus proviral DNA obtained after polymerase chain reaction amplification. J Infect Dis. 1990 Nov;162(5):1025–1030. [PubMed]
  • Gentric A, Blaschek M, Julien C, Jouquan J, Pennec Y, Berthelot JM, Mottier D, Casburn-Budd R, Youinou P. Nonorgan-specific autoantibodies in individuals infected with type 1 human immunodeficiency virus. Clin Immunol Immunopathol. 1991 Jun;59(3):487–494. [PubMed]
  • George JR, Ou CY, Parekh B, Brattegaard K, Brown V, Boateng E, De Cock KM. Prevalence of HIV-1 and HIV-2 mixed infections in Côte d'Ivoire. Lancet. 1992 Aug 8;340(8815):337–339. [PubMed]
  • Gerschenson LE, Rotello RJ. Apoptosis: a different type of cell death. FASEB J. 1992 Apr;6(7):2450–2455. [PubMed]
  • Ghazal P, Young J, Giulietti E, DeMattei C, Garcia J, Gaynor R, Stenberg RM, Nelson JA. A discrete cis element in the human immunodeficiency virus long terminal repeat mediates synergistic trans activation by cytomegalovirus immediate-early proteins. J Virol. 1991 Dec;65(12):6735–6742. [PMC free article] [PubMed]
  • Gibbons J, Cory JM, Hewlett IK, Epstein JS, Eyster ME. Silent infections with human immunodeficiency virus type 1 are highly unlikely in multitransfused seronegative hemophiliacs. Blood. 1990 Nov 15;76(10):1924–1926. [PubMed]
  • Gilbert JM, Mason D, White JM. Fusion of Rous sarcoma virus with host cells does not require exposure to low pH. J Virol. 1990 Oct;64(10):5106–5113. [PMC free article] [PubMed]
  • Gilbert M, Kirihara J, Mills J. Enzyme-linked immunoassay for human immunodeficiency virus type 1 envelope glycoprotein 120. J Clin Microbiol. 1991 Jan;29(1):142–147. [PMC free article] [PubMed]
  • Gill MJ, Sutherland LR, Church DL. Gastrointestinal tissue cultures for HIV in HIV-infected/AIDS patients. The University of Calgary Gastrointestinal/HIV Study Group. AIDS. 1992 Jun;6(6):553–556. [PubMed]
  • Gimble JM, Duh E, Ostrove JM, Gendelman HE, Max EE, Rabson AB. Activation of the human immunodeficiency virus long terminal repeat by herpes simplex virus type 1 is associated with induction of a nuclear factor that binds to the NF-kappa B/core enhancer sequence. J Virol. 1988 Nov;62(11):4104–4112. [PMC free article] [PubMed]
  • Giraldo G, Beth E, Huang ES. Kaposi's sarcoma and its relationship to cytomegalovirus (CMNV). III. CMV DNA and CMV early antigens in Kaposi's sarcoma. Int J Cancer. 1980 Jul 15;26(1):23–29. [PubMed]
  • Girard M, Kieny MP, Pinter A, Barre-Sinoussi F, Nara P, Kolbe H, Kusumi K, Chaput A, Reinhart T, Muchmore E, et al. Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus. Proc Natl Acad Sci U S A. 1991 Jan 15;88(2):542–546. [PMC free article] [PubMed]
  • Giulian D, Vaca K, Noonan CA. Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science. 1990 Dec 14;250(4987):1593–1596. [PubMed]
  • Gnann JW, Jr, McCormick JB, Mitchell S, Nelson JA, Oldstone MB. Synthetic peptide immunoassay distinguishes HIV type 1 and HIV type 2 infections. Science. 1987 Sep 11;237(4820):1346–1349. [PubMed]
  • Godfried MH, van der Poll T, Jansen J, Romijin JA, Schattenkerk JK, Endert E, van Deventer SJ, Sauerwein HP. Soluble receptors for tumour necrosis factor: a putative marker of disease progression in HIV infection. AIDS. 1993 Jan;7(1):33–36. [PubMed]
  • Goedert JJ, Duliège AM, Amos CI, Felton S, Biggar RJ. High risk of HIV-1 infection for first-born twins. The International Registry of HIV-exposed Twins. Lancet. 1991 Dec 14;338(8781):1471–1475. [PubMed]
  • Goedert JJ, Kessler CM, Aledort LM, Biggar RJ, Andes WA, White GC, 2nd, Drummond JE, Vaidya K, Mann DL, Eyster ME, et al. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. N Engl J Med. 1989 Oct 26;321(17):1141–1148. [PubMed]
  • Goedert JJ, Mendez H, Drummond JE, Robert-Guroff M, Minkoff HL, Holman S, Stevens R, Rubinstein A, Blattner WA, Willoughby A, et al. Mother-to-infant transmission of human immunodeficiency virus type 1: association with prematurity or low anti-gp120. Lancet. 1989 Dec 9;2(8676):1351–1354. [PubMed]
  • Golden MP, Kim S, Hammer SM, Ladd EA, Schaffer PA, DeLuca N, Albrecht MA. Activation of human immunodeficiency virus by herpes simplex virus. J Infect Dis. 1992 Sep;166(3):494–499. [PubMed]
  • Golding H, Robey FA, Gates FT, 3rd, Linder W, Beining PR, Hoffman T, Golding B. Identification of homologous regions in human immunodeficiency virus I gp41 and human MHC class II beta 1 domain. I. Monoclonal antibodies against the gp41-derived peptide and patients' sera react with native HLA class II antigens, suggesting a role for autoimmunity in the pathogenesis of acquired immune deficiency syndrome. J Exp Med. 1988 Mar 1;167(3):914–923. [PMC free article] [PubMed]
  • Golding H, Shearer GM, Hillman K, Lucas P, Manischewitz J, Zajac RA, Clerici M, Gress RE, Boswell RN, Golding B. Common epitope in human immunodeficiency virus (HIV) I-GP41 and HLA class II elicits immunosuppressive autoantibodies capable of contributing to immune dysfunction in HIV I-infected individuals. J Clin Invest. 1989 Apr;83(4):1430–1435. [PMC free article] [PubMed]
  • Gomatos PJ, Stamatos NM, Gendelman HE, Fowler A, Hoover DL, Kalter DC, Burke DS, Tramont EC, Meltzer MS. Relative inefficiency of soluble recombinant CD4 for inhibition of infection by monocyte-tropic HIV in monocytes and T cells. J Immunol. 1990 Jun 1;144(11):4183–4188. [PubMed]
  • Gonda MA, Wong-Staal F, Gallo RC, Clements JE, Narayan O, Gilden RV. Sequence homology and morphologic similarity of HTLV-III and visna virus, a pathogenic lentivirus. Science. 1985 Jan 11;227(4683):173–177. [PubMed]
  • Gonda MA. Bovine immunodeficiency virus. AIDS. 1992 Aug;6(8):759–776. [PubMed]
  • Gonzalez-Scarano F, Waxham MN, Ross AM, Hoxie JA. Sequence similarities between human immunodeficiency virus gp41 and paramyxovirus fusion proteins. AIDS Res Hum Retroviruses. 1987 Fall;3(3):245–252. [PubMed]
  • Goto T, Harada S, Yamamoto N, Nakai M. Entry of human immunodeficiency virus (HIV) into MT-2, human T cell leukemia virus carrier cell line. Arch Virol. 1988;102(1-2):29–38. [PubMed]
  • Gottlieb MS, Schroff R, Schanker HM, Weisman JD, Fan PT, Wolf RA, Saxon A. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med. 1981 Dec 10;305(24):1425–1431. [PubMed]
  • Goudsmit J, Lange JM, Paul DA, Dawson GJ. Antigenemia and antibody titers to core and envelope antigens in AIDS, AIDS-related complex, and subclinical human immunodeficiency virus infection. J Infect Dis. 1987 Mar;155(3):558–560. [PubMed]
  • Gowda SD, Stein BS, Mohagheghpour N, Benike CJ, Engleman EG. Evidence that T cell activation is required for HIV-1 entry in CD4+ lymphocytes. J Immunol. 1989 Feb 1;142(3):773–780. [PubMed]
  • Graham NM, Zeger SL, Park LP, Vermund SH, Detels R, Rinaldo CR, Phair JP. The effects on survival of early treatment of human immunodeficiency virus infection. N Engl J Med. 1992 Apr 16;326(16):1037–1042. [PubMed]
  • Grant MD, Weaver MS, Tsoukas C, Hoffmann GW. Distribution of antibodies against denatured collagen in AIDS risk groups and homosexual AIDS patients suggests a link between autoimmunity and the immunopathogenesis of AIDS. J Immunol. 1990 Feb 15;144(4):1241–1250. [PubMed]
  • Green DF, Resnick L, Bourgoignie JJ. HIV infects glomerular endothelial and mesangial but not epithelial cells in vitro. Kidney Int. 1992 Apr;41(4):956–960. [PubMed]
  • Greene LW, Cole W, Greene JB, Levy B, Louie E, Raphael B, Waitkevicz J, Blum M. Adrenal insufficiency as a complication of the acquired immunodeficiency syndrome. Ann Intern Med. 1984 Oct;101(4):497–498. [PubMed]
  • Greene WC. Regulation of HIV-1 gene expression. Annu Rev Immunol. 1990;8:453–475. [PubMed]
  • Greene WC. The molecular biology of human immunodeficiency virus type 1 infection. N Engl J Med. 1991 Jan 31;324(5):308–317. [PubMed]
  • Greenspan D, Greenspan JS, Conant M, Petersen V, Silverman S, Jr, de Souza Y. Oral "hairy" leucoplakia in male homosexuals: evidence of association with both papillomavirus and a herpes-group virus. Lancet. 1984 Oct 13;2(8407):831–834. [PubMed]
  • Griffiths JC, Berrie EL, Holdsworth LN, Moore JP, Harris SJ, Senior JM, Kingsman SM, Kingsman AJ, Adams SE. Induction of high-titer neutralizing antibodies, using hybrid human immunodeficiency virus V3-Ty viruslike particles in a clinically relevant adjuvant. J Virol. 1991 Jan;65(1):450–456. [PMC free article] [PubMed]
  • Grimaila RJ, Fuller BA, Rennert PD, Nelson MB, Hammarskjöld ML, Potts B, Murray M, Putney SD, Gray G. Mutations in the principal neutralization determinant of human immunodeficiency virus type 1 affect syncytium formation, virus infectivity, growth kinetics, and neutralization. J Virol. 1992 Apr;66(4):1875–1883. [PMC free article] [PubMed]
  • Grimaldi LM, Martino GV, Franciotta DM, Brustia R, Castagna A, Pristerà R, Lazzarin A. Elevated alpha-tumor necrosis factor levels in spinal fluid from HIV-1-infected patients with central nervous system involvement. Ann Neurol. 1991 Jan;29(1):21–25. [PubMed]
  • Grinspoon SK, Bilezikian JP. HIV disease and the endocrine system. N Engl J Med. 1992 Nov 5;327(19):1360–1365. [PubMed]
  • Grody WW, Cheng L, Lewis W. Infection of the heart by the human immunodeficiency virus. Am J Cardiol. 1990 Jul 15;66(2):203–206. [PubMed]
  • Groopman JE, Salahuddin SZ, Sarngadharan MG, Markham PD, Gonda M, Sliski A, Gallo RC. HTLV-III in saliva of people with AIDS-related complex and healthy homosexual men at risk for AIDS. Science. 1984 Oct 26;226(4673):447–449. [PubMed]
  • Groux H, Torpier G, Monté D, Mouton Y, Capron A, Ameisen JC. Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals. J Exp Med. 1992 Feb 1;175(2):331–340. [PMC free article] [PubMed]
  • Gruters RA, Neefjes JJ, Tersmette M, de Goede RE, Tulp A, Huisman HG, Miedema F, Ploegh HL. Interference with HIV-induced syncytium formation and viral infectivity by inhibitors of trimming glucosidase. Nature. 1987 Nov 5;330(6143):74–77. [PubMed]
  • Gruters RA, Terpstra FG, De Goede RE, Mulder JW, De Wolf F, Schellekens PT, Van Lier RA, Tersmette M, Miedema F. Immunological and virological markers in individuals progressing from seroconversion to AIDS. AIDS. 1991 Jul;5(7):837–844. [PubMed]
  • Guo HG, Chermann JC, Waters D, Hall L, Louie A, Gallo RC, Streicher H, Reitz MS, Popovic M, Blattner W. Sequence analysis of original HIV-1. Nature. 1991 Feb 28;349(6312):745–746. [PubMed]
  • Gupta P, Balachandran R, Ho M, Enrico A, Rinaldo C. Cell-to-cell transmission of human immunodeficiency virus type 1 in the presence of azidothymidine and neutralizing antibody. J Virol. 1989 May;63(5):2361–2365. [PMC free article] [PubMed]
  • Gupta S, Vayuvegula B. Human immunodeficiency virus-associated changes in signal transduction. J Clin Immunol. 1987 Nov;7(6):486–489. [PubMed]
  • Guy B, Kieny MP, Riviere Y, Le Peuch C, Dott K, Girard M, Montagnier L, Lecocq JP. HIV F/3' orf encodes a phosphorylated GTP-binding protein resembling an oncogene product. Nature. 1987 Nov 19;330(6145):266–269. [PubMed]
  • Guy B, Rivière Y, Dott K, Regnault A, Kieny MP. Mutational analysis of the HIV nef protein. Virology. 1990 Jun;176(2):413–425. [PubMed]
  • Guyader M, Emerman M, Sonigo P, Clavel F, Montagnier L, Alizon M. Genome organization and transactivation of the human immunodeficiency virus type 2. Nature. 1987 Apr 16;326(6114):662–669. [PubMed]
  • Gyorkey F, Melnick JL, Gyorkey P. Human immunodeficiency virus in brain biopsies of patients with AIDS and progressive encephalopathy. J Infect Dis. 1987 May;155(5):870–876. [PubMed]
  • Haase AT. The slow infection caused by visna virus. Curr Top Microbiol Immunol. 1975;72:101–156. [PubMed]
  • Haase AT. Pathogenesis of lentivirus infections. Nature. 1986 Jul 10;322(6075):130–136. [PubMed]
  • Haffar O, Garrigues J, Travis B, Moran P, Zarling J, Hu SL. Human immunodeficiency virus-like, nonreplicating, gag-env particles assemble in a recombinant vaccinia virus expression system. J Virol. 1990 Jun;64(6):2653–2659. [PMC free article] [PubMed]
  • Haggerty S, Stevenson M. Predominance of distinct viral genotypes in brain and lymph node compartments of HIV-1-infected individuals. Viral Immunol. 1991 Summer;4(2):123–131. [PubMed]
  • Hahn BH, Shaw GM, Arya SK, Popovic M, Gallo RC, Wong-Staal F. Molecular cloning and characterization of the HTLV-III virus associated with AIDS. Nature. 1984 Nov 8;312(5990):166–169. [PubMed]
  • Hahn BH, Shaw GM, Taylor ME, Redfield RR, Markham PD, Salahuddin SZ, Wong-Staal F, Gallo RC, Parks ES, Parks WP. Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS. Science. 1986 Jun 20;232(4757):1548–1553. [PubMed]
  • Haigwood NL, Nara PL, Brooks E, Van Nest GA, Ott G, Higgins KW, Dunlop N, Scandella CJ, Eichberg JW, Steimer KS. Native but not denatured recombinant human immunodeficiency virus type 1 gp120 generates broad-spectrum neutralizing antibodies in baboons. J Virol. 1992 Jan;66(1):172–182. [PMC free article] [PubMed]
  • Haigwood NL, Shuster JR, Moore GK, Lee H, Skiles PV, Higgins KW, Barr PJ, George-Nascimento C, Steimer KS. Importance of hypervariable regions of HIV-1 gp120 in the generation of virus neutralizing antibodies. AIDS Res Hum Retroviruses. 1990 Jul;6(7):855–869. [PubMed]
  • Hakkarainen K, Jansson E, Ranki A, Valle SL, Krohn KJ. Serological responses to mycoplasmas in HIV-infected and non-infected individuals. AIDS. 1992 Nov;6(11):1287–1292. [PubMed]
  • Halsey NA, Markham R, Wahren B, Boulos R, Rossi P, Wigzell H. Lack of association between maternal antibodies to V3 loop peptides and maternal-infant HIV-1 transmission. J Acquir Immune Defic Syndr. 1992;5(2):153–157. [PubMed]
  • Halstead SB. In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. J Infect Dis. 1979 Oct;140(4):527–533. [PubMed]
  • Hamilton DP. What next in the Gallo case? Science. 1991 Nov 15;254(5034):944–945. [PubMed]
  • Hamilton JD, Hartigan PM, Simberkoff MS, Day PL, Diamond GR, Dickinson GM, Drusano GL, Egorin MJ, George WL, Gordin FM, et al. A controlled trial of early versus late treatment with zidovudine in symptomatic human immunodeficiency virus infection. Results of the Veterans Affairs Cooperative Study. N Engl J Med. 1992 Feb 13;326(7):437–443. [PubMed]
  • Hammes SR, Dixon EP, Malim MH, Cullen BR, Greene WC. Nef protein of human immunodeficiency virus type 1: evidence against its role as a transcriptional inhibitor. Proc Natl Acad Sci U S A. 1989 Dec;86(23):9549–9553. [PMC free article] [PubMed]
  • Han XM, Laras A, Rounseville MP, Kumar A, Shank PR. Human immunodeficiency virus type 1 Tat-mediated trans activation correlates with the phosphorylation state of a cellular TAR RNA stem-binding factor. J Virol. 1992 Jul;66(7):4065–4072. [PMC free article] [PubMed]
  • Hansen JE, Nielsen C, Arendrup M, Olofsson S, Mathiesen L, Nielsen JO, Clausen H. Broadly neutralizing antibodies targeted to mucin-type carbohydrate epitopes of human immunodeficiency virus. J Virol. 1991 Dec;65(12):6461–6467. [PMC free article] [PubMed]
  • Hansen JE, Nielsen C, Mathiesen LR, Nielsen JO. Involvement of lymphocyte function-associated antigen-1 (LFA-1) in HIV infection: inhibition by monoclonal antibody. Scand J Infect Dis. 1991;23(1):31–36. [PubMed]
  • Hansen JE, Nielsen CM, Nielsen C, Heegaard P, Mathiesen LR, Nielsen JO. Correlation between carbohydrate structures on the envelope glycoprotein gp120 of HIV-1 and HIV-2 and syncytium inhibition with lectins. AIDS. 1989 Oct;3(10):635–641. [PubMed]
  • Harada S, Koyanagi Y, Nakashima H, Kobayashi N, Yamamoto N. Tumor promoter, TPA, enhances replication of HTLV-III/LAV. Virology. 1986 Oct 30;154(2):249–258. [PubMed]
  • Harada S, Koyanagi Y, Yamamoto N. Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay. Science. 1985 Aug 9;229(4713):563–566. [PubMed]
  • Harouse JM, Bhat S, Spitalnik SL, Laughlin M, Stefano K, Silberberg DH, Gonzalez-Scarano F. Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide. Science. 1991 Jul 19;253(5017):320–323. [PubMed]
  • Harouse JM, Kunsch C, Hartle HT, Laughlin MA, Hoxie JA, Wigdahl B, Gonzalez-Scarano F. CD4-independent infection of human neural cells by human immunodeficiency virus type 1. J Virol. 1989 Jun;63(6):2527–2533. [PMC free article] [PubMed]
  • Harouse JM, Wroblewska Z, Laughlin MA, Hickey WF, Schonwetter BS, Gonzalez-Scarano F. Human choroid plexus cells can be latently infected with human immunodeficiency virus. Ann Neurol. 1989 Apr;25(4):406–411. [PubMed]
  • Harper ME, Marselle LM, Gallo RC, Wong-Staal F. Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization. Proc Natl Acad Sci U S A. 1986 Feb;83(3):772–776. [PMC free article] [PubMed]
  • Harris C, Small CB, Klein RS, Friedland GH, Moll B, Emeson EE, Spigland I, Steigbigel NH. Immunodeficiency in female sexual partners of men with the acquired immunodeficiency syndrome. N Engl J Med. 1983 May 19;308(20):1181–1184. [PubMed]
  • Harris JD, Blum H, Scott J, Traynor B, Ventura P, Haase A. Slow virus visna: reproduction in vitro of virus from extrachromosomal DNA. Proc Natl Acad Sci U S A. 1984 Nov;81(22):7212–7215. [PMC free article] [PubMed]
  • Hart AR, Cloyd MW. Interference patterns of human immunodeficiency viruses HIV-1 and HIV-2. Virology. 1990 Jul;177(1):1–10. [PubMed]
  • Hart CE, Ou CY, Galphin JC, Moore J, Bacheler LT, Wasmuth JJ, Petteway SR, Jr, Schochetman G. Human chromosome 12 is required for elevated HIV-1 expression in human-hamster hybrid cells. Science. 1989 Oct 27;246(4929):488–491. [PubMed]
  • Hart TK, Kirsh R, Ellens H, Sweet RW, Lambert DM, Petteway SR, Jr, Leary J, Bugelski PJ. Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120. Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2189–2193. [PMC free article] [PubMed]
  • Haseltine WA. Replication and pathogenesis of the AIDS virus. J Acquir Immune Defic Syndr. 1988;1(3):217–240. [PubMed]
  • Hasunuma T, Tsubota H, Watanabe M, Chen ZW, Lord CI, Burkly LC, Daley JF, Letvin NL. Regions of the CD4 molecule not involved in virus binding or syncytia formation are required for HIV-1 infection of lymphocytes. J Immunol. 1992 Mar 15;148(6):1841–1846. [PubMed]
  • Hatakeyama M, Kono T, Kobayashi N, Kawahara A, Levin SD, Perlmutter RM, Taniguchi T. Interaction of the IL-2 receptor with the src-family kinase p56lck: identification of novel intermolecular association. Science. 1991 Jun 14;252(5012):1523–1528. [PubMed]
  • Hattori T, Koito A, Takatsuki K, Kido H, Katunuma N. Involvement of tryptase-related cellular protease(s) in human immunodeficiency virus type 1 infection. FEBS Lett. 1989 May 8;248(1-2):48–52. [PubMed]
  • Hawkins RE, Rickman LS, Vermund SH, Carl M. Association of mycoplasma and human immunodeficiency virus infection: detection of amplified Mycoplasma fermentans DNA in blood. J Infect Dis. 1992 Mar;165(3):581–585. [PubMed]
  • Healey D, Dianda L, Moore JP, McDougal JS, Moore MJ, Estess P, Buck D, Kwong PD, Beverley PC, Sattentau QJ. Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus binding. J Exp Med. 1990 Oct 1;172(4):1233–1242. [PMC free article] [PubMed]
  • Heise C, Dandekar S, Kumar P, Duplantier R, Donovan RM, Halsted CH. Human immunodeficiency virus infection of enterocytes and mononuclear cells in human jejunal mucosa. Gastroenterology. 1991 Jun;100(6):1521–1527. [PubMed]
  • Helseth E, Olshevsky U, Furman C, Sodroski J. Human immunodeficiency virus type 1 gp120 envelope glycoprotein regions important for association with the gp41 transmembrane glycoprotein. J Virol. 1991 Apr;65(4):2119–2123. [PMC free article] [PubMed]
  • Henderson EE, Yang JY, Zhang RD, Bealer M. Altered HIV expression and EBV-induced transformation in coinfected PBLs and PBL subpopulations. Virology. 1991 May;182(1):186–198. [PubMed]
  • Henderson LA, Qureshi NM, Rasheed S, Garry R. Human immunodeficiency virus-induced cytotoxicity for CD8 cells from some normal donors and virus-specific induction of a suppressor factor. Clin Immunol Immunopathol. 1988 Aug;48(2):174–186. [PubMed]
  • Hénin Y, Mandelbrot L, Henrion R, Pradinaud R, Coulaud JP, Montagnier L. Virus excretion in the cervicovaginal secretions of pregnant and nonpregnant HIV-infected women. J Acquir Immune Defic Syndr. 1993 Jan;6(1):72–75. [PubMed]
  • Heyes MP, Brew BJ, Martin A, Price RW, Salazar AM, Sidtis JJ, Yergey JA, Mouradian MM, Sadler AE, Keilp J, et al. Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Ann Neurol. 1991 Feb;29(2):202–209. [PubMed]
  • Heyes MP, Saito K, Jacobowitz D, Markey SP, Takikawa O, Vickers JH. Poliovirus induces indoleamine-2,3-dioxygenase and quinolinic acid synthesis in macaque brain. FASEB J. 1992 Aug;6(11):2977–2989. [PubMed]
  • Hildreth JE, Orentas RJ. Involvement of a leukocyte adhesion receptor (LFA-1) in HIV-induced syncytium formation. Science. 1989 Jun 2;244(4908):1075–1078. [PubMed]
  • Hilleman MR. Conclusions: in pursuit of an AIDS virus vaccine. Immunol Ser. 1989;44:605–620. [PubMed]
  • Hino S, Yamaguchi K, Katamine S, Sugiyama H, Amagasaki T, Kinoshita K, Yoshida Y, Doi H, Tsuji Y, Miyamoto T. Mother-to-child transmission of human T-cell leukemia virus type-I. Jpn J Cancer Res. 1985 Jun;76(6):474–480. [PubMed]
  • Hira SK, Kamanga J, Macuacua R, Mwansa N, Cruess DF, Perine PL. Genital ulcers and male circumcision as risk factors for acquiring HIV-1 in Zambia. J Infect Dis. 1990 Mar;161(3):584–585. [PubMed]
  • Hira SK, Mangrola UG, Mwale C, Chintu C, Tembo G, Brady WE, Perine PL. Apparent vertical transmission of human immunodeficiency virus type 1 by breast-feeding in Zambia. J Pediatr. 1990 Sep;117(3):421–424. [PubMed]
  • Hirsch MS, Schooley RT. Resistance to antiviral drugs: the end of innocence. N Engl J Med. 1989 Feb 2;320(5):313–314. [PubMed]
  • Hirsch VM, Olmsted RA, Murphey-Corb M, Purcell RH, Johnson PR. An African primate lentivirus (SIVsm) closely related to HIV-2. Nature. 1989 Jun 1;339(6223):389–392. [PubMed]
  • Ho DD, Byington RE, Schooley RT, Flynn T, Rota TR, Hirsch MS. Infrequency of isolation of HTLV-III virus from saliva in AIDS. N Engl J Med. 1985 Dec 19;313(25):1606–1606. [PubMed]
  • Ho DD, Fung MS, Cao YZ, Li XL, Sun C, Chang TW, Sun NC. Another discontinuous epitope on glycoprotein gp120 that is important in human immunodeficiency virus type 1 neutralization is identified by a monoclonal antibody. Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):8949–8952. [PMC free article] [PubMed]
  • Ho DD, Kaplan JC, Rackauskas IE, Gurney ME. Second conserved domain of gp120 is important for HIV infectivity and antibody neutralization. Science. 1988 Feb 26;239(4843):1021–1023. [PubMed]
  • Ho DD, McKeating JA, Li XL, Moudgil T, Daar ES, Sun NC, Robinson JE. Conformational epitope on gp120 important in CD4 binding and human immunodeficiency virus type 1 neutralization identified by a human monoclonal antibody. J Virol. 1991 Jan;65(1):489–493. [PMC free article] [PubMed]
  • Ho DD, Moudgil T, Alam M. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. N Engl J Med. 1989 Dec 14;321(24):1621–1625. [PubMed]
  • Ho DD, Rota TR, Hirsch MS. Infection of monocyte/macrophages by human T lymphotropic virus type III. J Clin Invest. 1986 May;77(5):1712–1715. [PMC free article] [PubMed]
  • Ho DD, Rota TR, Schooley RT, Kaplan JC, Allan JD, Groopman JE, Resnick L, Felsenstein D, Andrews CA, Hirsch MS. Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N Engl J Med. 1985 Dec 12;313(24):1493–1497. [PubMed]
  • Ho DD, Sarngadharan MG, Hirsch MS, Schooley RT, Rota TR, Kennedy RC, Chanh TC, Sato VL. Human immunodeficiency virus neutralizing antibodies recognize several conserved domains on the envelope glycoproteins. J Virol. 1987 Jun;61(6):2024–2028. [PMC free article] [PubMed]
  • Ho DD, Schooley RT, Rota TR, Kaplan JC, Flynn T, Salahuddin SZ, Gonda MA, Hirsch MS. HTLV-III in the semen and blood of a healthy homosexual man. Science. 1984 Oct 26;226(4673):451–453. [PubMed]
  • Ho WZ, Ayyavoo V, Srinivasan A, Stinski MF, Plotkin SA, Gönczöl E. Human immunodeficiency virus type 1 tat gene enhances human cytomegalovirus gene expression and viral replication. AIDS Res Hum Retroviruses. 1991 Aug;7(8):689–695. [PubMed]
  • Hoffenbach A, Langlade-Demoyen P, Dadaglio G, Vilmer E, Michel F, Mayaud C, Autran B, Plata F. Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans. J Immunol. 1989 Jan 15;142(2):452–462. [PubMed]
  • Hofmann B, Nishanian P, Baldwin RL, Insixiengmay P, Nel A, Fahey JL. HIV inhibits the early steps of lymphocyte activation, including initiation of inositol phospholipid metabolism. J Immunol. 1990 Dec 1;145(11):3699–3705. [PubMed]
  • Hollander H, Levy JA. Neurologic abnormalities and recovery of human immunodeficiency virus from cerebrospinal fluid. Ann Intern Med. 1987 May;106(5):692–695. [PubMed]
  • Holodniy M, Katzenstein DA, Sengupta S, Wang AM, Casipit C, Schwartz DH, Konrad M, Groves E, Merigan TC. Detection and quantification of human immunodeficiency virus RNA in patient serum by use of the polymerase chain reaction. J Infect Dis. 1991 Apr;163(4):862–866. [PubMed]
  • Homsy J, Meyer M, Levy JA. Serum enhancement of human immunodeficiency virus (HIV) infection correlates with disease in HIV-infected individuals. J Virol. 1990 Apr;64(4):1437–1440. [PMC free article] [PubMed]
  • Homsy J, Meyer M, Tateno M, Clarkson S, Levy JA. The Fc and not CD4 receptor mediates antibody enhancement of HIV infection in human cells. Science. 1989 Jun 16;244(4910):1357–1360. [PubMed]
  • Antibody-dependent enhancement of HIV infection. Lancet. 1988 Jun 4;1(8597):1285–1286. [PubMed]
  • Hook EW, 3rd, Cannon RO, Nahmias AJ, Lee FF, Campbell CH, Jr, Glasser D, Quinn TC. Herpes simplex virus infection as a risk factor for human immunodeficiency virus infection in heterosexuals. J Infect Dis. 1992 Feb;165(2):251–255. [PubMed]
  • Horsburgh CR, Jr, Ou CY, Jason J, Holmberg SD, Longini IM, Jr, Schable C, Mayer KH, Lifson AR, Schochetman G, Ward JW, et al. Duration of human immunodeficiency virus infection before detection of antibody. Lancet. 1989 Sep 16;2(8664):637–640. [PubMed]
  • Horvat RT, Wood C, Balachandran N. Transactivation of human immunodeficiency virus promoter by human herpesvirus 6. J Virol. 1989 Feb;63(2):970–973. [PMC free article] [PubMed]
  • Hoxie JA, Alpers JD, Rackowski JL, Huebner K, Haggarty BS, Cedarbaum AJ, Reed JC. Alterations in T4 (CD4) protein and mRNA synthesis in cells infected with HIV. Science. 1986 Nov 28;234(4780):1123–1127. [PubMed]
  • Hoxie JA, Brass LF, Pletcher CH, Haggarty BS, Hahn BH. Cytopathic variants of an attenuated isolate of human immunodeficiency virus type 2 exhibit increased affinity for CD4. J Virol. 1991 Sep;65(9):5096–5101. [PMC free article] [PubMed]
  • Hoxie JA, Fitzharris TP, Youngbar PR, Matthews DM, Rackowski JL, Radka SF. Nonrandom association of cellular antigens with HTLV-III virions. Hum Immunol. 1987 Jan;18(1):39–52. [PubMed]
  • Hoxie JA, Haggarty BS, Rackowski JL, Pillsbury N, Levy JA. Persistent noncytopathic infection of normal human T lymphocytes with AIDS-associated retrovirus. Science. 1985 Sep 27;229(4720):1400–1402. [PubMed]
  • Hsia K, Spector SA. Human immunodeficiency virus DNA is present in a high percentage of CD4+ lymphocytes of seropositive individuals. J Infect Dis. 1991 Sep;164(3):470–475. [PubMed]
  • Hu SL, Abrams K, Barber GN, Moran P, Zarling JM, Langlois AJ, Kuller L, Morton WR, Benveniste RE. Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160. Science. 1992 Jan 24;255(5043):456–459. [PubMed]
  • Hu SL, Travis BM, Garrigues J, Zarling JM, Sridhar P, Dykers T, Eichberg JW, Alpers C. Processing, assembly, and immunogenicity of human immunodeficiency virus core antigens expressed by recombinant vaccinia virus. Virology. 1990 Nov;179(1):321–329. [PubMed]
  • Hu WS, Temin HM. Retroviral recombination and reverse transcription. Science. 1990 Nov 30;250(4985):1227–1233. [PubMed]
  • Huang AS, Palma EL, Hewlett N, Roizman B. Pseudotype formation between enveloped RNA and DNA viruses. Nature. 1974 Dec 20;252(5485):743–745. [PubMed]
  • Huet T, Cheynier R, Meyerhans A, Roelants G, Wain-Hobson S. Genetic organization of a chimpanzee lentivirus related to HIV-1. Nature. 1990 May 24;345(6273):356–359. [PubMed]
  • Hughes RA, Macatonia SE, Rowe IF, Keat AC, Knight SC. The detection of human immunodeficiency virus DNA in dendritic cells from the joints of patients with aseptic arthritis. Br J Rheumatol. 1990 Jun;29(3):166–170. [PubMed]
  • Hügin AW, Vacchio MS, Morse HC., 3rd A virus-encoded "superantigen" in a retrovirus-induced immunodeficiency syndrome of mice. Science. 1991 Apr 19;252(5004):424–427. [PubMed]
  • Hussain LA, Kelly CG, Hecht EM, Fellowes R, Jourdan M, Lehner T. The expression of Fc receptors for immunoglobulin G in human rectal epithelium. AIDS. 1991 Sep;5(9):1089–1094. [PubMed]
  • Hutto C, Parks WP, Lai SH, Mastrucci MT, Mitchell C, Munoz J, Trapido E, Master IM, Scott GB. A hospital-based prospective study of perinatal infection with human immunodeficiency virus type 1. J Pediatr. 1991 Mar;118(3):347–353. [PubMed]
  • Hwang SS, Boyle TJ, Lyerly HK, Cullen BR. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science. 1991 Jul 5;253(5015):71–74. [PubMed]
  • Ijichi S, Ramundo MB, Takahashi H, Hall WW. In vivo cellular tropism of human T cell leukemia virus type II (HTLV-II). J Exp Med. 1992 Jul 1;176(1):293–296. [PMC free article] [PubMed]
  • Ikeuchi K, Kim S, Byrn RA, Goldring SR, Groopman JE. Infection of nonlymphoid cells by human immunodeficiency virus type 1 or type 2. J Virol. 1990 Sep;64(9):4226–4231. [PMC free article] [PubMed]
  • Imagawa DT, Lee MH, Wolinsky SM, Sano K, Morales F, Kwok S, Sninsky JJ, Nishanian PG, Giorgi J, Fahey JL, et al. Human immunodeficiency virus type 1 infection in homosexual men who remain seronegative for prolonged periods. N Engl J Med. 1989 Jun 1;320(22):1458–1462. [PubMed]
  • Imberti L, Sottini A, Bettinardi A, Puoti M, Primi D. Selective depletion in HIV infection of T cells that bear specific T cell receptor V beta sequences. Science. 1991 Nov 8;254(5033):860–862. [PubMed]
  • Imboden JB, Weiss A, Stobo JD. The antigen receptor on a human T cell line initiates activation by increasing cytoplasmic free calcium. J Immunol. 1985 Feb;134(2):663–665. [PubMed]
  • Issel CJ, Horohov DW, Lea DF, Adams WV, Jr, Hagius SD, McManus JM, Allison AC, Montelaro RC. Efficacy of inactivated whole-virus and subunit vaccines in preventing infection and disease caused by equine infectious anemia virus. J Virol. 1992 Jun;66(6):3398–3408. [PMC free article] [PubMed]
  • Ivanoff LA, Dubay JW, Morris JF, Roberts SJ, Gutshall L, Sternberg EJ, Hunter E, Matthews TJ, Petteway SR., Jr V3 loop region of the HIV-1 gp120 envelope protein is essential for virus infectivity. Virology. 1992 Apr;187(2):423–432. [PubMed]
  • Ivey-Hoyle M, Culp JS, Chaikin MA, Hellmig BD, Matthews TJ, Sweet RW, Rosenberg M. Envelope glycoproteins from biologically diverse isolates of immunodeficiency viruses have widely different affinities for CD4. Proc Natl Acad Sci U S A. 1991 Jan 15;88(2):512–516. [PMC free article] [PubMed]
  • Jabbar MA, Nayak DP. Intracellular interaction of human immunodeficiency virus type 1 (ARV-2) envelope glycoprotein gp160 with CD4 blocks the movement and maturation of CD4 to the plasma membrane. J Virol. 1990 Dec;64(12):6297–6304. [PMC free article] [PubMed]
  • Jackson GG, Perkins JT, Rubenis M, Paul DA, Knigge M, Despotes JC, Spencer P. Passive immunoneutralization of human immunodeficiency virus in patients with advanced AIDS. Lancet. 1988 Sep 17;2(8612):647–652. [PubMed]
  • Jacobson MA, Fusaro RE, Galmarini M, Lang W. Decreased serum dehydroepiandrosterone is associated with an increased progression of human immunodeficiency virus infection in men with CD4 cell counts of 200-499. J Infect Dis. 1991 Nov;164(5):864–868. [PubMed]
  • Jaffe HW, Bregman DJ, Selik RM. Acquired immune deficiency syndrome in the United States: the first 1,000 cases. J Infect Dis. 1983 Aug;148(2):339–345. [PubMed]
  • Jameson BA, Rao PE, Kong LI, Hahn BH, Shaw GM, Hood LE, Kent SB. Location and chemical synthesis of a binding site for HIV-1 on the CD4 protein. Science. 1988 Jun 3;240(4857):1335–1339. [PubMed]
  • Jassoy C, Johnson RP, Navia BA, Worth J, Walker BD. Detection of a vigorous HIV-1-specific cytotoxic T lymphocyte response in cerebrospinal fluid from infected persons with AIDS dementia complex. J Immunol. 1992 Nov 1;149(9):3113–3119. [PubMed]
  • Javaherian K, Langlois AJ, LaRosa GJ, Profy AT, Bolognesi DP, Herlihy WC, Putney SD, Matthews TJ. Broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of HIV-1. Science. 1990 Dec 14;250(4987):1590–1593. [PubMed]
  • Javaherian K, Langlois AJ, McDanal C, Ross KL, Eckler LI, Jellis CL, Profy AT, Rusche JR, Bolognesi DP, Putney SD, et al. Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein. Proc Natl Acad Sci U S A. 1989 Sep;86(17):6768–6772. [PMC free article] [PubMed]
  • Jeffrey AA, Israël-Biet D, Andrieu JM, Even P, Venet A. HIV isolation from pulmonary cells derived from bronchoalveolar lavage. Clin Exp Immunol. 1991 Jun;84(3):488–492. [PMC free article] [PubMed]
  • Jehuda-Cohen T, Powell JD, Sell KW, Villinger F, Lockwood E, McClure HM, Ahmed-Ansari A. Transmission of retroviral infection by transfusion of seronegative blood in nonhuman primates. J Infect Dis. 1991 Jun;163(6):1223–1228. [PubMed]
  • Jehuda-Cohen T, Slade BA, Powell JD, Villinger F, De B, Folks TM, McClure HM, Sell KW, Ahmed-Ansari A. Polyclonal B-cell activation reveals antibodies against human immunodeficiency virus type 1 (HIV-1) in HIV-1-seronegative individuals. Proc Natl Acad Sci U S A. 1990 May;87(10):3972–3976. [PMC free article] [PubMed]
  • Jiang JD, Chu FN, Naylor PH, Kirkley JE, Mandeli J, Wallace JI, Sarin PS, Goldstein AL, Holland JF, Bekesi JG. Specific antibody responses to synthetic peptides of HIV-1 p17 correlate with different stages of HIV-1 infection. J Acquir Immune Defic Syndr. 1992;5(4):382–390. [PubMed]
  • Jiang SB, Lin K, Neurath AR. Enhancement of human immunodeficiency virus type 1 infection by antisera to peptides from the envelope glycoproteins gp120/gp41. J Exp Med. 1991 Dec 1;174(6):1557–1563. [PMC free article] [PubMed]
  • Jiang S, Neurath AR. Potential risks of eliciting antibodies enhancing HIV-1 infection of monocytic cells by vaccination with V3 loops of unmatched HIV-1 isolates. AIDS. 1992 Mar;6(3):331–332. [PubMed]
  • Johnson PR, Montefiori DC, Goldstein S, Hamm TE, Zhou J, Kitov S, Haigwood NL, Misher L, London WT, Gerin JL, et al. Inactivated whole-virus vaccine derived from a proviral DNA clone of simian immunodeficiency virus induces high levels of neutralizing antibodies and confers protection against heterologous challenge. Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2175–2179. [PMC free article] [PubMed]
  • Johnson VA, Merrill DP, Videler JA, Chou TC, Byington RE, Eron JJ, D'Aquila RT, Hirsch MS. Two-drug combinations of zidovudine, didanosine, and recombinant interferon-alpha A inhibit replication of zidovudine-resistant human immunodeficiency virus type 1 synergistically in vitro. J Infect Dis. 1991 Oct;164(4):646–655. [PubMed]
  • Joly P, Guillon JM, Mayaud C, Plata F, Theodorou I, Denis M, Debre P, Autran B. Cell-mediated suppression of HIV-specific cytotoxic T lymphocytes. J Immunol. 1989 Oct 1;143(7):2193–2201. [PubMed]
  • Jones KA, Kadonaga JT, Luciw PA, Tjian R. Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1. Science. 1986 May 9;232(4751):755–759. [PubMed]
  • Jordan CA, Watkins BA, Kufta C, Dubois-Dalcq M. Infection of brain microglial cells by human immunodeficiency virus type 1 is CD4 dependent. J Virol. 1991 Feb;65(2):736–742. [PMC free article] [PubMed]
  • Jovaisas E, Koch MA, Schäfer A, Stauber M, Löwenthal D. LAV/HTLV-III in 20-week fetus. Lancet. 1985 Nov 16;2(8464):1129–1129. [PubMed]
  • Jurriaans S, Dekker JT, de Ronde A. HIV-1 viral DNA load in peripheral blood mononuclear cells from seroconverters and long-term infected individuals. AIDS. 1992 Jul;6(7):635–641. [PubMed]
  • Juszczak RJ, Turchin H, Truneh A, Culp J, Kassis S. Effect of human immunodeficiency virus gp120 glycoprotein on the association of the protein tyrosine kinase p56lck with CD4 in human T lymphocytes. J Biol Chem. 1991 Jun 15;266(17):11176–11183. [PubMed]
  • Kahn JO, Kaplan LD, Gambertoglio JG, Bredesen D, Arri CJ, Turin L, Kibort T, Williams RL, Lifson JD, Volberding PA. The safety and pharmacokinetics of GLQ223 in subjects with AIDS and AIDS-related complex: a phase I study. AIDS. 1990 Dec;4(12):1197–1204. [PubMed]
  • Kahn JO, Lagakos SW, Richman DD, Cross A, Pettinelli C, Liou SH, Brown M, Volberding PA, Crumpacker CS, Beall G, et al. A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. The NIAID AIDS Clinical Trials Group. N Engl J Med. 1992 Aug 27;327(9):581–587. [PubMed]
  • Kaiser PK, Offermann JT, Lipton SA. Neuronal injury due to HIV-1 envelope protein is blocked by anti-gp120 antibodies but not by anti-CD4 antibodies. Neurology. 1990 Nov;40(11):1757–1761. [PubMed]
  • Kalter DC, Gendelman HE, Meltzer MS. Inhibition of human immunodeficiency virus infection in monocytes by monoclonal antibodies against leukocyte adhesion molecules. Immunol Lett. 1991 Oct;30(2):219–227. [PubMed]
  • Kamel-Reid S, Dick JE. Engraftment of immune-deficient mice with human hematopoietic stem cells. Science. 1988 Dec 23;242(4886):1706–1709. [PubMed]
  • Kaminsky LS, McHugh T, Stites D, Volberding P, Henle G, Henle W, Levy JA. High prevalence of antibodies to acquired immune deficiency syndrome (AIDS)-associated retrovirus (ARV) in AIDS and related conditions but not in other disease states. Proc Natl Acad Sci U S A. 1985 Aug;82(16):5535–5539. [PMC free article] [PubMed]
  • Kang CY, Nara P, Chamat S, Caralli V, Chen A, Nguyen ML, Yoshiyama H, Morrow WJ, Ho DD, Köhler H. Anti-idiotype monoclonal antibody elicits broadly neutralizing anti-gp120 antibodies in monkeys. Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):2546–2550. [PMC free article] [PubMed]
  • Kang CY, Nara P, Chamat S, Caralli V, Ryskamp T, Haigwood N, Newman R, Köhler H. Evidence for non-V3-specific neutralizing antibodies that interfere with gp120/CD4 binding in human immunodeficiency virus 1-infected humans. Proc Natl Acad Sci U S A. 1991 Jul 15;88(14):6171–6175. [PMC free article] [PubMed]
  • Kanitakis J, Marchand C, Su H, Thivolet J, Zambruno G, Schmitt D, Gazzolo L. Immunohistochemical study of normal skin of HIV-1-infected patients shows no evidence of infection of epidermal Langerhans cells by HIV. AIDS Res Hum Retroviruses. 1989 Jun;5(3):293–302. [PubMed]
  • Kannagi M, Chalifoux LV, Lord CI, Letvin NL. Suppression of simian immunodeficiency virus replication in vitro by CD8+ lymphocytes. J Immunol. 1988 Apr 1;140(7):2237–2242. [PubMed]
  • Kannagi M, Masuda T, Hattori T, Kanoh T, Nasu K, Yamamoto N, Harada S. Interference with human immunodeficiency virus (HIV) replication by CD8+ T cells in peripheral blood leukocytes of asymptomatic HIV carriers in vitro. J Virol. 1990 Jul;64(7):3399–3406. [PMC free article] [PubMed]
  • Karin M. Signal transduction from cell surface to nucleus in development and disease. FASEB J. 1992 May;6(8):2581–2590. [PubMed]
  • Karpas A, Hewlett IK, Hill F, Gray J, Byron N, Gilgen D, Bally V, Oates JK, Gazzard B, Epstein JE. Polymerase chain reaction evidence for human immunodeficiency virus 1 neutralization by passive immunization in patients with AIDS and AIDS-related complex. Proc Natl Acad Sci U S A. 1990 Oct;87(19):7613–7617. [PMC free article] [PubMed]
  • Karpatkin S, Nardi M. Autoimmune anti-HIV-1gp120 antibody with antiidiotype-like activity in sera and immune complexes of HIV-1-related immunologic thrombocytopenia. J Clin Invest. 1992 Feb;89(2):356–364. [PMC free article] [PubMed]
  • Kato H, Horikoshi M, Roeder RG. Repression of HIV-1 transcription by a cellular protein. Science. 1991 Mar 22;251(5000):1476–1479. [PubMed]
  • Kawashima H, Bandyopadhyay S, Rutstein R, Plotkin SA. Excretion of human immunodeficiency type 1 in the throat but not in urine by infected children. J Pediatr. 1991 Jan;118(1):80–82. [PubMed]
  • Kazazi F, Mathijs JM, Foley P, Cunningham AL. Variations in CD4 expression by human monocytes and macrophages and their relationships to infection with the human immunodeficiency virus. J Gen Virol. 1989 Oct;70(Pt 10):2661–2672. [PubMed]
  • Keay S, Tacket CO, Murphy JR, Handwerger BS. Anti-CD4 anti-idiotype antibodies in volunteers immunized with rgp160 of HIV-1 or infected with HIV-1. AIDS Res Hum Retroviruses. 1992 Jun;8(6):1091–1098. [PubMed]
  • Keet IP, Krijnen P, Koot M, Lange JM, Miedema F, Goudsmit J, Coutinho RA. Predictors of rapid progression to AIDS in HIV-1 seroconverters. AIDS. 1993 Jan;7(1):51–57. [PubMed]
  • Kehrl JH, Alvarez-Mon M, Delsing GA, Fauci AS. Lymphotoxin is an important T cell-derived growth factor for human B cells. Science. 1987 Nov 20;238(4830):1144–1146. [PubMed]
  • Keller A, Garrett ED, Cullen BR. The Bel-1 protein of human foamy virus activates human immunodeficiency virus type 1 gene expression via a novel DNA target site. J Virol. 1992 Jun;66(6):3946–3949. [PMC free article] [PubMed]
  • Keller R, Peitchel R, Goldman JN, Goldman M. An IgG-Fc receptor induced in cytomegalovirus-infected human fibroblasts. J Immunol. 1976 Mar;116(3):772–777. [PubMed]
  • Kenney S, Kamine J, Markovitz D, Fenrick R, Pagano J. An Epstein-Barr virus immediate-early gene product trans-activates gene expression from the human immunodeficiency virus long terminal repeat. Proc Natl Acad Sci U S A. 1988 Mar;85(5):1652–1656. [PMC free article] [PubMed]
  • Kensil CR, Patel U, Lennick M, Marciani D. Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex. J Immunol. 1991 Jan 15;146(2):431–437. [PubMed]
  • Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972 Aug;26(4):239–257. [PMC free article] [PubMed]
  • Keshet E, Temin HM. Cell killing by spleen necrosis virus is correlated with a transient accumulation of spleen necrosis virus DNA. J Virol. 1979 Aug;31(2):376–388. [PMC free article] [PubMed]
  • Kestler H, Kodama T, Ringler D, Marthas M, Pedersen N, Lackner A, Regier D, Sehgal P, Daniel M, King N, et al. Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus. Science. 1990 Jun 1;248(4959):1109–1112. [PubMed]
  • Kestler HW, 3rd, Ringler DJ, Mori K, Panicali DL, Sehgal PK, Daniel MD, Desrosiers RC. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell. 1991 May 17;65(4):651–662. [PubMed]
  • Ketzler S, Weis S, Haug H, Budka H. Loss of neurons in the frontal cortex in AIDS brains. Acta Neuropathol. 1990;80(1):92–94. [PubMed]
  • Kido H, Fukutomi A, Katunuma N. Tryptase TL2 in the membrane of human T4+ lymphocytes is a novel binding protein of the V3 domain of HIV-1 envelope glycoprotein gp 120. FEBS Lett. 1991 Jul 29;286(1-2):233–236. [PubMed]
  • Kido H, Fukutomi A, Katunuma N. A novel membrane-bound serine esterase in human T4+ lymphocytes immunologically reactive with antibody inhibiting syncytia induced by HIV-1. Purification and characterization. J Biol Chem. 1990 Dec 15;265(35):21979–21985. [PubMed]
  • Kikukawa R, Koyanagi Y, Harada S, Kobayashi N, Hatanaka M, Yamamoto N. Differential susceptibility to the acquired immunodeficiency syndrome retrovirus in cloned cells of human leukemic T-cell line Molt-4. J Virol. 1986 Mar;57(3):1159–1162. [PMC free article] [PubMed]
  • Kim SY, Byrn R, Groopman J, Baltimore D. Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression. J Virol. 1989 Sep;63(9):3708–3713. [PMC free article] [PubMed]
  • Kim S, Ikeuchi K, Byrn R, Groopman J, Baltimore D. Lack of a negative influence on viral growth by the nef gene of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A. 1989 Dec;86(23):9544–9548. [PMC free article] [PubMed]
  • Kim S, Ikeuchi K, Groopman J, Baltimore D. Factors affecting cellular tropism of human immunodeficiency virus. J Virol. 1990 Nov;64(11):5600–5604. [PMC free article] [PubMed]
  • Kimmel PL, Phillips TM, Ferreira-Centeno A, Farkas-Szallasi T, Abraham AA, Garrett CT. Brief report: idiotypic IgA nephropathy in patients with human immunodeficiency virus infection. N Engl J Med. 1992 Sep 3;327(10):702–706. [PubMed]
  • Kimpton J, Emerman M. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene. J Virol. 1992 Apr;66(4):2232–2239. [PMC free article] [PubMed]
  • Kinter AL, Poli G, Maury W, Folks TM, Fauci AS. Direct and cytokine-mediated activation of protein kinase C induces human immunodeficiency virus expression in chronically infected promonocytic cells. J Virol. 1990 Sep;64(9):4306–4312. [PMC free article] [PubMed]
  • Kion TA, Hoffmann GW. Anti-HIV and anti-anti-MHC antibodies in alloimmune and autoimmune mice. Science. 1991 Sep 6;253(5024):1138–1140. [PubMed]
  • Kiprov D, Pfaeffl W, Parry G, Lippert R, Lang W, Miller R. Antibody-mediated peripheral neuropathies associated with ARC and AIDS: successful treatment with plasmapheresis. J Clin Apher. 1988;4(1):3–7. [PubMed]
  • Kiprov DD, Anderson RE, Morand PR, Simpson DM, Chermann JC, Levy JA, Ross AR. Antilymphocyte antibodies and seropositivity for retroviruses in groups at high risk for AIDS. N Engl J Med. 1985 Jun 6;312(23):1517–1517. [PubMed]
  • Kiprov DD, Kwiatkowska BJ, Miller RG. Therapeutic apheresis in human immunodeficiency virus-related syndromes. Curr Stud Hematol Blood Transfus. 1990;(57):184–197. [PubMed]
  • Klaassen RJ, Goldschmeding R, Dolman KM, Vlekke AB, Weigel HM, Eeftinck Schattenkerk JK, Mulder JW, Westedt ML, von dem Borne AE. Anti-neutrophil cytoplasmic autoantibodies in patients with symptomatic HIV infection. Clin Exp Immunol. 1992 Jan;87(1):24–30. [PMC free article] [PubMed]
  • Klaassen RJ, Mulder JW, Vlekke AB, Eeftinck Schattenkerk JK, Weigel HM, Lange JM, von dem Borne AE. Autoantibodies against peripheral blood cells appear early in HIV infection and their prevalence increases with disease progression. Clin Exp Immunol. 1990 Jul;81(1):11–17. [PMC free article] [PubMed]
  • Klatzmann D, Barré-Sinoussi F, Nugeyre MT, Danquet C, Vilmer E, Griscelli C, Brun-Veziret F, Rouzioux C, Gluckman JC, Chermann JC, et al. Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes. Science. 1984 Jul 6;225(4657):59–63. [PubMed]
  • Klatzmann D, Champagne E, Chamaret S, Gruest J, Guetard D, Hercend T, Gluckman JC, Montagnier L. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature. 1984 Dec 20;312(5996):767–768. [PubMed]
  • Klebanoff SJ, Coombs RW. Viricidal effect of polymorphonuclear leukocytes on human immunodeficiency virus-1. Role of the myeloperoxidase system. J Clin Invest. 1992 Jun;89(6):2014–2017. [PMC free article] [PubMed]
  • Kieburtz KD, Giang DW, Schiffer RB, Vakil N. Abnormal vitamin B12 metabolism in human immunodeficiency virus infection. Association with neurological dysfunction. Arch Neurol. 1991 Mar;48(3):312–314. [PubMed]
  • Kleim JP, Ackermann A, Brackmann HH, Gahr M, Schneweis KE. Epidemiologically closely related viruses from hemophilia B patients display high homology in two hypervariable regions of the HIV-1 env gene. AIDS Res Hum Retroviruses. 1991 Apr;7(4):417–421. [PubMed]
  • Kliks SC, Nisalak A, Brandt WE, Wahl L, Burke DS. Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am J Trop Med Hyg. 1989 Apr;40(4):444–451. [PubMed]
  • Kloster BE, Tomar RH, Spira TJ. Lymphocytotoxic antibodies in the acquired immune deficiency syndrome (AIDS). Clin Immunol Immunopathol. 1984 Feb;30(2):330–335. [PubMed]
  • Koenig S, Gendelman HE, Orenstein JM, Dal Canto MC, Pezeshkpour GH, Yungbluth M, Janotta F, Aksamit A, Martin MA, Fauci AS. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science. 1986 Sep 5;233(4768):1089–1093. [PubMed]
  • Koerper MA. AIDS and hemophilia. Immunol Ser. 1989;44:79–95. [PubMed]
  • Koff WC, Hoth DF. Development and testing of AIDS vaccines. Science. 1988 Jul 22;241(4864):426–432. [PubMed]
  • Koga Y, Sasaki M, Yoshida H, Oh-Tsu M, Kimura G, Nomoto K. Disturbance of nuclear transport of proteins in CD4+ cells expressing gp160 of human immunodeficiency virus. J Virol. 1991 Oct;65(10):5609–5612. [PMC free article] [PubMed]
  • Koga Y, Sasaki M, Yoshida H, Wigzell H, Kimura G, Nomoto K. Cytopathic effect determined by the amount of CD4 molecules in human cell lines expressing envelope glycoprotein of HIV. J Immunol. 1990 Jan 1;144(1):94–102. [PubMed]
  • Koito A, Hattori T, Murakami T, Matsushita S, Maeda Y, Yamamoto T, Takatsuki K. A neutralizing epitope of human immunodeficiency virus type 1 has homologous amino acid sequences with the active site of inter-alpha-trypsin inhibitor. Int Immunol. 1989;1(6):613–618. [PubMed]
  • Kong LI, Lee SW, Kappes JC, Parkin JS, Decker D, Hoxie JA, Hahn BH, Shaw GM. West African HIV-2-related human retrovirus with attenuated cytopathicity. Science. 1988 Jun 10;240(4858):1525–1529. [PubMed]
  • Koot M, Vos AH, Keet RP, de Goede RE, Dercksen MW, Terpstra FG, Coutinho RA, Miedema F, Tersmette M. HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay. AIDS. 1992 Jan;6(1):49–54. [PubMed]
  • Kornfeld H, Cruikshank WW, Pyle SW, Berman JS, Center DM. Lymphocyte activation by HIV-1 envelope glycoprotein. Nature. 1988 Sep 29;335(6189):445–448. [PubMed]
  • Kotler DP, Gaetz HP, Lange M, Klein EB, Holt PR. Enteropathy associated with the acquired immunodeficiency syndrome. Ann Intern Med. 1984 Oct;101(4):421–428. [PubMed]
  • Kotler DP, Reka S, Borcich A, Cronin WJ. Detection, localization, and quantitation of HIV-associated antigens in intestinal biopsies from patients with HIV. Am J Pathol. 1991 Oct;139(4):823–830. [PMC free article] [PubMed]
  • Koup RA, Sullivan JL, Levine PH, Brewster F, Mahr A, Mazzara G, McKenzie S, Panicali D. Antigenic specificity of antibody-dependent cell-mediated cytotoxicity directed against human immunodeficiency virus in antibody-positive sera. J Virol. 1989 Feb;63(2):584–590. [PMC free article] [PubMed]
  • Koval V, Clark C, Vaishnav M, Spector SA, Spector DH. Human cytomegalovirus inhibits human immunodeficiency virus replication in cells productively infected by both viruses. J Virol. 1991 Dec;65(12):6969–6978. [PMC free article] [PubMed]
  • Kowalski M, Ardman B, Basiripour L, Lu YC, Blohm D, Haseltine W, Sodroski J. Antibodies to CD4 in individuals infected with human immunodeficiency virus type 1. Proc Natl Acad Sci U S A. 1989 May;86(9):3346–3350. [PMC free article] [PubMed]
  • Kowalski M, Bergeron L, Dorfman T, Haseltine W, Sodroski J. Attenuation of human immunodeficiency virus type 1 cytopathic effect by a mutation affecting the transmembrane envelope glycoprotein. J Virol. 1991 Jan;65(1):281–291. [PMC free article] [PubMed]
  • Kowalski M, Potz J, Basiripour L, Dorfman T, Goh WC, Terwilliger E, Dayton A, Rosen C, Haseltine W, Sodroski J. Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1. Science. 1987 Sep 11;237(4820):1351–1355. [PubMed]
  • Koyanagi Y, Miles S, Mitsuyasu RT, Merrill JE, Vinters HV, Chen IS. Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science. 1987 May 15;236(4803):819–822. [PubMed]
  • Koyanagi Y, O'Brien WA, Zhao JQ, Golde DW, Gasson JC, Chen IS. Cytokines alter production of HIV-1 from primary mononuclear phagocytes. Science. 1988 Sep 23;241(4873):1673–1675. [PubMed]
  • Kreiss J, Ngugi E, Holmes K, Ndinya-Achola J, Waiyaki P, Roberts PL, Ruminjo I, Sajabi R, Kimata J, Fleming TR, et al. Efficacy of nonoxynol 9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes. JAMA. 1992 Jul 22;268(4):477–482. [PubMed]
  • Krieger JN, Coombs RW, Collier AC, Ross SO, Chaloupka K, Cummings DK, Murphy VL, Corey L. Recovery of human immunodeficiency virus type 1 from semen: minimal impact of stage of infection and current antiviral chemotherapy. J Infect Dis. 1991 Feb;163(2):386–388. [PubMed]
  • Krivine A, Firtion G, Cao L, Francoual C, Henrion R, Lebon P. HIV replication during the first weeks of life. Lancet. 1992 May 16;339(8803):1187–1189. [PubMed]
  • Krowka J, Stites D, Debs R, Larsen C, Fedor J, Brunette E, Düzgünes N. Lymphocyte proliferative responses to soluble and liposome-conjugated envelope peptides of HIV-1. J Immunol. 1990 Apr 1;144(7):2535–2540. [PubMed]
  • Kühnel H, von Briesen H, Dietrich U, Adamski M, Mix D, Biesert L, Kreutz R, Immelmann A, Henco K, Meichsner C, et al. Molecular cloning of two west African human immunodeficiency virus type 2 isolates that replicate well in macrophages: a Gambian isolate, from a patient with neurologic acquired immunodeficiency syndrome, and a highly divergent Ghanian isolate. Proc Natl Acad Sci U S A. 1989 Apr;86(7):2383–2387. [PMC free article] [PubMed]
  • Kuiken CL, de Jong JJ, Baan E, Keulen W, Tersmette M, Goudsmit J. Evolution of the V3 envelope domain in proviral sequences and isolates of human immunodeficiency virus type 1 during transition of the viral biological phenotype. J Virol. 1992 Jul;66(7):4622–4627. [PMC free article] [PubMed]
  • Kumar M, Resnick L, Loewenstein DA, Berger J, Eisdorfer C. Brain-reactive antibodies and the AIDS dementia complex. J Acquir Immune Defic Syndr. 1989;2(5):469–471. [PubMed]
  • Kumar P, Hui HX, Kappes JC, Haggarty BS, Hoxie JA, Arya SK, Shaw GM, Hahn BH. Molecular characterization of an attenuated human immunodeficiency virus type 2 isolate. J Virol. 1990 Feb;64(2):890–901. [PMC free article] [PubMed]
  • Kundu SK, Katzenstein D, Moses LE, Merigan TC. Enhancement of human immunodeficiency virus (HIV)-specific CD4+ and CD8+ cytotoxic T-lymphocyte activities in HIV-infected asymptomatic patients given recombinant gp160 vaccine. Proc Natl Acad Sci U S A. 1992 Dec 1;89(23):11204–11208. [PMC free article] [PubMed]
  • Kundu SK, Merigan TC. Equivalent recognition of HIV proteins, Env, Gag and Pol, by CD4+ and CD8+ cytotoxic T-lymphocytes. AIDS. 1992 Jul;6(7):643–649. [PubMed]
  • Kunsch C, Hartle HT, Wigdahl B. Infection of human fetal dorsal root ganglion glial cells with human immunodeficiency virus type 1 involves an entry mechanism independent of the CD4 T4A epitope. J Virol. 1989 Dec;63(12):5054–5061. [PMC free article] [PubMed]
  • Kusumi K, Conway B, Cunningham S, Berson A, Evans C, Iversen AK, Colvin D, Gallo MV, Coutre S, Shpaer EG, et al. Human immunodeficiency virus type 1 envelope gene structure and diversity in vivo and after cocultivation in vitro. J Virol. 1992 Feb;66(2):875–885. [PMC free article] [PubMed]
  • Kwok S, Mack DH, Mullis KB, Poiesz B, Ehrlich G, Blair D, Friedman-Kien A, Sninsky JJ. Identification of human immunodeficiency virus sequences by using in vitro enzymatic amplification and oligomer cleavage detection. J Virol. 1987 May;61(5):1690–1694. [PMC free article] [PubMed]
  • Lafon M, Lafage M, Martinez-Arends A, Ramirez R, Vuillier F, Charron D, Lotteau V, Scott-Algara D. Evidence for a viral superantigen in humans. Nature. 1992 Aug 6;358(6386):507–510. [PubMed]
  • Lafon ME, Steffan AM, Gendrault JL, Klein-Soyer C, Gloeckler-Tondre L, Royer C, Kirn A. Interaction of human immunodeficiency virus with human macrovascular endothelial cells in vitro. AIDS Res Hum Retroviruses. 1992 Sep;8(9):1567–1570. [PubMed]
  • Lähdevirta J, Maury CP, Teppo AM, Repo H. Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am J Med. 1988 Sep;85(3):289–291. [PubMed]
  • Lamarre D, Ashkenazi A, Fleury S, Smith DH, Sekaly RP, Capon DJ. The MHC-binding and gp120-binding functions of CD4 are separable. Science. 1989 Aug 18;245(4919):743–746. [PubMed]
  • Lambert JS, Seidlin M, Reichman RC, Plank CS, Laverty M, Morse GD, Knupp C, McLaren C, Pettinelli C, Valentine FT, et al. 2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. A phase I trial. N Engl J Med. 1990 May 10;322(19):1333–1340. [PubMed]
  • Landau NR, Page KA, Littman DR. Pseudotyping with human T-cell leukemia virus type I broadens the human immunodeficiency virus host range. J Virol. 1991 Jan;65(1):162–169. [PMC free article] [PubMed]
  • Landau NR, Warton M, Littman DR. The envelope glycoprotein of the human immunodeficiency virus binds to the immunoglobulin-like domain of CD4. Nature. 1988 Jul 14;334(6178):159–162. [PubMed]
  • Landay A, Kessler HA, Benson CA, Pottage JC, Jr, Murphy R, Urbanski P, Kucik S, Phair J. Isolation of HIV-1 from monocytes of individuals negative by conventional culture. J Infect Dis. 1990 Apr;161(4):706–710. [PubMed]
  • Landesman S, Weiblen B, Mendez H, Willoughby A, Goedert JJ, Rubinstein A, Minkoff H, Moroso G, Hoff R. Clinical utility of HIV-IgA immunoblot assay in the early diagnosis of perinatal HIV infection. JAMA. 1991 Dec 25;266(24):3443–3446. [PubMed]
  • Lang W, Perkins H, Anderson RE, Royce R, Jewell N, Winkelstein W., Jr Patterns of T lymphocyte changes with human immunodeficiency virus infection: from seroconversion to the development of AIDS. J Acquir Immune Defic Syndr. 1989;2(1):63–69. [PubMed]
  • Lange JM, de Wolf F, Krone WJ, Danner SA, Coutinho RA, Goudsmit J. Decline of antibody reactivity to outer viral core protein p17 is an earlier serological marker of disease progression in human immunodeficiency virus infection than anti-p24 decline. AIDS. 1987 Sep;1(3):155–159. [PubMed]
  • Lange JM, Paul DA, Huisman HG, de Wolf F, van den Berg H, Coutinho RA, Danner SA, van der Noordaa J, Goudsmit J. Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS. Br Med J (Clin Res Ed) 1986 Dec 6;293(6560):1459–1462. [PMC free article] [PubMed]
  • Langhoff E, Terwilliger EF, Bos HJ, Kalland KH, Poznansky MC, Bacon OM, Haseltine WA. Replication of human immunodeficiency virus type 1 in primary dendritic cell cultures. Proc Natl Acad Sci U S A. 1991 Sep 15;88(18):7998–8002. [PMC free article] [PubMed]
  • Langlade-Demoyen P, Michel F, Hoffenbach A, Vilmer E, Dadaglio G, Garicia-Pons F, Mayaud C, Autran B, Wain-Hobson S, Plata F. Immune recognition of AIDS virus antigens by human and murine cytotoxic T lymphocytes. J Immunol. 1988 Sep 15;141(6):1949–1957. [PubMed]
  • Langlois AJ, Weinhold KJ, Matthews TJ, Greenberg ML, Bolognesi DP. The ability of certain SIV vaccines to provoke reactions against normal cells. Science. 1992 Jan 17;255(5042):292–293. [PubMed]
  • Lanzavecchia A, Roosnek E, Gregory T, Berman P, Abrignani S. T cells can present antigens such as HIV gp120 targeted to their own surface molecules. Nature. 1988 Aug 11;334(6182):530–532. [PubMed]
  • Larder BA, Darby G, Richman DD. HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Science. 1989 Mar 31;243(4899):1731–1734. [PubMed]
  • Larder BA, Kemp SD. Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT). Science. 1989 Dec 1;246(4934):1155–1158. [PubMed]
  • LaRosa GJ, Davide JP, Weinhold K, Waterbury JA, Profy AT, Lewis JA, Langlois AJ, Dreesman GR, Boswell RN, Shadduck P, et al. Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant. Science. 1990 Aug 24;249(4971):932–935. [PubMed]
  • Lasky LA, Nakamura G, Smith DH, Fennie C, Shimasaki C, Patzer E, Berman P, Gregory T, Capon DJ. Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor. Cell. 1987 Sep 11;50(6):975–985. [PubMed]
  • Laure F, Courgnaud V, Rouzioux C, Blanche S, Veber F, Burgard M, Jacomet C, Griscelli C, Brechot C. Detection of HIV1 DNA in infants and children by means of the polymerase chain reaction. Lancet. 1988 Sep 3;2(8610):538–541. [PubMed]
  • Laurence J. Molecular interactions among herpesviruses and human immunodeficiency viruses. J Infect Dis. 1990 Aug;162(2):338–346. [PubMed]
  • Laurence J. Novel vaccination and antireceptor strategies against HIV. AIDS Res Hum Retroviruses. 1990 Feb;6(2):175–181. [PubMed]
  • Laurence J, Gottlieb AB, Kunkel HG. Soluble suppressor factors in patients with acquired immune deficiency syndrome and its prodrome. Elaboration in vitro by T lymphocyte-adherent cell interactions. J Clin Invest. 1983 Dec;72(6):2072–2081. [PMC free article] [PubMed]
  • Laurence J, Saunders A, Early E, Salmon JE. Human immunodeficiency virus infection of monocytes: relationship to Fc-gamma receptors and antibody-dependent viral enhancement. Immunology. 1990 Jul;70(3):338–343. [PMC free article] [PubMed]
  • Laurent AG, Hovanessian AG, Rivière Y, Krust B, Regnault A, Montagnier L, Findeli A, Kieny MP, Guy B. Production of a non-functional nef protein in human immunodeficiency virus type 1-infected CEM cells. J Gen Virol. 1990 Oct;71(Pt 10):2273–2281. [PubMed]
  • Laurent-Crawford AG, Krust B, Muller S, Rivière Y, Rey-Cuillé MA, Béchet JM, Montagnier L, Hovanessian AG. The cytopathic effect of HIV is associated with apoptosis. Virology. 1991 Dec;185(2):829–839. [PubMed]
  • Layne SP, Merges MJ, Dembo M, Spouge JL, Conley SR, Moore JP, Raina JL, Renz H, Gelderblom HR, Nara PL. Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus. Virology. 1992 Aug;189(2):695–714. [PubMed]
  • Layne SP, Merges MJ, Spouge JL, Dembo M, Nara PL. Blocking of human immunodeficiency virus infection depends on cell density and viral stock age. J Virol. 1991 Jun;65(6):3293–3300. [PMC free article] [PubMed]
  • Lecatsas G, Houff S, Macher A, Gelman E, Steis R, Reichert C, Masur H, Sever JL. Retrovirus-like particles in salivary glands, prostate and testes of AIDS patients. Proc Soc Exp Biol Med. 1985 Apr;178(4):653–655. [PubMed]
  • Lee MR, Ho DD, Gurney ME. Functional interaction and partial homology between human immunodeficiency virus and neuroleukin. Science. 1987 Aug 28;237(4818):1047–1051. [PubMed]
  • Lee WR, Syu WJ, Du B, Matsuda M, Tan S, Wolf A, Essex M, Lee TH. Nonrandom distribution of gp120 N-linked glycosylation sites important for infectivity of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2213–2217. [PMC free article] [PubMed]
  • Legrain P, Goud B, Buttin G. Increase of retroviral infection in vitro by the binding of antiretroviral antibodies. J Virol. 1986 Dec;60(3):1141–1144. [PMC free article] [PubMed]
  • Le Guern M, Levy JA. Human immunodeficiency virus (HIV) type 1 can superinfect HIV-2-infected cells: pseudotype virions produced with expanded cellular host range. Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):363–367. [PMC free article] [PubMed]
  • Lehner T, Bergmeier LA, Panagiotidi C, Tao L, Brookes R, Klavinskis LS, Walker P, Walker J, Ward RG, Hussain L, et al. Induction of mucosal and systemic immunity to a recombinant simian immunodeficiency viral protein. Science. 1992 Nov 20;258(5086):1365–1369. [PubMed]
  • Leis J, Baltimore D, Bishop JM, Coffin J, Fleissner E, Goff SP, Oroszlan S, Robinson H, Skalka AM, Temin HM, et al. Standardized and simplified nomenclature for proteins common to all retroviruses. J Virol. 1988 May;62(5):1808–1809. [PMC free article] [PubMed]
  • Lemaître M, Guétard D, Hénin Y, Montagnier L, Zerial A. Protective activity of tetracycline analogs against the cytopathic effect of the human immunodeficiency viruses in CEM cells. Res Virol. 1990 Jan-Feb;141(1):5–16. [PubMed]
  • Leonard R, Zagury D, Desportes I, Bernard J, Zagury JF, Gallo RC. Cytopathic effect of human immunodeficiency virus in T4 cells is linked to the last stage of virus infection. Proc Natl Acad Sci U S A. 1988 May;85(10):3570–3574. [PMC free article] [PubMed]
  • Levacher M, Hulstaert F, Tallet S, Ullery S, Pocidalo JJ, Bach BA. The significance of activation markers on CD8 lymphocytes in human immunodeficiency syndrome: staging and prognostic value. Clin Exp Immunol. 1992 Dec;90(3):376–382. [PMC free article] [PubMed]
  • Levy JA. Xenotropic type C viruses. Curr Top Microbiol Immunol. 1978;79:111–213. [PubMed]
  • Levy JA. The multifaceted retrovirus. Cancer Res. 1986 Nov;46(11):5457–5468. [PubMed]
  • Levy JA. Can an AIDS vaccine be developed? Transfus Med Rev. 1988 Dec;2(4):264–271. [PubMed]
  • Levy JA. Mysteries of HIV: challenges for therapy and prevention. Nature. 1988 Jun 9;333(6173):519–522. [PubMed]
  • Levy JA. The transmission of AIDS: the case of the infected cell. JAMA. 1988 May 27;259(20):3037–3038. [PubMed]
  • Levy JA. The human immunodeficiency viruses. Detection and pathogenesis. Immunol Ser. 1989;44:159–229. [PubMed]
  • Levy JA. Human immunodeficiency viruses and the pathogenesis of AIDS. JAMA. 1989 May 26;261(20):2997–3006. [PubMed]
  • Levy JA. Changing concepts in HIV infection: challenges for the 1990s. AIDS. 1990 Nov;4(11):1051–1058. [PubMed]
  • Levy JA, Cheng-Mayer C, Dina D, Luciw PA. AIDS retrovirus (ARV-2) clone replicates in transfected human and animal fibroblasts. Science. 1986 May 23;232(4753):998–1001. [PubMed]
  • Levy JA, Greenspan D. HIV in saliva. Lancet. 1988 Nov 26;2(8622):1248–1248. [PubMed]
  • Levy JA, Hoffman AD, Kramer SM, Landis JA, Shimabukuro JM, Oshiro LS. Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS. Science. 1984 Aug 24;225(4664):840–842. [PubMed]
  • Levy JA, Shimabukuro J, Hollander H, Mills J, Kaminsky L. Isolation of AIDS-associated retroviruses from cerebrospinal fluid and brain of patients with neurological symptoms. Lancet. 1985 Sep 14;2(8455):586–588. [PubMed]
  • Levy JA, Kaminsky LS, Morrow WJ, Steimer K, Luciw P, Dina D, Hoxie J, Oshiro L. Infection by the retrovirus associated with the acquired immunodeficiency syndrome. Clinical, biological, and molecular features. Ann Intern Med. 1985 Nov;103(5):694–699. [PubMed]
  • Levy JA, Landay A, Lennette ET. Human herpesvirus 6 inhibits human immunodeficiency virus type 1 replication in cell culture. J Clin Microbiol. 1990 Oct;28(10):2362–2364. [PMC free article] [PubMed]
  • Levy JA, Margaretten W, Nelson J. Detection of HIV in enterochromaffin cells in the rectal mucosa of an AIDS patient. Am J Gastroenterol. 1989 Jul;84(7):787–789. [PubMed]
  • Levy JA, Mitra G, Mozen MM. Recovery and inactivation of infectious retroviruses from factor VIII concentration. Lancet. 1984 Sep 29;2(8405):722–723. [PubMed]
  • Levy JA, Mitra GA, Wong MF, Mozen MM. Inactivation by wet and dry heat of AIDS-associated retroviruses during factor VIII purification from plasma. Lancet. 1985 Jun 22;1(8443):1456–1457. [PubMed]
  • Levy JA, Shimabukuro J, McHugh T, Casavant C, Stites D, Oshiro L. AIDS-associated retroviruses (ARV) can productively infect other cells besides human T helper cells. Virology. 1985 Dec;147(2):441–448. [PubMed]
  • Levy JA, Ziegler JL. Acquired immunodeficiency syndrome is an opportunistic infection and Kaposi's sarcoma results from secondary immune stimulation. Lancet. 1983 Jul 9;2(8341):78–81. [PubMed]
  • Lewis P, Hensel M, Emerman M. Human immunodeficiency virus infection of cells arrested in the cell cycle. EMBO J. 1992 Aug;11(8):3053–3058. [PMC free article] [PubMed]
  • Lewis SH, Reynolds-Kohler C, Fox HE, Nelson JA. HIV-1 in trophoblastic and villous Hofbauer cells, and haematological precursors in eight-week fetuses. Lancet. 1990 Mar 10;335(8689):565–568. [PubMed]
  • Li J, Lord CI, Haseltine W, Letvin NL, Sodroski J. Infection of cynomolgus monkeys with a chimeric HIV-1/SIVmac virus that expresses the HIV-1 envelope glycoproteins. J Acquir Immune Defic Syndr. 1992;5(7):639–646. [PubMed]
  • Li JJ, Friedman-Kien AE, Huang YQ, Mirabile M, Cao YZ. HIV-1 DNA proviral sequences in fresh urine pellets from HIV-1 seropositive persons. Lancet. 1990 Jun 30;335(8705):1590–1591. [PubMed]
  • Li Y, Kappes JC, Conway JA, Price RW, Shaw GM, Hahn BH. Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective viral genomes. J Virol. 1991 Aug;65(8):3973–3985. [PMC free article] [PubMed]
  • Li Y, Luo L, Rasool N, Kang CY. Glycosylation is necessary for the correct folding of human immunodeficiency virus gp120 in CD4 binding. J Virol. 1993 Jan;67(1):584–588. [PMC free article] [PubMed]
  • Lieberman AP, Pitha PM, Shin HS, Shin ML. Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. Proc Natl Acad Sci U S A. 1989 Aug;86(16):6348–6352. [PMC free article] [PubMed]
  • Lifson AR, Buchbinder SP, Sheppard HW, Mawle AC, Wilber JC, Stanley M, Hart CE, Hessol NA, Holmberg SD. Long-term human immunodeficiency virus infection in asymptomatic homosexual and bisexual men with normal CD4+ lymphocyte counts: immunologic and virologic characteristics. J Infect Dis. 1991 May;163(5):959–965. [PubMed]
  • Lifson AR, Hessol NA, Buchbinder SP, O'Malley PM, Barnhart L, Segal M, Katz MH, Holmberg SD. Serum beta 2-microglobulin and prediction of progression to AIDS in HIV infection. Lancet. 1992 Jun 13;339(8807):1436–1440. [PubMed]
  • Lifson AR, Stanley M, Pane J, O'Malley PM, Wilber JC, Stanley A, Jeffery B, Rutherford GW, Sohmer PR. Detection of human immunodeficiency virus DNA using the polymerase chain reaction in a well-characterized group of homosexual and bisexual men. J Infect Dis. 1990 Mar;161(3):436–439. [PubMed]
  • Lifson J, Coutré S, Huang E, Engleman E. Role of envelope glycoprotein carbohydrate in human immunodeficiency virus (HIV) infectivity and virus-induced cell fusion. J Exp Med. 1986 Dec 1;164(6):2101–2106. [PMC free article] [PubMed]
  • Lifson JD, Feinberg MB, Reyes GR, Rabin L, Banapour B, Chakrabarti S, Moss B, Wong-Staal F, Steimer KS, Engleman EG. Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein. Nature. 1986 Oct 23;323(6090):725–728. [PubMed]
  • Lifson JD, Hwang KM, Nara PL, Fraser B, Padgett M, Dunlop NM, Eiden LE. Synthetic CD4 peptide derivatives that inhibit HIV infection and cytopathicity. Science. 1988 Aug 5;241(4866):712–716. [PubMed]
  • Lifson JD, Reyes GR, McGrath MS, Stein BS, Engleman EG. AIDS retrovirus induced cytopathology: giant cell formation and involvement of CD4 antigen. Science. 1986 May 30;232(4754):1123–1127. [PubMed]
  • Lindenmann J. Viruses as immunological adjuvants in cancer. Biochim Biophys Acta. 1974 Apr 29;355(1):49–75. [PubMed]
  • Lindgren S, Anzén B, Bohlin AB, Lidman K. HIV and child-bearing: clinical outcome and aspects of mother-to-infant transmission. AIDS. 1991 Sep;5(9):1111–1116. [PubMed]
  • Linette GP, Hartzman RJ, Ledbetter JA, June CH. HIV-1-infected T cells show a selective signaling defect after perturbation of CD3/antigen receptor. Science. 1988 Jul 29;241(4865):573–576. [PubMed]
  • Linsley PS, Ledbetter JA, Kinney-Thomas E, Hu SL. Effects of anti-gp120 monoclonal antibodies on CD4 receptor binding by the env protein of human immunodeficiency virus type 1. J Virol. 1988 Oct;62(10):3695–3702. [PMC free article] [PubMed]
  • Lipshultz SE, Fox CH, Perez-Atayde AR, Sanders SP, Colan SD, McIntosh K, Winter HS. Identification of human immunodeficiency virus-1 RNA and DNA in the heart of a child with cardiovascular abnormalities and congenital acquired immune deficiency syndrome. Am J Cardiol. 1990 Jul 15;66(2):246–250. [PubMed]
  • Lipton SA. Calcium channel antagonists and human immunodeficiency virus coat protein-mediated neuronal injury. Ann Neurol. 1991 Jul;30(1):110–114. [PubMed]
  • Lipton SA, Sucher NJ, Kaiser PK, Dreyer EB. Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity. Neuron. 1991 Jul;7(1):111–118. [PubMed]
  • Liu ZQ, Wood C, Levy JA, Cheng-Mayer C. The viral envelope gene is involved in macrophage tropism of a human immunodeficiency virus type 1 strain isolated from brain tissue. J Virol. 1990 Dec;64(12):6148–6153. [PMC free article] [PubMed]
  • Ljunggren K, Biberfeld G, Jondal M, Fenyö EM. Antibody-dependent cellular cytotoxicity detects type- and strain-specific antigens among human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus SIVmac isolates. J Virol. 1989 Aug;63(8):3376–3381. [PMC free article] [PubMed]
  • Ljunggren K, Böttiger B, Biberfeld G, Karlson A, Fenyö EM, Jondal M. Antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus. Presence at different clinical stages. J Immunol. 1987 Oct 1;139(7):2263–2267. [PubMed]
  • Ljunggren K, Broliden PA, Morfeldt-Månson L, Jondal M, Wahren B. IgG subclass response to HIV in relation to antibody-dependent cellular cytotoxicity at different clinical stages. Clin Exp Immunol. 1988 Sep;73(3):343–347. [PMC free article] [PubMed]
  • Lo SC. Isolation and identification of a novel virus from patients with AIDS. Am J Trop Med Hyg. 1986 Jul;35(4):675–676. [PubMed]
  • Lo SC, Dawson MS, Newton PB, 3rd, Sonoda MA, Shih JW, Engler WF, Wang RY, Wear DJ. Association of the virus-like infectious agent originally reported in patients with AIDS with acute fatal disease in previously healthy non-AIDS patients. Am J Trop Med Hyg. 1989 Sep;41(3):364–376. [PubMed]
  • Lo SC, Hayes MM, Wang RY, Pierce PF, Kotani H, Shih JW. Newly discovered mycoplasma isolated from patients infected with HIV. Lancet. 1991 Dec 7;338(8780):1415–1418. [PubMed]
  • Lo SC, Tsai S, Benish JR, Shih JW, Wear DJ, Wong DM. Enhancement of HIV-1 cytocidal effects in CD4+ lymphocytes by the AIDS-associated mycoplasma. Science. 1991 Mar 1;251(4997):1074–1076. [PubMed]
  • Lo SC, Wang RY, Newton PB, 3rd, Yang NY, Sonoda MA, Shih JW. Fatal infection of silvered leaf monkeys with a virus-like infectious agent (VLIA) derived from a patient with AIDS. Am J Trop Med Hyg. 1989 Apr;40(4):399–409. [PubMed]
  • Looney DJ, Fisher AG, Putney SD, Rusche JR, Redfield RR, Burke DS, Gallo RC, Wong-Staal F. Type-restricted neutralization of molecular clones of human immunodeficiency virus. Science. 1988 Jul 15;241(4863):357–359. [PubMed]
  • Lori F, di Marzo Veronese F, de Vico AL, Lusso P, Reitz MS, Jr, Gallo RC. Viral DNA carried by human immunodeficiency virus type 1 virions. J Virol. 1992 Aug;66(8):5067–5074. [PMC free article] [PubMed]
  • Luciw PA, Cheng-Mayer C, Levy JA. Mutational analysis of the human immunodeficiency virus: the orf-B region down-regulates virus replication. Proc Natl Acad Sci U S A. 1987 Mar;84(5):1434–1438. [PMC free article] [PubMed]
  • Luciw PA, Potter SJ, Steimer K, Dina D, Levy JA. Molecular cloning of AIDS-associated retrovirus. Nature. 1984 Dec 20;312(5996):760–763. [PubMed]
  • Liuzzi GM, Mastroianni CM, Vullo V, Jirillo E, Delia S, Riccio P. Cerebrospinal fluid myelin basic protein as predictive marker of demyelination in AIDS dementia complex. J Neuroimmunol. 1992 Feb;36(2-3):251–254. [PubMed]
  • Luria S, Chambers I, Berg P. Expression of the type 1 human immunodeficiency virus Nef protein in T cells prevents antigen receptor-mediated induction of interleukin 2 mRNA. Proc Natl Acad Sci U S A. 1991 Jun 15;88(12):5326–5330. [PMC free article] [PubMed]
  • Lusso P, De Maria A, Malnati M, Lori F, DeRocco SE, Baseler M, Gallo RC. Induction of CD4 and susceptibility to HIV-1 infection in human CD8+ T lymphocytes by human herpesvirus 6. Nature. 1991 Feb 7;349(6309):533–535. [PubMed]
  • Lusso P, Ensoli B, Markham PD, Ablashi DV, Salahuddin SZ, Tschachler E, Wong-Staal F, Gallo RC. Productive dual infection of human CD4+ T lymphocytes by HIV-1 and HHV-6. Nature. 1989 Jan 26;337(6205):370–373. [PubMed]
  • Lynn WS, Tweedale A, Cloyd MW. Human immunodeficiency virus (HIV-1) cytotoxicity: perturbation of the cell membrane and depression of phospholipid synthesis. Virology. 1988 Mar;163(1):43–51. [PubMed]
  • Mackewicz C, Levy JA. CD8+ cell anti-HIV activity: nonlytic suppression of virus replication. AIDS Res Hum Retroviruses. 1992 Jun;8(6):1039–1050. [PubMed]
  • Mackewicz CE, Ortega HW, Levy JA. CD8+ cell anti-HIV activity correlates with the clinical state of the infected individual. J Clin Invest. 1991 Apr;87(4):1462–1466. [PMC free article] [PubMed]
  • Maclean C, Flegg PJ, Kilpatrick DC. Anti-cardiolipin antibodies and HIV infection. Clin Exp Immunol. 1990 Aug;81(2):263–266. [PMC free article] [PubMed]
  • Maddon PJ, Dalgleish AG, McDougal JS, Clapham PR, Weiss RA, Axel R. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell. 1986 Nov 7;47(3):333–348. [PubMed]
  • Maitra RK, Ahmad N, Holland SM, Venkatesan S. Human immunodeficiency virus type 1 (HIV-1) provirus expression and LTR transcription are repressed in NEF-expressing cell lines. Virology. 1991 Jun;182(2):522–533. [PubMed]
  • Mangan DF, Robertson B, Wahl SM. IL-4 enhances programmed cell death (apoptosis) in stimulated human monocytes. J Immunol. 1992 Mar 15;148(6):1812–1816. [PubMed]
  • Mann DL, Lasane F, Popovic M, Arthur LO, Robey WG, Blattner WA, Newman MJ. HTLV-III large envelope protein (gp120) suppresses PHA-induced lymphocyte blastogenesis. J Immunol. 1987 Apr 15;138(8):2640–2644. [PubMed]
  • Mano H, Chermann JC. Fetal human immunodeficiency virus type 1 infection of different organs in the second trimester. AIDS Res Hum Retroviruses. 1991 Jan;7(1):83–88. [PubMed]
  • Margolick JB, Volkman DJ, Folks TM, Fauci AS. Amplification of HTLV-III/LAV infection by antigen-induced activation of T cells and direct suppression by virus of lymphocyte blastogenic responses. J Immunol. 1987 Mar 15;138(6):1719–1723. [PubMed]
  • Mariotti M, Lefrère JJ, Noel B, Ferrer-Le-Coeur F, Vittecoq D, Girot R, Bosser C, Couroucé AM, Salmon C, Rouger P. DNA amplification of HIV-1 in seropositive individuals and in seronegative at-risk individuals. AIDS. 1990 Jul;4(7):633–637. [PubMed]
  • Markwell MA, Svennerholm L, Paulson JC. Specific gangliosides function as host cell receptors for Sendai virus. Proc Natl Acad Sci U S A. 1981 Sep;78(9):5406–5410. [PMC free article] [PubMed]
  • Marthas ML, Sutjipto S, Higgins J, Lohman B, Torten J, Luciw PA, Marx PA, Pedersen NC. Immunization with a live, attenuated simian immunodeficiency virus (SIV) prevents early disease but not infection in rhesus macaques challenged with pathogenic SIV. J Virol. 1990 Aug;64(8):3694–3700. [PMC free article] [PubMed]
  • Martin NL, Levy JA, Legg H, Weintrub PS, Cowan MJ, Wara DW. Detection of infection with human immunodeficiency virus (HIV) type 1 in infants by an anti-HIV immunoglobulin A assay using recombinant proteins. J Pediatr. 1991 Mar;118(3):354–358. [PubMed]
  • Martins LP, Chenciner N, Asjö B, Meyerhans A, Wain-Hobson S. Independent fluctuation of human immunodeficiency virus type 1 rev and gp41 quasispecies in vivo. J Virol. 1991 Aug;65(8):4502–4507. [PMC free article] [PubMed]
  • Marx PA, Li Y, Lerche NW, Sutjipto S, Gettie A, Yee JA, Brotman BH, Prince AM, Hanson A, Webster RG, et al. Isolation of a simian immunodeficiency virus related to human immunodeficiency virus type 2 from a west African pet sooty mangabey. J Virol. 1991 Aug;65(8):4480–4485. [PMC free article] [PubMed]
  • Masur H, Michelis MA, Greene JB, Onorato I, Stouwe RA, Holzman RS, Wormser G, Brettman L, Lange M, Murray HW, et al. An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction. N Engl J Med. 1981 Dec 10;305(24):1431–1438. [PubMed]
  • Mathijs JM, Hing M, Grierson J, Dwyer DE, Goldschmidt C, Cooper DA, Cunningham AL. HIV infection of rectal mucosa. Lancet. 1988 May 14;1(8594):1111–1111. [PubMed]
  • Matsuyama T, Kobayashi N, Yamamoto N. Cytokines and HIV infection: is AIDS a tumor necrosis factor disease? AIDS. 1991 Dec;5(12):1405–1417. [PubMed]
  • Matthews TJ, Langlois AJ, Robey WG, Chang NT, Gallo RC, Fischinger PJ, Bolognesi DP. Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein. Proc Natl Acad Sci U S A. 1986 Dec;83(24):9709–9713. [PMC free article] [PubMed]
  • Matthews TJ, Weinhold KJ, Lyerly HK, Langlois AJ, Wigzell H, Bolognesi DP. Interaction between the human T-cell lymphotropic virus type IIIB envelope glycoprotein gp120 and the surface antigen CD4: role of carbohydrate in binding and cell fusion. Proc Natl Acad Sci U S A. 1987 Aug;84(15):5424–5428. [PMC free article] [PubMed]
  • Maury W, Potts BJ, Rabson AB. HIV-1 infection of first-trimester and term human placental tissue: a possible mode of maternal-fetal transmission. J Infect Dis. 1989 Oct;160(4):583–588. [PubMed]
  • McClure HM, Anderson DC, Fultz PN, Ansari AA, Jehuda-Cohen T, Villinger F, Klumpp SA, Switzer W, Lockwood E, Brodie A, et al. Maternal transmission of SIVsmm in rhesus macaques. J Med Primatol. 1991 Jun;20(4):182–187. [PubMed]
  • McClure MO, Marsh M, Weiss RA. Human immunodeficiency virus infection of CD4-bearing cells occurs by a pH-independent mechanism. EMBO J. 1988 Feb;7(2):513–518. [PMC free article] [PubMed]
  • McClure MO, Moore JP, Blanc DF, Scotting P, Cook GM, Keynes RJ, Weber JN, Davies D, Weiss RA. Investigations into the mechanism by which sulfated polysaccharides inhibit HIV infection in vitro. AIDS Res Hum Retroviruses. 1992 Jan;8(1):19–26. [PubMed]
  • McCune JM, Rabin LB, Feinberg MB, Lieberman M, Kosek JC, Reyes GR, Weissman IL. Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus. Cell. 1988 Apr 8;53(1):55–67. [PubMed]
  • McCutchan FE, Sanders-Buell E, Oster CW, Redfield RR, Hira SK, Perine PL, Ungar BL, Burke DS. Genetic comparison of human immunodeficiency virus (HIV-1) isolates by polymerase chain reaction. J Acquir Immune Defic Syndr. 1991;4(12):1241–1250. [PubMed]
  • McDougal JS, Kennedy MS, Sligh JM, Cort SP, Mawle A, Nicholson JK. Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule. Science. 1986 Jan 24;231(4736):382–385. [PubMed]
  • McDougal JS, Klatzmann DR, Maddon PJ. CD4-gp120 interactions. Curr Opin Immunol. 1991 Aug;3(4):552–558. [PubMed]
  • McDougal JS, Martin LS, Cort SP, Mozen M, Heldebrant CM, Evatt BL. Thermal inactivation of the acquired immunodeficiency syndrome virus, human T lymphotropic virus-III/lymphadenopathy-associated virus, with special reference to antihemophilic factor. J Clin Invest. 1985 Aug;76(2):875–877. [PMC free article] [PubMed]
  • McElrath MJ, Pruett JE, Cohn ZA. Mononuclear phagocytes of blood and bone marrow: comparative roles as viral reservoirs in human immunodeficiency virus type 1 infections. Proc Natl Acad Sci U S A. 1989 Jan;86(2):675–679. [PMC free article] [PubMed]
  • McGrath MS, Hwang KM, Caldwell SE, Gaston I, Luk KC, Wu P, Ng VL, Crowe S, Daniels J, Marsh J, et al. GLQ223: an inhibitor of human immunodeficiency virus replication in acutely and chronically infected cells of lymphocyte and mononuclear phagocyte lineage. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2844–2848. [PMC free article] [PubMed]
  • McGuire TC, Adams DS, Johnson GC, Klevjer-Anderson P, Barbee DD, Gorham JR. Acute arthritis in caprine arthritis-encephalitis virus challenge exposure of vaccinated or persistently infected goats. Am J Vet Res. 1986 Mar;47(3):537–540. [PubMed]
  • McKeating JA, McKnight A, Moore JP. Differential loss of envelope glycoprotein gp120 from virions of human immunodeficiency virus type 1 isolates: effects on infectivity and neutralization. J Virol. 1991 Feb;65(2):852–860. [PMC free article] [PubMed]
  • McKeating JA, Cordell J, Dean CJ, Balfe P. Synergistic interaction between ligands binding to the CD4 binding site and V3 domain of human immunodeficiency virus type I gp120. Virology. 1992 Dec;191(2):732–742. [PubMed]
  • McKeating JA, Gow J, Goudsmit J, Pearl LH, Mulder C, Weiss RA. Characterization of HIV-1 neutralization escape mutants. AIDS. 1989 Dec;3(12):777–784. [PubMed]
  • McKeating JA, Griffiths PD, Weiss RA. HIV susceptibility conferred to human fibroblasts by cytomegalovirus-induced Fc receptor. Nature. 1990 Feb 15;343(6259):659–661. [PubMed]
  • McMillan A, Bishop PE, Aw D, Peutherer JF. Immunohistology of the skin rash associated with acute HIV infection. AIDS. 1989 May;3(5):309–312. [PubMed]
  • McNearney T, Hornickova Z, Markham R, Birdwell A, Arens M, Saah A, Ratner L. Relationship of human immunodeficiency virus type 1 sequence heterogeneity to stage of disease. Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10247–10251. [PMC free article] [PubMed]
  • McNearney T, Westervelt P, Thielan BJ, Trowbridge DB, Garcia J, Whittier R, Ratner L. Limited sequence heterogeneity among biologically distinct human immunodeficiency virus type 1 isolates from individuals involved in a clustered infectious outbreak. Proc Natl Acad Sci U S A. 1990 Mar;87(5):1917–1921. [PMC free article] [PubMed]
  • McQuade TJ, Tomasselli AG, Liu L, Karacostas V, Moss B, Sawyer TK, Heinrikson RL, Tarpley WG. A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation. Science. 1990 Jan 26;247(4941):454–456. [PubMed]
  • Meek TD, Lambert DM, Dreyer GB, Carr TJ, Tomaszek TA, Jr, Moore ML, Strickler JE, Debouck C, Hyland LJ, Matthews TJ, et al. Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues. Nature. 1990 Jan 4;343(6253):90–92. [PubMed]
  • Meerloo T, Parmentier HK, Osterhaus AD, Goudsmit J, Schuurman HJ. Modulation of cell surface molecules during HIV-1 infection of H9 cells. An immunoelectron microscopic study. AIDS. 1992 Oct;6(10):1105–1116. [PubMed]
  • Mellert W, Kleinschmidt A, Schmidt J, Festl H, Emler S, Roth WK, Erfle V. Infection of human fibroblasts and osteoblast-like cells with HIV-1. AIDS. 1990 Jun;4(6):527–535. [PubMed]
  • Menez-Bautista R, Fikrig SM, Pahwa S, Sarangadharan MG, Stoneburner RL. Monozygotic twins discordant for the acquired immunodeficiency syndrome. Am J Dis Child. 1986 Jul;140(7):678–679. [PubMed]
  • Mermin JH, Holodniy M, Katzenstein DA, Merigan TC. Detection of human immunodeficiency virus DNA and RNA in semen by the polymerase chain reaction. J Infect Dis. 1991 Oct;164(4):769–772. [PubMed]
  • Merrill JE. Cytokines and retroviruses. Clin Immunol Immunopathol. 1992 Jul;64(1):23–27. [PubMed]
  • Merrill JE, Koyanagi Y, Chen IS. Interleukin-1 and tumor necrosis factor alpha can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor. J Virol. 1989 Oct;63(10):4404–4408. [PMC free article] [PubMed]
  • Merrill JE, Koyanagi Y, Zack J, Thomas L, Martin F, Chen IS. Induction of interleukin-1 and tumor necrosis factor alpha in brain cultures by human immunodeficiency virus type 1. J Virol. 1992 Apr;66(4):2217–2225. [PMC free article] [PubMed]
  • Meyaard L, Otto SA, Jonker RR, Mijnster MJ, Keet RP, Miedema F. Programmed death of T cells in HIV-1 infection. Science. 1992 Jul 10;257(5067):217–219. [PubMed]
  • Meyenhofer MF, Epstein LG, Cho ES, Sharer LR. Ultrastructural morphology and intracellular production of human immunodeficiency virus (HIV) in brain. J Neuropathol Exp Neurol. 1987 Jul;46(4):474–484. [PubMed]
  • Meyerhans A, Cheynier R, Albert J, Seth M, Kwok S, Sninsky J, Morfeldt-Månson L, Asjö B, Wain-Hobson S. Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations. Cell. 1989 Sep 8;58(5):901–910. [PubMed]
  • Meyerhans A, Dadaglio G, Vartanian JP, Langlade-Demoyen P, Frank R, Asjö B, Plata F, Wain-Hobson S. In vivo persistence of a HIV-1-encoded HLA-B27-restricted cytotoxic T lymphocyte epitope despite specific in vitro reactivity. Eur J Immunol. 1991 Oct;21(10):2637–2640. [PubMed]
  • Michael NL, Morrow P, Mosca J, Vahey M, Burke DS, Redfield RR. Induction of human immunodeficiency virus type 1 expression in chronically infected cells is associated primarily with a shift in RNA splicing patterns. J Virol. 1991 Mar;65(3):1291–1303. [PMC free article] [PubMed]
  • Michaelis BA, Levy JA. Recovery of human immunodeficiency virus from serum. JAMA. 1987 Mar 13;257(10):1327–1327. [PubMed]
  • Michaelis B, Levy JA. HIV replication can be blocked by recombinant human interferon beta. AIDS. 1989 Jan;3(1):27–31. [PubMed]
  • Michaels J, Sharer LR, Epstein LG. Human immunodeficiency virus type 1 (HIV-1) infection of the nervous system: a review. Immunodefic Rev. 1988;1(1):71–104. [PubMed]
  • Michel ML, Mancini M, Riviere Y, Dormont D, Tiollais P. T- and B-lymphocyte responses to human immunodeficiency virus (HIV) type 1 in macaques immunized with hybrid HIV/hepatitis B surface antigen particles. J Virol. 1990 May;64(5):2452–2455. [PMC free article] [PubMed]
  • Miedema F, Petit AJ, Terpstra FG, Schattenkerk JK, de Wolf F, Al BJ, Roos M, Lange JM, Danner SA, Goudsmit J, et al. Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs. J Clin Invest. 1988 Dec;82(6):1908–1914. [PMC free article] [PubMed]
  • Mildvan D, Mathur U, Enlow RW, Romain PL, Winchester RJ, Colp C, Singman H, Adelsberg BR, Spigland I. Opportunistic infections and immune deficiency in homosexual men. Ann Intern Med. 1982 Jun;96(6 Pt 1):700–704. [PubMed]
  • Miller C, Gardner MB. AIDS and mucosal immunity: usefulness of the SIV macaque model of genital mucosal transmission. J Acquir Immune Defic Syndr. 1991;4(12):1169–1172. [PubMed]
  • Miller MA, Garry RF, Jaynes JM, Montelaro RC. A structural correlation between lentivirus transmembrane proteins and natural cytolytic peptides. AIDS Res Hum Retroviruses. 1991 Jun;7(6):511–519. [PubMed]
  • Mitsuya H, Weinhold KJ, Furman PA, St Clair MH, Lehrman SN, Gallo RC, Bolognesi D, Barry DW, Broder S. 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. Proc Natl Acad Sci U S A. 1985 Oct;82(20):7096–7100. [PMC free article] [PubMed]
  • Mitsuya H, Yarchoan R, Broder S. Molecular targets for AIDS therapy. Science. 1990 Sep 28;249(4976):1533–1544. [PubMed]
  • Miyoshi I, Kubonishi I, Yoshimoto S, Akagi T, Ohtsuki Y, Shiraishi Y, Nagata K, Hinuma Y. Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells. Nature. 1981 Dec 24;294(5843):770–771. [PubMed]
  • Mizukami T, Fuerst TR, Berger EA, Moss B. Binding region for human immunodeficiency virus (HIV) and epitopes for HIV-blocking monoclonal antibodies of the CD4 molecule defined by site-directed mutagenesis. Proc Natl Acad Sci U S A. 1988 Dec;85(23):9273–9277. [PMC free article] [PubMed]
  • Moebius U, Clayton LK, Abraham S, Harrison SC, Reinherz EL. The human immunodeficiency virus gp120 binding site on CD4: delineation by quantitative equilibrium and kinetic binding studies of mutants in conjunction with a high-resolution CD4 atomic structure. J Exp Med. 1992 Aug 1;176(2):507–517. [PMC free article] [PubMed]
  • Molina JM, Scadden DT, Sakaguchi M, Fuller B, Woon A, Groopman JE. Lack of evidence for infection of or effect on growth of hematopoietic progenitor cells after in vivo or in vitro exposure to human immunodeficiency virus. Blood. 1990 Dec 15;76(12):2476–2482. [PubMed]
  • Molina JM, Schindler R, Ferriani R, Sakaguchi M, Vannier E, Dinarello CA, Groopman JE. Production of cytokines by peripheral blood monocytes/macrophages infected with human immunodeficiency virus type 1 (HIV-1). J Infect Dis. 1990 May;161(5):888–893. [PubMed]
  • Monroe JE, Calender A, Mulder C. Epstein-Barr virus-positive and -negative B-cell lines can be infected with human immunodeficiency virus types 1 and 2. J Virol. 1988 Sep;62(9):3497–3500. [PMC free article] [PubMed]
  • Montagnier L, Gruest J, Chamaret S, Dauguet C, Axler C, Guétard D, Nugeyre MT, Barré-Sinoussi F, Chermann JC, Brunet JB, et al. Adaptation of lymphadenopathy associated virus (LAV) to replication in EBV-transformed B lymphoblastoid cell lines. Science. 1984 Jul 6;225(4657):63–66. [PubMed]
  • Montefiori DC, Lefkowitz LB, Jr, Keller RE, Holmberg V, Sandstrom E, Phair JP. Absence of a clinical correlation for complement-mediated, infection-enhancing antibodies in plasma or sera from HIV-1-infected individuals. Multicenter AIDS Cohort Study Group. AIDS. 1991 May;5(5):513–517. [PubMed]
  • Montefiori DC, Murphey-Corb M, Desrosiers RC, Daniel MD. Complement-mediated, infection-enhancing antibodies in plasma from vaccinated macaques before and after inoculation with live simian immunodeficiency virus. J Virol. 1990 Oct;64(10):5223–5225. [PMC free article] [PubMed]
  • Montefiori DC, Robinson WE, Jr, Hirsch VM, Modliszewski A, Mitchell WM, Johnson PR. Antibody-dependent enhancement of simian immunodeficiency virus (SIV) infection in vitro by plasma from SIV-infected rhesus macaques. J Virol. 1990 Jan;64(1):113–119. [PMC free article] [PubMed]
  • Moore JP, McKeating JA, Huang YX, Ashkenazi A, Ho DD. Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolates. J Virol. 1992 Jan;66(1):235–243. [PMC free article] [PubMed]
  • Moore JP, McKeating JA, Norton WA, Sattentau QJ. Direct measurement of soluble CD4 binding to human immunodeficiency virus type 1 virions: gp120 dissociation and its implications for virus-cell binding and fusion reactions and their neutralization by soluble CD4. J Virol. 1991 Mar;65(3):1133–1140. [PMC free article] [PubMed]
  • Moore JP, McKeating JA, Weiss RA, Sattentau QJ. Dissociation of gp120 from HIV-1 virions induced by soluble CD4. Science. 1990 Nov 23;250(4984):1139–1142. [PubMed]
  • Morein B, Sundquist B, Höglund S, Dalsgaard K, Osterhaus A. Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses. Nature. 308(5958):457–460. [PubMed]
  • Mori S, Takada R, Shimotohno K, Okamoto T. Repressive effect of the nef cDNA of human immunodeficiency virus type 1 on the promoter activity of the viral long terminal repeat. Jpn J Cancer Res. 1990 Nov;81(11):1124–1131. [PubMed]
  • Morikawa Y, Moore JP, Wilkinson AJ, Jones IM. Reduction in CD4 binding affinity associated with removal of a single glycosylation site in the external glycoprotein of HIV-2. Virology. 1991 Feb;180(2):853–856. [PubMed]
  • Morrow WJ, Isenberg DA, Sobol RE, Stricker RB, Kieber-Emmons T. AIDS virus infection and autoimmunity: a perspective of the clinical, immunological, and molecular origins of the autoallergic pathologies associated with HIV disease. Clin Immunol Immunopathol. 1991 Feb;58(2):163–180. [PubMed]
  • Morrow WJ, Wharton M, Stricker RB, Levy JA. Circulating immune complexes in patients with acquired immune deficiency syndrome contain the AIDS-associated retrovirus. Clin Immunol Immunopathol. 1986 Sep;40(3):515–524. [PubMed]
  • Mosca JD, Bednarik DP, Raj NB, Rosen CA, Sodroski JG, Haseltine WA, Pitha PM. Herpes simplex virus type-1 can reactivate transcription of latent human immunodeficiency virus. Nature. 1987 Jan 1;325(6099):67–70. [PubMed]
  • Mosier DE, Gulizia RJ, Baird SM, Wilson DB. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature. 1988 Sep 15;335(6187):256–259. [PubMed]
  • Mosier DE, Gulizia RJ, Baird SM, Wilson DB, Spector DH, Spector SA. Human immunodeficiency virus infection of human-PBL-SCID mice. Science. 1991 Feb 15;251(4995):791–794. [PubMed]
  • Moss AR. Predicting who will progress to AIDS. BMJ. 1988 Oct 29;297(6656):1067–1068. [PMC free article] [PubMed]
  • Moss AR, Bacchetti P. Natural history of HIV infection. AIDS. 1989 Feb;3(2):55–61. [PubMed]
  • Moyer MP, Huot RI, Ramirez A, Jr, Joe S, Meltzer MS, Gendelman HE. Infection of human gastrointestinal cells by HIV-1. AIDS Res Hum Retroviruses. 1990 Dec;6(12):1409–1415. [PubMed]
  • Muesing MA, Smith DH, Cabradilla CD, Benton CV, Lasky LA, Capon DJ. Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus. Nature. 1985 Feb 7;313(6002):450–458. [PubMed]
  • Mulder C. Human AIDS virus not from monkeys. Nature. 1988 Jun 2;333(6172):396–396. [PubMed]
  • Mulder JW, Krijnen P, Goudsmit J, Schattenkerk JK, Reiss P, Lange JM. HIV-1 P24 antigenaemia does not predict time of survival in AIDS patients. Genitourin Med. 1990 Jun;66(3):138–141. [PMC free article] [PubMed]
  • Mundy DC, Schinazi RF, Gerber AR, Nahmias AJ, Randall HW., Jr Human immunodeficiency virus isolated from amniotic fluid. Lancet. 1987 Aug 22;2(8556):459–460. [PubMed]
  • Munis JR, Kornbluth RS, Guatelli JC, Richman DD. Ordered appearance of human immunodeficiency virus type 1 nucleic acids following high multiplicity infection of macrophages. J Gen Virol. 1992 Aug;73(Pt 8):1899–1906. [PubMed]
  • Murakami T, Hattori T, Takatsuki K. A principal neutralizing domain of human immunodeficiency virus type 1 interacts with proteinase-like molecule(s) at the surface of Molt-4 clone 8 cells. Biochim Biophys Acta. 1991 Sep 20;1079(3):279–284. [PubMed]
  • Murphey-Corb M, Martin LN, Davison-Fairburn B, Montelaro RC, Miller M, West M, Ohkawa S, Baskin GB, Zhang JY, Putney SD, et al. A formalin-inactivated whole SIV vaccine confers protection in macaques. Science. 1989 Dec 8;246(4935):1293–1297. [PubMed]
  • Murphey-Corb M, Martin LN, Rangan SR, Baskin GB, Gormus BJ, Wolf RH, Andes WA, West M, Montelaro RC. Isolation of an HTLV-III-related retrovirus from macaques with simian AIDS and its possible origin in asymptomatic mangabeys. Nature. 1986 May 22;321(6068):435–437. [PubMed]
  • Murphey-Corb M, Montelaro RC, Miller MA, West M, Martin LN, Davison-Fairburn B, Ohkawa S, Baskin GB, Zhang JY, Miller GB, et al. Efficacy of SIV/deltaB670 glycoprotein-enriched and glycoprotein-depleted subunit vaccines in protecting against infection and disease in rhesus monkeys. AIDS. 1991 Jun;5(6):655–662. [PubMed]
  • Myers G, MacInnes K, Korber B. The emergence of simian/human immunodeficiency viruses. AIDS Res Hum Retroviruses. 1992 Mar;8(3):373–386. [PubMed]
  • Nabel G, Baltimore D. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature. 1987 Apr 16;326(6114):711–713. [PubMed]
  • Nabel GJ, Rice SA, Knipe DM, Baltimore D. Alternative mechanisms for activation of human immunodeficiency virus enhancer in T cells. Science. 1988 Mar 11;239(4845):1299–1302. [PubMed]
  • Namikawa R, Kaneshima H, Lieberman M, Weissman IL, McCune JM. Infection of the SCID-hu mouse by HIV-1. Science. 1988 Dec 23;242(4886):1684–1686. [PubMed]
  • Nara PL, Smit L, Dunlop N, Hatch W, Merges M, Waters D, Kelliher J, Gallo RC, Fischinger PJ, Goudsmit J. Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzees. J Virol. 1990 Aug;64(8):3779–3791. [PMC free article] [PubMed]
  • Navia BA, Price RW. The acquired immunodeficiency syndrome dementia complex as the presenting or sole manifestation of human immunodeficiency virus infection. Arch Neurol. 1987 Jan;44(1):65–69. [PubMed]
  • Naylor PH, Naylor CW, Badamchian M, Wada S, Goldstein AL, Wang SS, Sun DK, Thornton AH, Sarin PS. Human immunodeficiency virus contains an epitope immunoreactive with thymosin alpha 1 and the 30-amino acid synthetic p17 group-specific antigen peptide HGP-30. Proc Natl Acad Sci U S A. 1987 May;84(9):2951–2955. [PMC free article] [PubMed]
  • Nelbock P, Dillon PJ, Perkins A, Rosen CA. A cDNA for a protein that interacts with the human immunodeficiency virus Tat transactivator. Science. 1990 Jun 29;248(4963):1650–1653. [PubMed]
  • Nelson JA, Ghazal P, Wiley CA. Role of opportunistic viral infections in AIDS. AIDS. 1990 Jan;4(1):1–10. [PubMed]
  • Nelson JA, Reynolds-Kohler C, Oldstone MB, Wiley CA. HIV and HCMV coinfect brain cells in patients with AIDS. Virology. 1988 Jul;165(1):286–290. [PubMed]
  • Nelson JA, Wiley CA, Reynolds-Kohler C, Reese CE, Margaretten W, Levy JA. Human immunodeficiency virus detected in bowel epithelium from patients with gastrointestinal symptoms. Lancet. 1988 Feb 6;1(8580):259–262. [PubMed]
  • Newburg DS, Viscidi RP, Ruff A, Yolken RH. A human milk factor inhibits binding of human immunodeficiency virus to the CD4 receptor. Pediatr Res. 1992 Jan;31(1):22–28. [PubMed]
  • Risk factors for mother-to-child transmission of HIV-1. Lancet. 1992 Apr 25;339(8800):1007–1012. [PubMed]
  • Newstein M, Stanbridge EJ, Casey G, Shank PR. Human chromosome 12 encodes a species-specific factor which increases human immunodeficiency virus type 1 tat-mediated trans activation in rodent cells. J Virol. 1990 Sep;64(9):4565–4567. [PMC free article] [PubMed]
  • Ngugi EN, Plummer FA, Simonsen JN, Cameron DW, Bosire M, Waiyaki P, Ronald AR, Ndinya-Achola JO. Prevention of transmission of human immunodeficiency virus in Africa: effectiveness of condom promotion and health education among prostitutes. Lancet. 1988 Oct 15;2(8616):887–890. [PubMed]
  • Nicholson JK, Cross GD, Callaway CS, McDougal JS. In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). J Immunol. 1986 Jul 1;137(1):323–329. [PubMed]
  • Niederman TM, Garcia JV, Hastings WR, Luria S, Ratner L. Human immunodeficiency virus type 1 Nef protein inhibits NF-kappa B induction in human T cells. J Virol. 1992 Oct;66(10):6213–6219. [PMC free article] [PubMed]
  • Niederman TM, Hu W, Ratner L. Simian immunodeficiency virus negative factor suppresses the level of viral mRNA in COS cells. J Virol. 1991 Jul;65(7):3538–3546. [PMC free article] [PubMed]
  • Niederman TM, Thielan BJ, Ratner L. Human immunodeficiency virus type 1 negative factor is a transcriptional silencer. Proc Natl Acad Sci U S A. 1989 Feb;86(4):1128–1132. [PMC free article] [PubMed]
  • Niruthisard S, Roddy RE, Chutivongse S. The effects of frequent nonoxynol-9 use on the vaginal and cervical mucosa. Sex Transm Dis. 1991 Jul-Sep;18(3):176–179. [PubMed]
  • Nixon DF, McMichael AJ. Cytotoxic T-cell recognition of HIV proteins and peptides. AIDS. 1991 Sep;5(9):1049–1059. [PubMed]
  • Nkowane BM. Prevalence and incidence of HIV infection in Africa: a review of data published in 1990. AIDS. 1991;5 (Suppl 1):S7–15. [PubMed]
  • Nolan GP, Ghosh S, Liou HC, Tempst P, Baltimore D. DNA binding and I kappa B inhibition of the cloned p65 subunit of NF-kappa B, a rel-related polypeptide. Cell. 1991 Mar 8;64(5):961–969. [PubMed]
  • Norley SG, Mikschy U, Werner A, Staszewski S, Helm EB, Kurth R. Demonstration of cross-reactive antibodies able to elicit lysis of both HIV-1- and HIV-2-infected cells. J Immunol. 1990 Sep 15;145(6):1700–1705. [PubMed]
  • Noronha IL, Daniel V, Schimpf K, Opelz G. Soluble IL-2 receptor and tumour necrosis factor-alpha in plasma of haemophilia patients infected with HIV. Clin Exp Immunol. 1992 Feb;87(2):287–292. [PMC free article] [PubMed]
  • Notkins AL, Mergenhagen SE, Howard RJ. Effect of virus infections on the function of the immune system. Annu Rev Microbiol. 1970;24:525–538. [PubMed]
  • Numazaki K, Bai XQ, Goldman H, Wong I, Spira B, Wainberg MA. Infection of cultured human thymic epithelial cells by human immunodeficiency virus. Clin Immunol Immunopathol. 1989 May;51(2):185–195. [PubMed]
  • Nygren A, Bergman T, Matthews T, Jörnvall H, Wigzell H. 95- and 25-kDa fragments of the human immunodeficiency virus envelope glycoprotein gp120 bind to the CD4 receptor. Proc Natl Acad Sci U S A. 1988 Sep;85(17):6543–6546. [PMC free article] [PubMed]
  • O'Brien TR, George JR, Holmberg SD. Human immunodeficiency virus type 2 infection in the United States. Epidemiology, diagnosis, and public health implications. JAMA. 1992 May 27;267(20):2775–2779. [PubMed]
  • O'Brien WA, Chen IS, Ho DD, Daar ES. Mapping genetic determinants for human immunodeficiency virus type 1 resistance to soluble CD4. J Virol. 1992 May;66(5):3125–3130. [PMC free article] [PubMed]
  • O'Brien WA, Koyanagi Y, Namazie A, Zhao JQ, Diagne A, Idler K, Zack JA, Chen IS. HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain. Nature. 1990 Nov 1;348(6296):69–73. [PubMed]
  • Ochs HD, Morton WR, Tsai CC, Thouless ME, Zhu Q, Kuller LD, Wu YP, Benveniste RE. Maternal-fetal transmission of SIV in macaques: disseminated adenovirus infection in an offspring with congenital SIV infection. J Med Primatol. 1991 Jun;20(4):193–200. [PubMed]
  • Ohki K, Kishi M, Ohmura K, Morikawa Y, Jones IM, Azuma I, Ikuta K. Human immunodeficiency virus type 1 (HIV-1) superinfection of a cell clone converting it from production of defective to infectious HIV-1 is mediated predominantly by CD4 regions other than the major binding site for HIV-1 glycoproteins. J Gen Virol. 1992 Jul;73(Pt 7):1761–1772. [PubMed]
  • Ojo-Amaize EA, Nishanian P, Keith DE, Jr, Houghton RL, Heitjan DF, Fahey JL, Giorgi JV. Antibodies to human immunodeficiency virus in human sera induce cell-mediated lysis of human immunodeficiency virus-infected cells. J Immunol. 1987 Oct 1;139(7):2458–2463. [PubMed]
  • Olafsson K, Smith MS, Marshburn P, Carter SG, Haskill S. Variation of HIV infectibility of macrophages as a function of donor, stage of differentiation, and site of origin. J Acquir Immune Defic Syndr. 1991;4(2):154–164. [PubMed]
  • Oldstone MB. Molecular mimicry and autoimmune disease. Cell. 1987 Sep 11;50(6):819–820. [PubMed]
  • Olshevsky U, Helseth E, Furman C, Li J, Haseltine W, Sodroski J. Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding. J Virol. 1990 Dec;64(12):5701–5707. [PMC free article] [PubMed]
  • Orentas RJ, Hildreth JE, Obah E, Polydefkis M, Smith GE, Clements ML, Siliciano RF. Induction of CD4+ human cytolytic T cells specific for HIV-infected cells by a gp160 subunit vaccine. Science. 1990 Jun 8;248(4960):1234–1237. [PubMed]
  • Orloff GM, Kennedy MS, Dawson C, McDougal JS. HIV-1 binding to CD4 T cells does not induce a Ca2+ influx or lead to activation of protein kinases. AIDS Res Hum Retroviruses. 1991 Jul;7(7):587–593. [PubMed]
  • Orloff GM, Orloff SL, Kennedy MS, Maddon PJ, McDougal JS. Penetration of CD4 T cells by HIV-1. The CD4 receptor does not internalize with HIV, and CD4-related signal transduction events are not required for entry. J Immunol. 1991 Apr 15;146(8):2578–2587. [PubMed]
  • Oroszlan S, Luftig RB. Retroviral proteinases. Curr Top Microbiol Immunol. 1990;157:153–185. [PubMed]
  • Osborn L, Kunkel S, Nabel GJ. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc Natl Acad Sci U S A. 1989 Apr;86(7):2336–2340. [PMC free article] [PubMed]
  • O'Shea S, Rostron T, Hamblin AS, Palmer SJ, Banatvala JE. Quantitation of HIV: correlation with clinical, virological, and immunological status. J Med Virol. 1991 Sep;35(1):65–69. [PubMed]
  • Osmond DH, Shiboski S, Bacchetti P, Winger EE, Moss AR. Immune activation markers and AIDS prognosis. AIDS. 1991 May;5(5):505–511. [PubMed]
  • Ostrove JM, Leonard J, Weck KE, Rabson AB, Gendelman HE. Activation of the human immunodeficiency virus by herpes simplex virus type 1. J Virol. 1987 Dec;61(12):3726–3732. [PMC free article] [PubMed]
  • Ou CY, Ciesielski CA, Myers G, Bandea CI, Luo CC, Korber BT, Mullins JI, Schochetman G, Berkelman RL, Economou AN, et al. Molecular epidemiology of HIV transmission in a dental practice. Science. 1992 May 22;256(5060):1165–1171. [PubMed]
  • Ou CY, Kwok S, Mitchell SW, Mack DH, Sninsky JJ, Krebs JW, Feorino P, Warfield D, Schochetman G. DNA amplification for direct detection of HIV-1 in DNA of peripheral blood mononuclear cells. Science. 1988 Jan 15;239(4837):295–297. [PubMed]
  • Overbaugh J, Hoover EA, Mullins JI, Burns DP, Rudensey L, Quackenbush SL, Stallard V, Donahue PR. Structure and pathogenicity of individual variants within an immunodeficiency disease-inducing isolate of FeLV. Virology. 1992 Jun;188(2):558–569. [PubMed]
  • Owens RJ, Compans RW. Expression of the human immunodeficiency virus envelope glycoprotein is restricted to basolateral surfaces of polarized epithelial cells. J Virol. 1989 Feb;63(2):978–982. [PMC free article] [PubMed]
  • Oxtoby MJ. Perinatally acquired human immunodeficiency virus infection. Pediatr Infect Dis J. 1990 Sep;9(9):609–619. [PubMed]
  • Oyaizu N, Chirmule N, Kalyanaraman VS, Hall WW, Pahwa R, Shuster M, Pahwa S. Human immunodeficiency virus type 1 envelope glycoprotein gp120 produces immune defects in CD4+ T lymphocytes by inhibiting interleukin 2 mRNA. Proc Natl Acad Sci U S A. 1990 Mar;87(6):2379–2383. [PMC free article] [PubMed]
  • Ozel M, Pauli G, Gelderblom HR. The organization of the envelope projections on the surface of HIV. Arch Virol. 1988;100(3-4):255–266. [PubMed]
  • Padian NS, Shiboski SC, Jewell NP. Female-to-male transmission of human immunodeficiency virus. JAMA. 1991 Sep 25;266(12):1664–1667. [PubMed]
  • Page JB, Lai SH, Chitwood DD, Klimas NG, Smith PC, Fletcher MA. HTLV-I/II seropositivity and death from AIDS among HIV-1 seropositive intravenous drug users. Lancet. 1990 Jun 16;335(8703):1439–1441. [PubMed]
  • Page KA, Stearns SM, Littman DR. Analysis of mutations in the V3 domain of gp160 that affect fusion and infectivity. J Virol. 1992 Jan;66(1):524–533. [PMC free article] [PubMed]
  • Pahwa S, Chirmule N, Leombruno C, Lim W, Harper R, Bhalla R, Pahwa R, Nelson RP, Good RA. In vitro synthesis of human immunodeficiency virus-specific antibodies in peripheral blood lymphocytes of infants. Proc Natl Acad Sci U S A. 1989 Oct;86(19):7532–7536. [PMC free article] [PubMed]
  • Pahwa S, Pahwa R, Saxinger C, Gallo RC, Good RA. Influence of the human T-lymphotropic virus/lymphadenopathy-associated virus on functions of human lymphocytes: evidence for immunosuppressive effects and polyclonal B-cell activation by banded viral preparations. Proc Natl Acad Sci U S A. 1985 Dec;82(23):8198–8202. [PMC free article] [PubMed]
  • Pan LZ, Werner A, Levy JA. Detection of plasma viremia in human immunodeficiency virus-infected individuals at all clinical stages. J Clin Microbiol. 1993 Feb;31(2):283–288. [PMC free article] [PubMed]
  • Pang S, Koyanagi Y, Miles S, Wiley C, Vinters HV, Chen IS. High levels of unintegrated HIV-1 DNA in brain tissue of AIDS dementia patients. Nature. 1990 Jan 4;343(6253):85–89. [PubMed]
  • Pang S, Shlesinger Y, Daar ES, Moudgil T, Ho DD, Chen IS. Rapid generation of sequence variation during primary HIV-1 infection. AIDS. 1992 May;6(5):453–460. [PubMed]
  • Pang S, Vinters HV, Akashi T, O'Brien WA, Chen IS. HIV-1 env sequence variation in brain tissue of patients with AIDS-related neurologic disease. J Acquir Immune Defic Syndr. 1991;4(11):1082–1092. [PubMed]
  • Pantaleo G, Butini L, Graziosi C, Poli G, Schnittman SM, Greenhouse JJ, Gallin JI, Fauci AS. Human immunodeficiency virus (HIV) infection in CD4+ T lymphocytes genetically deficient in LFA-1: LFA-1 is required for HIV-mediated cell fusion but not for viral transmission. J Exp Med. 1991 Feb 1;173(2):511–514. [PMC free article] [PubMed]
  • Pantaleo G, De Maria A, Koenig S, Butini L, Moss B, Baseler M, Lane HC, Fauci AS. CD8+ T lymphocytes of patients with AIDS maintain normal broad cytolytic function despite the loss of human immunodeficiency virus-specific cytotoxicity. Proc Natl Acad Sci U S A. 1990 Jun;87(12):4818–4822. [PMC free article] [PubMed]
  • Pantaleo G, Graziosi C, Butini L, Pizzo PA, Schnittman SM, Kotler DP, Fauci AS. Lymphoid organs function as major reservoirs for human immunodeficiency virus. Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9838–9842. [PMC free article] [PubMed]
  • Papsidero LD, Sheu M, Ruscetti FW. Human immunodeficiency virus type 1-neutralizing monoclonal antibodies which react with p17 core protein: characterization and epitope mapping. J Virol. 1989 Jan;63(1):267–272. [PMC free article] [PubMed]
  • Parekh BS, Shaffer N, Pau CP, Abrams E, Thomas P, Pollack H, Bamji M, Kaul A, Schochetman G, Rogers M, et al. Lack of correlation between maternal antibodies to V3 loop peptides of gp120 and perinatal HIV-1 transmission. The NYC Perinatal HIV Transmission Collaborative Study. AIDS. 1991 Oct;5(10):1179–1184. [PubMed]
  • Parravicini CL, Klatzmann D, Jaffray P, Costanzi G, Gluckman JC. Monoclonal antibodies to the human immunodeficiency virus p18 protein cross-react with normal human tissues. AIDS. 1988 Jun;2(3):171–177. [PubMed]
  • Patterson S, Knight SC. Susceptibility of human peripheral blood dendritic cells to infection by human immunodeficiency virus. J Gen Virol. 1987 Apr;68(Pt 4):1177–1181. [PubMed]
  • Pauza CD, Galindo JE, Richman DD. Reinfection results in accumulation of unintegrated viral DNA in cytopathic and persistent human immunodeficiency virus type 1 infection of CEM cells. J Exp Med. 1990 Oct 1;172(4):1035–1042. [PMC free article] [PubMed]
  • Pauza CD, Price TM. Human immunodeficiency virus infection of T cells and monocytes proceeds via receptor-mediated endocytosis. J Cell Biol. 1988 Sep;107(3):959–968. [PMC free article] [PubMed]
  • Peden K, Emerman M, Montagnier L. Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL, and HIV-1ELI. Virology. 1991 Dec;185(2):661–672. [PubMed]
  • Pedersen NC, Ho EW, Brown ML, Yamamoto JK. Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science. 1987 Feb 13;235(4790):790–793. [PubMed]
  • Peeters M, Fransen K, Delaporte E, Van den Haesevelde M, Gershy-Damet GM, Kestens L, van der Groen G, Piot P. Isolation and characterization of a new chimpanzee lentivirus (simian immunodeficiency virus isolate cpz-ant) from a wild-captured chimpanzee. AIDS. 1992 May;6(5):447–451. [PubMed]
  • Peeters M, Gershy-Damet GM, Fransen K, Koffi K, Coulibaly M, Delaporte E, Piot P, van der Groen G. Virological and polymerase chain reaction studies of HIV-1/HIV-2 dual infection in Côte d'Ivoire. Lancet. 1992 Aug 8;340(8815):339–340. [PubMed]
  • Peiris JS, Porterfield JS. Antibody-mediated enhancement of Flavivirus replication in macrophage-like cell lines. Nature. 1979 Nov 29;282(5738):509–511. [PubMed]
  • Pepin J, Morgan G, Dunn D, Gevao S, Mendy M, Gaye I, Scollen N, Tedder R, Whittle H. HIV-2-induced immunosuppression among asymptomatic West African prostitutes: evidence that HIV-2 is pathogenic, but less so than HIV-1. AIDS. 1991 Oct;5(10):1165–1172. [PubMed]
  • Perez LG, O'Donnell MA, Stephens EB. The transmembrane glycoprotein of human immunodeficiency virus type 1 induces syncytium formation in the absence of the receptor binding glycoprotein. J Virol. 1992 Jul;66(7):4134–4143. [PMC free article] [PubMed]
  • Perkins HA, Samson S, Garner J, Echenberg D, Allen JR, Cowan M, Levy JA. Risk of AIDS for recipients of blood components from donors who subsequently developed AIDS. Blood. 1987 Nov;70(5):1604–1610. [PubMed]
  • Perno CF, Baseler MW, Broder S, Yarchoan R. Infection of monocytes by human immunodeficiency virus type 1 blocked by inhibitors of CD4-gp120 binding, even in the presence of enhancing antibodies. J Exp Med. 1990 Apr 1;171(4):1043–1056. [PMC free article] [PubMed]
  • Perry VH, Gordon S. Macrophages and microglia in the nervous system. Trends Neurosci. 1988 Jun;11(6):273–277. [PubMed]
  • Pert CB, Hill JM, Ruff MR, Berman RM, Robey WG, Arthur LO, Ruscetti FW, Farrar WL. Octapeptides deduced from the neuropeptide receptor-like pattern of antigen T4 in brain potently inhibit human immunodeficiency virus receptor binding and T-cell infectivity. Proc Natl Acad Sci U S A. 1986 Dec;83(23):9254–9258. [PMC free article] [PubMed]
  • Pert CB, Smith CC, Ruff MR, Hill JM. AIDS and its dementia as a neuropeptide disorder: role of VIP receptor blockade by human immunodeficiency virus envelope. Ann Neurol. 1988;23 (Suppl):S71–S73. [PubMed]
  • Peterson A, Seed B. Genetic analysis of monoclonal antibody and HIV binding sites on the human lymphocyte antigen CD4. Cell. 1988 Jul 1;54(1):65–72. [PubMed]
  • Peterson PK, Gekker G, Chao CC, Hu SX, Edelman C, Balfour HH, Jr, Verhoef J. Human cytomegalovirus-stimulated peripheral blood mononuclear cells induce HIV-1 replication via a tumor necrosis factor-alpha-mediated mechanism. J Clin Invest. 1992 Feb;89(2):574–580. [PMC free article] [PubMed]
  • Petito CK, Navia BA, Cho ES, Jordan BD, George DC, Price RW. Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with the acquired immunodeficiency syndrome. N Engl J Med. 1985 Apr 4;312(14):874–879. [PubMed]
  • Peudenier S, Hery C, Montagnier L, Tardieu M. Human microglial cells: characterization in cerebral tissue and in primary culture, and study of their susceptibility to HIV-1 infection. Ann Neurol. 1991 Feb;29(2):152–161. [PubMed]
  • Phillips AN, Lee CA, Elford J, Janossy G, Timms A, Bofill M, Kernoff PB. Serial CD4 lymphocyte counts and development of AIDS. Lancet. 1991 Feb 16;337(8738):389–392. [PubMed]
  • Phillips DM, Bourinbaiar AS. Mechanism of HIV spread from lymphocytes to epithelia. Virology. 1992 Jan;186(1):261–273. [PubMed]
  • Phillips RE, Rowland-Jones S, Nixon DF, Gotch FM, Edwards JP, Ogunlesi AO, Elvin JG, Rothbard JA, Bangham CR, Rizza CR, et al. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature. 1991 Dec 12;354(6353):453–459. [PubMed]
  • Picard O, Achour A, Bernard J, Halbreich A, Bizzini B, Boyer V, Desgranges C, Bertho JM, Lachgar A, Polliotti B, et al. A 2-year follow-up of an anti-HIV immune reaction in HIV-1 gp160-immunized healthy seronegative humans: evidence for persistent cell-mediated immunity. J Acquir Immune Defic Syndr. 1992;5(6):539–546. [PubMed]
  • Pinter A, Honnen WJ, Tilley SA, Bona C, Zaghouani H, Gorny MK, Zolla-Pazner S. Oligomeric structure of gp41, the transmembrane protein of human immunodeficiency virus type 1. J Virol. 1989 Jun;63(6):2674–2679. [PMC free article] [PubMed]
  • Plata F. HIV-specific cytotoxic T lymphocytes. Res Immunol. 1989 Jan;140(1):89–91. [PubMed]
  • Plata F, Garcia-Pons F, Ryter A, Lebargy F, Goodenow MM, Dat MH, Autran B, Mayaud C. HIV-1 infection of lung alveolar fibroblasts and macrophages in humans. AIDS Res Hum Retroviruses. 1990 Aug;6(8):979–986. [PubMed]
  • Plummer FA, Simonsen JN, Cameron DW, Ndinya-Achola JO, Kreiss JK, Gakinya MN, Waiyaki P, Cheang M, Piot P, Ronald AR, et al. Cofactors in male-female sexual transmission of human immunodeficiency virus type 1. J Infect Dis. 1991 Feb;163(2):233–239. [PubMed]
  • Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 1980 Dec;77(12):7415–7419. [PMC free article] [PubMed]
  • Polak JM, Pearse AG, Heath CM. Complete identification of endocrine cells in the gastrointestinal tract using semithin-thin sections to identify motilin cells in human and animal intestine. Gut. 1975 Mar;16(3):225–229. [PMC free article] [PubMed]
  • Poli G, Fauci AS. The effect of cytokines and pharmacologic agents on chronic HIV infection. AIDS Res Hum Retroviruses. 1992 Feb;8(2):191–197. [PubMed]
  • Poli G, Kinter A, Justement JS, Kehrl JH, Bressler P, Stanley S, Fauci AS. Tumor necrosis factor alpha functions in an autocrine manner in the induction of human immunodeficiency virus expression. Proc Natl Acad Sci U S A. 1990 Jan;87(2):782–785. [PMC free article] [PubMed]
  • Poli G, Orenstein JM, Kinter A, Folks TM, Fauci AS. Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines. Science. 1989 May 5;244(4904):575–577. [PubMed]
  • Pollard SR, Meier W, Chow P, Rosa JJ, Wiley DC. CD4-binding regions of human immunodeficiency virus envelope glycoprotein gp120 defined by proteolytic digestion. Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11320–11324. [PMC free article] [PubMed]
  • Pomerantz RJ, de la Monte SM, Donegan SP, Rota TR, Vogt MW, Craven DE, Hirsch MS. Human immunodeficiency virus (HIV) infection of the uterine cervix. Ann Intern Med. 1988 Mar;108(3):321–327. [PubMed]
  • Pomerantz RJ, Kuritzkes DR, de la Monte SM, Rota TR, Baker AS, Albert D, Bor DH, Feldman EL, Schooley RT, Hirsch MS. Infection of the retina by human immunodeficiency virus type I. N Engl J Med. 1987 Dec 24;317(26):1643–1647. [PubMed]
  • Pomerantz RJ, Trono D, Feinberg MB, Baltimore D. Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: a molecular model for latency. Cell. 1990 Jun 29;61(7):1271–1276. [PubMed]
  • Popovic M, Gartner S. Isolation of HIV-1 from monocytes but not T lymphocytes. Lancet. 1987 Oct 17;2(8564):916–916. [PubMed]
  • Popovic M, Sarngadharan MG, Read E, Gallo RC. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science. 1984 May 4;224(4648):497–500. [PubMed]
  • Portegies P, de Gans J, Lange JM, Derix MM, Speelman H, Bakker M, Danner SA, Goudsmit J. Declining incidence of AIDS dementia complex after introduction of zidovudine treatment. BMJ. 1989 Sep 30;299(6703):819–821. [PMC free article] [PubMed]
  • Posner MR, Hideshima T, Cannon T, Mukherjee M, Mayer KH, Byrn RA. An IgG human monoclonal antibody that reacts with HIV-1/GP120, inhibits virus binding to cells, and neutralizes infection. J Immunol. 1991 Jun 15;146(12):4325–4332. [PubMed]
  • Poulin L, Evans LA, Tang SB, Barboza A, Legg H, Littman DR, Levy JA. Several CD4 domains can play a role in human immunodeficiency virus infection in cells. J Virol. 1991 Sep;65(9):4893–4901. [PMC free article] [PubMed]
  • Poulin L, Levy JA. The HIV-1 nef gene product is associated with phosphorylation of a 46 kD cellular protein. AIDS. 1992 Aug;6(8):787–791. [PubMed]
  • Poulsen AG, Kvinesdal B, Aaby P, Mølbak K, Frederiksen K, Dias F, Lauritzen E. Prevalence of and mortality from human immunodeficiency virus type 2 in Bissau, West Africa. Lancet. 1989 Apr 15;1(8642):827–831. [PubMed]
  • Pourtois M, Binet C, Van Tieghem N, Courtois PR, Vandenabbeele A, Thirty L. Saliva can contribute in quick inhibition of HIV infectivity. AIDS. 1991 May;5(5):598–600. [PubMed]
  • Prabhakar BS, Nathanson N. Acute rabies death mediated by antibody. Nature. 1981 Apr 16;290(5807):590–591. [PubMed]
  • Preston BD, Poiesz BJ, Loeb LA. Fidelity of HIV-1 reverse transcriptase. Science. 1988 Nov 25;242(4882):1168–1171. [PubMed]
  • Price RW, Brew B, Sidtis J, Rosenblum M, Scheck AC, Cleary P. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science. 1988 Feb 5;239(4840):586–592. [PubMed]
  • Prince AM, Horowitz B, Baker L, Shulman RW, Ralph H, Valinsky J, Cundell A, Brotman B, Boehle W, Rey F, et al. Failure of a human immunodeficiency virus (HIV) immune globulin to protect chimpanzees against experimental challenge with HIV. Proc Natl Acad Sci U S A. 1988 Sep;85(18):6944–6948. [PMC free article] [PubMed]
  • Prince AM, Reesink H, Pascual D, Horowitz B, Hewlett I, Murthy KK, Cobb KE, Eichberg JW. Prevention of HIV infection by passive immunization with HIV immunoglobulin. AIDS Res Hum Retroviruses. 1991 Dec;7(12):971–973. [PubMed]
  • Psallidopoulos MC, Schnittman SM, Thompson LM, 3rd, Baseler M, Fauci AS, Lane HC, Salzman NP. Integrated proviral human immunodeficiency virus type 1 is present in CD4+ peripheral blood lymphocytes in healthy seropositive individuals. J Virol. 1989 Nov;63(11):4626–4631. [PMC free article] [PubMed]
  • Pudney J, Oneta M, Mayer K, Seage G, 3rd, Anderson D. Pre-ejaculatory fluid as potential vector for sexual transmission of HIV-1. Lancet. 1992 Dec 12;340(8833):1470–1470. [PubMed]
  • Pulakhandam U, Dincsoy HP. Cytomegaloviral adrenalitis and adrenal insufficiency in AIDS. Am J Clin Pathol. 1990 May;93(5):651–656. [PubMed]
  • Pulliam L, Herndier BG, Tang NM, McGrath MS. Human immunodeficiency virus-infected macrophages produce soluble factors that cause histological and neurochemical alterations in cultured human brains. J Clin Invest. 1991 Feb;87(2):503–512. [PMC free article] [PubMed]
  • Pumarola-Sune T, Navia BA, Cordon-Cardo C, Cho ES, Price RW. HIV antigen in the brains of patients with the AIDS dementia complex. Ann Neurol. 1987 May;21(5):490–496. [PubMed]
  • Putkonen P, Thorstensson R, Albert J, Hild K, Norrby E, Biberfeld P, Biberfeld G. Infection of cynomolgus monkeys with HIV-2 protects against pathogenic consequences of a subsequent simian immunodeficiency virus infection. AIDS. 1990 Aug;4(8):783–789. [PubMed]
  • Putkonen P, Thorstensson R, Ghavamzadeh L, Albert J, Hild K, Biberfeld G, Norrby E. Prevention of HIV-2 and SIVsm infection by passive immunization in cynomolgus monkeys. Nature. 1991 Aug 1;352(6334):436–438. [PubMed]
  • Putkonen P, Thorstensson R, Walther L, Albert J, Akerblom L, Granquist O, Wadell G, Norrby E, Biberfeld G. Vaccine protection against HIV-2 infection in cynomolgus monkeys. AIDS Res Hum Retroviruses. 1991 Mar;7(3):271–277. [PubMed]
  • Putney SD, Matthews TJ, Robey WG, Lynn DL, Robert-Guroff M, Mueller WT, Langlois AJ, Ghrayeb J, Petteway SR, Jr, Weinhold KJ, et al. HTLV-III/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelope. Science. 1986 Dec 12;234(4782):1392–1395. [PubMed]
  • Qureshi NM, Coy DH, Garry RF, Henderson LA. Characterization of a putative cellular receptor for HIV-1 transmembrane glycoprotein using synthetic peptides. AIDS. 1990 Jun;4(6):553–558. [PubMed]
  • Quinn TC, Kline RL, Halsey N, Hutton N, Ruff A, Butz A, Boulos R, Modlin JF. Early diagnosis of perinatal HIV infection by detection of viral-specific IgA antibodies. JAMA. 1991 Dec 25;266(24):3439–3442. [PubMed]
  • Rabeneck L, Popovic M, Gartner S, McLean DM, McLeod WA, Read E, Wong KK, Boyko WJ. Acute HIV infection presenting with painful swallowing and esophageal ulcers. JAMA. 1990 May 2;263(17):2318–2322. [PubMed]
  • Rabson AB, Martin MA. Molecular organization of the AIDS retrovirus. Cell. 1985 Mar;40(3):477–480. [PubMed]
  • Rahman AA, Teschner M, Sethi KK, Brandis H. Appearance of IgG (Fc) receptor(s) on cultured human fibroblasts infected with human cytomegalovirus. J Immunol. 1976 Jul;117(1):253–258. [PubMed]
  • Rando RF, Srinivasan A, Feingold J, Gonczol E, Plotkin S. Characterization of multiple molecular interactions between human cytomegalovirus (HCMV) and human immunodeficiency virus type 1 (HIV-1). Virology. 1990 May;176(1):87–97. [PubMed]
  • Rao TK, Filippone EJ, Nicastri AD, Landesman SH, Frank E, Chen CK, Friedman EA. Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. N Engl J Med. 1984 Mar 15;310(11):669–673. [PubMed]
  • Rappersberger K, Gartner S, Schenk P, Stingl G, Groh V, Tschachler E, Mann DL, Wolff K, Konrad K, Popovic M. Langerhans' cells are an actual site of HIV-1 replication. Intervirology. 1988;29(4):185–194. [PubMed]
  • Rasheed S, Gottlieb AA, Garry RF. Cell killing by ultraviolet-inactivated human immunodeficiency virus. Virology. 1986 Oct 30;154(2):395–400. [PubMed]
  • Ratner L. Glucosidase inhibitors for treatment of HIV-1 infection. AIDS Res Hum Retroviruses. 1992 Feb;8(2):165–173. [PubMed]
  • Ratner L, Haseltine W, Patarca R, Livak KJ, Starcich B, Josephs SF, Doran ER, Rafalski JA, Whitehorn EA, Baumeister K, et al. Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature. 1985 Jan 24;313(6000):277–284. [PubMed]
  • Rayfield M, De Cock K, Heyward W, Goldstein L, Krebs J, Kwok S, Lee S, McCormick J, Moreau JM, Odehouri K, et al. Mixed human immunodeficiency virus (HIV) infection in an individual: demonstration of both HIV type 1 and type 2 proviral sequences by using polymerase chain reaction. J Infect Dis. 1988 Dec;158(6):1170–1176. [PubMed]
  • Reddy MM, Grieco MH. Neopterin and alpha and beta interleukin-1 levels in sera of patients with human immunodeficiency virus infection. J Clin Microbiol. 1989 Sep;27(9):1919–1923. [PMC free article] [PubMed]
  • Redfield RR, Birx DL, Ketter N, Tramont E, Polonis V, Davis C, Brundage JF, Smith G, Johnson S, Fowler A, et al. A phase I evaluation of the safety and immunogenicity of vaccination with recombinant gp160 in patients with early human immunodeficiency virus infection. Military Medical Consortium for Applied Retroviral Research. N Engl J Med. 1991 Jun 13;324(24):1677–1684. [PubMed]
  • Reiher WE, 3rd, Blalock JE, Brunck TK. Sequence homology between acquired immunodeficiency syndrome virus envelope protein and interleukin 2. Proc Natl Acad Sci U S A. 1986 Dec;83(23):9188–9192. [PMC free article] [PubMed]
  • Reisinger EC, Vogetseder W, Berzow D, Köfler D, Bitterlich G, Lehr HA, Wachter H, Dierich MP. Complement-mediated enhancement of HIV-1 infection of the monoblastoid cell line U937. AIDS. 1990 Oct;4(10):961–965. [PubMed]
  • Reitz MS, Jr, Wilson C, Naugle C, Gallo RC, Robert-Guroff M. Generation of a neutralization-resistant variant of HIV-1 is due to selection for a point mutation in the envelope gene. Cell. 1988 Jul 1;54(1):57–63. [PubMed]
  • Resnick L, Berger JR, Shapshak P, Tourtellotte WW. Early penetration of the blood-brain-barrier by HIV. Neurology. 1988 Jan;38(1):9–14. [PubMed]
  • Rey F, Donker G, Hirsch I, Chermann JC. Productive infection of CD4+ cells by selected HIV strains is not inhibited by anti-CD4 monoclonal antibodies. Virology. 1991 Mar;181(1):165–171. [PubMed]
  • Rich EA, Chen IS, Zack JA, Leonard ML, O'Brien WA. Increased susceptibility of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1 (HIV-1). J Clin Invest. 1992 Jan;89(1):176–183. [PMC free article] [PubMed]
  • Richards RL, Hayre MD, Hockmeyer WT, Alving CR. Liposomes, lipid A, and aluminum hydroxide enhance the immune response to a synthetic malaria sporozoite antigen. Infect Immun. 1988 Mar;56(3):682–686. [PMC free article] [PubMed]
  • Richardson NE, Brown NR, Hussey RE, Vaid A, Matthews TJ, Bolognesi DP, Reinherz EL. Binding site for human immunodeficiency virus coat protein gp120 is located in the NH2-terminal region of T4 (CD4) and requires the intact variable-region-like domain. Proc Natl Acad Sci U S A. 1988 Aug;85(16):6102–6106. [PMC free article] [PubMed]
  • Richman D, Shih CK, Lowy I, Rose J, Prodanovich P, Goff S, Griffin J. Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture. Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11241–11245. [PMC free article] [PubMed]
  • Richman DD. HIV drug resistance. AIDS Res Hum Retroviruses. 1992 Jun;8(6):1065–1071. [PubMed]
  • Richman DD, Fischl MA, Grieco MH, Gottlieb MS, Volberding PA, Laskin OL, Leedom JM, Groopman JE, Mildvan D, Hirsch MS, et al. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med. 1987 Jul 23;317(4):192–197. [PubMed]
  • Rickman LS, Gordon DM, Wistar R, Jr, Krzych U, Gross M, Hollingdale MR, Egan JE, Chulay JD, Hoffman SL. Use of adjuvant containing mycobacterial cell-wall skeleton, monophosphoryl lipid A, and squalane in malaria circumsporozoite protein vaccine. Lancet. 1991 Apr 27;337(8748):998–1001. [PubMed]
  • Rinaldo C, Kingsley L, Neumann J, Reed D, Gupta P, Lyter D. Association of human immunodeficiency virus (HIV) p24 antigenemia with decrease in CD4+ lymphocytes and onset of acquired immunodeficiency syndrome during the early phase of HIV infection. J Clin Microbiol. 1989 May;27(5):880–884. [PMC free article] [PubMed]
  • Ritter J, Sepetjan M, Monier JC. Lack of reactivity of anti-human immunodeficiency virus (HIV) P17/18 antibodies against alpha 1 thymosin and of anti-alpha 1 thymosin monoclonal antibody against P17/18 protein. Immunol Lett. 1987 Nov;16(2):97–100. [PubMed]
  • Riviere Y, Tanneau-Salvadori F, Regnault A, Lopez O, Sansonetti P, Guy B, Kieny MP, Fournel JJ, Montagnier L. Human immunodeficiency virus-specific cytotoxic responses of seropositive individuals: distinct types of effector cells mediate killing of targets expressing gag and env proteins. J Virol. 1989 May;63(5):2270–2277. [PMC free article] [PubMed]
  • Robbins DS, Shirazi Y, Drysdale BE, Lieberman A, Shin HS, Shin ML. Production of cytotoxic factor for oligodendrocytes by stimulated astrocytes. J Immunol. 1987 Oct 15;139(8):2593–2597. [PubMed]
  • Robert-Guroff M, Aldrich K, Muldoon R, Stern TL, Bansal GP, Matthews TJ, Markham PD, Gallo RC, Franchini G. Cross-neutralization of human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus isolates. J Virol. 1992 Jun;66(6):3602–3608. [PMC free article] [PubMed]
  • Robert-Guroff M, Brown M, Gallo RC. HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complex. Nature. 1985 Jul 4;316(6023):72–74. [PubMed]
  • Robert-Guroff M, Reitz MS, Jr, Robey WG, Gallo RC. In vitro generation of an HTLV-III variant by neutralizing antibody. J Immunol. 1986 Nov 15;137(10):3306–3309. [PubMed]
  • Roberts JD, Bebenek K, Kunkel TA. The accuracy of reverse transcriptase from HIV-1. Science. 1988 Nov 25;242(4882):1171–1173. [PubMed]
  • Roberts NA, Martin JA, Kinchington D, Broadhurst AV, Craig JC, Duncan IB, Galpin SA, Handa BK, Kay J, Kröhn A, et al. Rational design of peptide-based HIV proteinase inhibitors. Science. 1990 Apr 20;248(4953):358–361. [PubMed]
  • Robertson CA, Mok JY, Froebel KS, Simmonds P, Burns SM, Marsden HS, Graham S. Maternal antibodies to gp120 V3 sequence do not correlate with protection against vertical transmission of human immunodeficiency virus. J Infect Dis. 1992 Oct;166(4):704–709. [PubMed]
  • Robinson HL, Zinkus DM. Accumulation of human immunodeficiency virus type 1 DNA in T cells: results of multiple infection events. J Virol. 1990 Oct;64(10):4836–4841. [PMC free article] [PubMed]
  • Robinson WE, Jr, Gorny MK, Xu JY, Mitchell WM, Zolla-Pazner S. Two immunodominant domains of gp41 bind antibodies which enhance human immunodeficiency virus type 1 infection in vitro. J Virol. 1991 Aug;65(8):4169–4176. [PMC free article] [PubMed]
  • Robinson WE, Jr, Kawamura T, Gorny MK, Lake D, Xu JY, Matsumoto Y, Sugano T, Masuho Y, Mitchell WM, Hersh E, et al. Human monoclonal antibodies to the human immunodeficiency virus type 1 (HIV-1) transmembrane glycoprotein gp41 enhance HIV-1 infection in vitro. Proc Natl Acad Sci U S A. 1990 Apr;87(8):3185–3189. [PMC free article] [PubMed]
  • Robinson WE, Jr, Kawamura T, Lake D, Masuho Y, Mitchell WM, Hersh EM. Antibodies to the primary immunodominant domain of human immunodeficiency virus type 1 (HIV-1) glycoprotein gp41 enhance HIV-1 infection in vitro. J Virol. 1990 Nov;64(11):5301–5305. [PMC free article] [PubMed]
  • Robinson WE, Jr, Montefiori DC, Mitchell WM. Antibody-dependent enhancement of human immunodeficiency virus type 1 infection. Lancet. 1988 Apr 9;1(8589):790–794. [PubMed]
  • Robinson WE, Jr, Montefiori DC, Mitchell WM, Prince AM, Alter HJ, Dreesman GR, Eichberg JW. Antibody-dependent enhancement of human immunodeficiency virus type 1 (HIV-1) infection in vitro by serum from HIV-1-infected and passively immunized chimpanzees. Proc Natl Acad Sci U S A. 1989 Jun;86(12):4710–4714. [PMC free article] [PubMed]
  • Robinson WE, Jr, Montefiori DC, Mitchell WM. Complement-mediated antibody-dependent enhancement of HIV-1 infection requires CD4 and complement receptors. Virology. 1990 Apr;175(2):600–604. [PubMed]
  • Roederer M, Staal FJ, Raju PA, Ela SW, Herzenberg LA, Herzenberg LA. Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-L-cysteine. Proc Natl Acad Sci U S A. 1990 Jun;87(12):4884–4888. [PMC free article] [PubMed]
  • Rogers MF, Ou CY, Kilbourne B, Schochetman G. Advances and problems in the diagnosis of human immunodeficiency virus infection in infants. Pediatr Infect Dis J. 1991 Jul;10(7):523–531. [PubMed]
  • Rogers MF, Ou CY, Rayfield M, Thomas PA, Schoenbaum EE, Abrams E, Krasinski K, Selwyn PA, Moore J, Kaul A, et al. Use of the polymerase chain reaction for early detection of the proviral sequences of human immunodeficiency virus in infants born to seropositive mothers. New York City Collaborative Study of Maternal HIV Transmission and Montefiore Medical Center HIV Perinatal Transmission Study Group. N Engl J Med. 1989 Jun 22;320(25):1649–1654. [PubMed]
  • Rojko JL, Fulton RM, Rezanka LJ, Williams LL, Copelan E, Cheney CM, Reichel GS, Neil JC, Mathes LE, Fisher TG, et al. Lymphocytotoxic strains of feline leukemia virus induce apoptosis in feline T4-thymic lymphoma cells. Lab Invest. 1992 Apr;66(4):418–426. [PubMed]
  • Ronco J, Charbit A, Dedieu JF, Mancini M, Michel ML, Henin Y, O'Callaghan D, Kaczorek M, Girard M, Hofnung M. Is there a neutralization epitope in the second conserved domain of HIV-1 envelope protein? AIDS Res Hum Retroviruses. 1991 Jan;7(1):1–2. [PubMed]
  • Rooke R, Tremblay M, Soudeyns H, DeStephano L, Yao XJ, Fanning M, Montaner JS, O'Shaughnessy M, Gelmon K, Tsoukas C, et al. Isolation of drug-resistant variants of HIV-1 from patients on long-term zidovudine therapy. Canadian Zidovudine Multi-Centre Study Group. AIDS. 1989 Jul;3(7):411–415. [PubMed]
  • Roos MT, Lange JM, de Goede RE, Coutinho RA, Schellekens PT, Miedema F, Tersmette M. Viral phenotype and immune response in primary human immunodeficiency virus type 1 infection. J Infect Dis. 1992 Mar;165(3):427–432. [PubMed]
  • Rosen CA, Terwilliger E, Dayton A, Sodroski JG, Haseltine WA. Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus. Proc Natl Acad Sci U S A. 1988 Apr;85(7):2071–2075. [PMC free article] [PubMed]
  • Rosenberg ZF, Fauci AS. Immunopathogenic mechanisms of HIV infection: cytokine induction of HIV expression. Immunol Today. 1990 May;11(5):176–180. [PubMed]
  • Rossi JJ, Elkins D, Zaia JA, Sullivan S. Ribozymes as anti-HIV-1 therapeutic agents: principles, applications, and problems. AIDS Res Hum Retroviruses. 1992 Feb;8(2):183–189. [PubMed]
  • Rossi P, Moschese V, Broliden PA, Fundaró C, Quinti I, Plebani A, Giaquinto C, Tovo PA, Ljunggren K, Rosen J, et al. Presence of maternal antibodies to human immunodeficiency virus 1 envelope glycoprotein gp120 epitopes correlates with the uninfected status of children born to seropositive mothers. Proc Natl Acad Sci U S A. 1989 Oct;86(20):8055–8058. [PMC free article] [PubMed]
  • Rouse BT, Horohov DW. Immunosuppression in viral infections. Rev Infect Dis. 1986 Nov-Dec;8(6):850–873. [PubMed]
  • Rouzioux C, Puel J, Agut H, Brun-Vézinet F, Ferchal F, Tamalet C, Descamps P, Fleury H. Comparative assessment of quantitative HIV viraemia assays. AIDS. 1992 Apr;6(4):373–377. [PubMed]
  • Roy S, Fitz-Gibbon L, Poulin L, Wainberg MA. Infection of human monocytes/macrophages by HIV-1: effect on secretion of IL-1 activity. Immunology. 1988 Jun;64(2):233–239. [PMC free article] [PubMed]
  • Rusche JR, Javaherian K, McDanal C, Petro J, Lynn DL, Grimaila R, Langlois A, Gallo RC, Arthur LO, Fischinger PJ, et al. Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120. Proc Natl Acad Sci U S A. 1988 May;85(9):3198–3202. [PMC free article] [PubMed]
  • Rutherford GW, Lifson AR, Hessol NA, Darrow WW, O'Malley PM, Buchbinder SP, Barnhart JL, Bodecker TW, Cannon L, Doll LS, et al. Course of HIV-I infection in a cohort of homosexual and bisexual men: an 11 year follow up study. BMJ. 1990 Nov 24;301(6762):1183–1188. [PMC free article] [PubMed]
  • Rutka JT, Giblin JR, Berens ME, Bar-Shiva E, Tokuda K, McCulloch JR, Rosenblum ML, Eessalu TE, Aggarwal BB, Bodell WJ. The effects of human recombinant tumor necrosis factor on glioma-derived cell lines: cellular proliferation, cytotoxicity, morphological and radioreceptor studies. Int J Cancer. 1988 Apr 15;41(4):573–582. [PubMed]
  • Ryu SE, Kwong PD, Truneh A, Porter TG, Arthos J, Rosenberg M, Dai XP, Xuong NH, Axel R, Sweet RW, et al. Crystal structure of an HIV-binding recombinant fragment of human CD4. Nature. 1990 Nov 29;348(6300):419–426. [PubMed]
  • Saag MS, Crain MJ, Decker WD, Campbell-Hill S, Robinson S, Brown WE, Leuther M, Whitley RJ, Hahn BH, Shaw GM. High-level viremia in adults and children infected with human immunodeficiency virus: relation to disease stage and CD4+ lymphocyte levels. J Infect Dis. 1991 Jul;164(1):72–80. [PubMed]
  • Sabatier JM, Vives E, Mabrouk K, Benjouad A, Rochat H, Duval A, Hue B, Bahraoui E. Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1. J Virol. 1991 Feb;65(2):961–967. [PMC free article] [PubMed]
  • Sakaguchi M, Sato T, Groopman JE. Human immunodeficiency virus infection of megakaryocytic cells. Blood. 1991 Feb 1;77(3):481–485. [PubMed]
  • Sakai K, Dewhurst S, Ma XY, Volsky DJ. Differences in cytopathogenicity and host cell range among infectious molecular clones of human immunodeficiency virus type 1 simultaneously isolated from an individual. J Virol. 1988 Nov;62(11):4078–4085. [PMC free article] [PubMed]
  • Sakai K, Ma XY, Gordienko I, Volsky DJ. Recombinational analysis of a natural noncytopathic human immunodeficiency virus type 1 (HIV-1) isolate: role of the vif gene in HIV-1 infection kinetics and cytopathicity. J Virol. 1991 Nov;65(11):5765–5773. [PMC free article] [PubMed]
  • Salahuddin SZ, Markham PD, Popovic M, Sarngadharan MG, Orndorff S, Fladagar A, Patel A, Gold J, Gallo RC. Isolation of infectious human T-cell leukemia/lymphotropic virus type III (HTLV-III) from patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex (ARC) and from healthy carriers: a study of risk groups and tissue sources. Proc Natl Acad Sci U S A. 1985 Aug;82(16):5530–5534. [PMC free article] [PubMed]
  • Salahuddin SZ, Palestine AG, Heck E, Ablashi D, Luckenbach M, McCulley JP, Nussenblatt RB. Isolation of the human T-cell leukemia/lymphotropic virus type III from the cornea. Am J Ophthalmol. 1986 Feb 15;101(2):149–152. [PubMed]
  • Salim YS, Faber V, Wiik A, Andersen PL, Høier-Madsen M, Mouritsen S. Anti-corticosteroid antibodies in AIDS patients. APMIS. 1988 Oct;96(10):889–894. [PubMed]
  • Salk J. Prospects for the control of AIDS by immunizing seropositive individuals. Nature. 1987 Jun 11;327(6122):473–476. [PubMed]
  • Salmon P, Olivier R, Riviere Y, Brisson E, Gluckman JC, Kieny MP, Montagnier L, Klatzmann D. Loss of CD4 membrane expression and CD4 mRNA during acute human immunodeficiency virus replication. J Exp Med. 1988 Dec 1;168(6):1953–1969. [PMC free article] [PubMed]
  • Samuel KP, Seth A, Konopka A, Lautenberger JA, Papas TS. The 3'-orf protein of human immunodeficiency virus shows structural homology with the phosphorylation domain of human interleukin-2 receptor and the ATP-binding site of the protein kinase family. FEBS Lett. 1987 Jun 22;218(1):81–86. [PubMed]
  • Sanchez-Pescador R, Power MD, Barr PJ, Steimer KS, Stempien MM, Brown-Shimer SL, Gee WW, Renard A, Randolph A, Levy JA, et al. Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2). Science. 1985 Feb 1;227(4686):484–492. [PubMed]
  • Sarin PS, Sun DK, Thornton AH, Naylor PH, Goldstein AL. Neutralization of HTLV-III/LAV replication by antiserum to thymosin alpha 1. Science. 1986 May 30;232(4754):1135–1137. [PubMed]
  • Sarngadharan MG, Popovic M, Bruch L, Schüpbach J, Gallo RC. Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS. Science. 1984 May 4;224(4648):506–508. [PubMed]
  • Sastry KJ, Reddy HR, Pandita R, Totpal K, Aggarwal BB. HIV-1 tat gene induces tumor necrosis factor-beta (lymphotoxin) in a human B-lymphoblastoid cell line. J Biol Chem. 1990 Nov 25;265(33):20091–20093. [PubMed]
  • Sato H, Orenstein J, Dimitrov D, Martin M. Cell-to-cell spread of HIV-1 occurs within minutes and may not involve the participation of virus particles. Virology. 1992 Feb;186(2):712–724. [PubMed]
  • Satow Y, Hashido M, Ishikawa K, Honda H, Mizuno M, Kawana T, Hayami M. Detection of HTLV-I antigen in peripheral and cord blood lymphocytes from carrier mothers. Lancet. 1991 Oct 12;338(8772):915–916. [PubMed]
  • Sattentau QJ, Dalgleish AG, Weiss RA, Beverley PC. Epitopes of the CD4 antigen and HIV infection. Science. 1986 Nov 28;234(4780):1120–1123. [PubMed]
  • Sattentau QJ, Moore JP. Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding. J Exp Med. 1991 Aug 1;174(2):407–415. [PMC free article] [PubMed]
  • Sattentau QJ, Weiss RA. The CD4 antigen: physiological ligand and HIV receptor. Cell. 1988 Mar 11;52(5):631–633. [PubMed]
  • Sawyer LA, Katzenstein DA, Hendry RM, Boone EJ, Vujcic LK, Williams CC, Zeger SL, Saah AJ, Rinaldo CR, Jr, Phair JP, et al. Possible beneficial effects of neutralizing antibodies and antibody-dependent, cell-mediated cytotoxicity in human immunodeficiency virus infection. AIDS Res Hum Retroviruses. 1990 Mar;6(3):341–356. [PubMed]
  • Sayers MH, Beatty PG, Hansen JA. HLA antibodies as a cause of false-positive reactions in screening enzyme immunoassays for antibodies to human T-lymphotropic virus type III. Transfusion. 1986 Jan-Feb;26(1):113–115. [PubMed]
  • Scarlatti G, Lombardi V, Plebani A, Principi N, Vegni C, Ferraris G, Bucceri A, Fenyö EM, Wigzell H, Rossi P, et al. Polymerase chain reaction, virus isolation and antigen assay in HIV-1-antibody-positive mothers and their children. AIDS. 1991 Oct;5(10):1173–1178. [PubMed]
  • Schattner A, Rager-Zisman B. Virus-induced autoimmunity. Rev Infect Dis. 1990 Mar-Apr;12(2):204–222. [PubMed]
  • Schellekens PT, Tersmette M, Roos MT, Keet RP, de Wolf F, Coutinho RA, Miedema F. Biphasic rate of CD4+ cell count decline during progression to AIDS correlates with HIV-1 phenotype. AIDS. 1992 Jul;6(7):665–669. [PubMed]
  • Schlienger K, Mancini M, Rivière Y, Dormont D, Tiollais P, Michel ML. Human immunodeficiency virus type 1 major neutralizing determinant exposed on hepatitis B surface antigen particles is highly immunogenic in primates. J Virol. 1992 Apr;66(4):2570–2576. [PMC free article] [PubMed]
  • Schmidtmayerova H, Bolmont C, Baghdiguian S, Hirsch I, Chermann JC. Distinctive pattern of infection and replication of HIV1 strains in blood-derived macrophages. Virology. 1992 Sep;190(1):124–133. [PubMed]
  • Schmitt MP, Gendrault JL, Schweitzer C, Steffan AM, Beyer C, Royer C, Jaeck D, Pasquali JL, Kirn A, Aubertin AM. Permissivity of primary cultures of human Kupffer cells for HIV-1. AIDS Res Hum Retroviruses. 1990 Aug;6(8):987–991. [PubMed]
  • Schneider-Schaulies J, Schneider-Schaulies S, Brinkmann R, Tas P, Halbrügge M, Walter U, Holmes HC, Ter Meulen V. HIV-1 gp120 receptor on CD4-negative brain cells activates a tyrosine kinase. Virology. 1992 Dec;191(2):765–772. [PubMed]
  • Schnittman SM, Greenhouse JJ, Psallidopoulos MC, Baseler M, Salzman NP, Fauci AS, Lane HC. Increasing viral burden in CD4+ T cells from patients with human immunodeficiency virus (HIV) infection reflects rapidly progressive immunosuppression and clinical disease. Ann Intern Med. 1990 Sep 15;113(6):438–443. [PubMed]
  • Schnittman SM, Lane HC, Greenhouse J, Justement JS, Baseler M, Fauci AS. Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individuals. Proc Natl Acad Sci U S A. 1990 Aug;87(16):6058–6062. [PMC free article] [PubMed]
  • Schnittman SM, Psallidopoulos MC, Lane HC, Thompson L, Baseler M, Massari F, Fox CH, Salzman NP, Fauci AS. The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. Science. 1989 Jul 21;245(4915):305–308. [PubMed]
  • Schols D, Pauwels R, Desmyter J, De Clercq E. Presence of class II histocompatibility DR proteins on the envelope of human immunodeficiency virus demonstrated by FACS analysis. Virology. 1992 Jul;189(1):374–376. [PubMed]
  • Schrier RD, McCutchan JA, Venable JC, Nelson JA, Wiley CA. T-cell-induced expression of human immunodeficiency virus in macrophages. J Virol. 1990 Jul;64(7):3280–3288. [PMC free article] [PubMed]
  • Schuitemaker H, Kootstra NA, de Goede RE, de Wolf F, Miedema F, Tersmette M. Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture. J Virol. 1991 Jan;65(1):356–363. [PMC free article] [PubMed]
  • Schuitemaker H, Kootstra NA, Koppelman MH, Bruisten SM, Huisman HG, Tersmette M, Miedema F. Proliferation-dependent HIV-1 infection of monocytes occurs during differentiation into macrophages. J Clin Invest. 1992 Apr;89(4):1154–1160. [PMC free article] [PubMed]
  • Schulz TF, Whitby D, Hoad JG, Corrah T, Whittle H, Weiss RA. Biological and molecular variability of human immunodeficiency virus type 2 isolates from The Gambia. J Virol. 1990 Oct;64(10):5177–5182. [PMC free article] [PubMed]
  • Schulz TF, Jameson BA, Lopalco L, Siccardi AG, Weiss RA, Moore JP. Conserved structural features in the interaction between retroviral surface and transmembrane glycoproteins? AIDS Res Hum Retroviruses. 1992 Sep;8(9):1571–1580. [PubMed]
  • Schüpbach J, Popovic M, Gilden RV, Gonda MA, Sarngadharan MG, Gallo RC. Serological analysis of a subgroup of human T-lymphotropic retroviruses (HTLV-III) associated with AIDS. Science. 1984 May 4;224(4648):503–505. [PubMed]
  • Schwartz S, Felber BK, Fenyö EM, Pavlakis GN. Rapidly and slowly replicating human immunodeficiency virus type 1 isolates can be distinguished according to target-cell tropism in T-cell and monocyte cell lines. Proc Natl Acad Sci U S A. 1989 Sep;86(18):7200–7203. [PMC free article] [PubMed]
  • Sei Y, Tsang PH, Chu FN, Wallace I, Roboz JP, Sarin PS, Bekesi JG. Inverse relationship between HIV-1 p24 antigenemia, anti-p24 antibody and neutralizing antibody response in all stages of HIV-1 infection. Immunol Lett. 1989 Feb;20(3):223–230. [PubMed]
  • Sei Y, Tsang PH, Roboz JP, Sarin PS, Wallace JI, Bekesi JG. Neutralizing antibodies as a prognostic indicator in the progression of acquired immune deficiency syndrome (AIDS)-related disorders: a double-blind study. J Clin Immunol. 1988 Nov;8(6):464–472. [PubMed]
  • Selmaj K, Raine CS, Farooq M, Norton WT, Brosnan CF. Cytokine cytotoxicity against oligodendrocytes. Apoptosis induced by lymphotoxin. J Immunol. 1991 Sep 1;147(5):1522–1529. [PubMed]
  • Selmaj KW, Raine CS. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol. 1988 Apr;23(4):339–346. [PubMed]
  • Semple MG, Loveday C, Preston E, Tedder RS. Detection of HIV-1 RNA in factor VIII concentrate. AIDS. 1991 May;5(5):597–598. [PubMed]
  • Serwadda D, Mugerwa RD, Sewankambo NK, Lwegaba A, Carswell JW, Kirya GB, Bayley AC, Downing RG, Tedder RS, Clayden SA, et al. Slim disease: a new disease in Uganda and its association with HTLV-III infection. Lancet. 1985 Oct 19;2(8460):849–852. [PubMed]
  • Shadduck PP, Weinberg JB, Haney AF, Bartlett JA, Langlois AJ, Bolognesi DP, Matthews TJ. Lack of enhancing effect of human anti-human immunodeficiency virus type 1 (HIV-1) antibody on HIV-1 infection of human blood monocytes and peritoneal macrophages. J Virol. 1991 Aug;65(8):4309–4316. [PMC free article] [PubMed]
  • Shafferman A, Jahrling PB, Benveniste RE, Lewis MG, Phipps TJ, Eden-McCutchan F, Sadoff J, Eddy GA, Burke DS. Protection of macaques with a simian immunodeficiency virus envelope peptide vaccine based on conserved human immunodeficiency virus type 1 sequences. Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):7126–7130. [PMC free article] [PubMed]
  • Shahabuddin M, Volsky B, Hsu MC, Volsky DJ. Restoration of cell surface CD4 expression in human immunodeficiency virus type 1-infected cells by treatment with a Tat antagonist. J Virol. 1992 Nov;66(11):6802–6805. [PMC free article] [PubMed]
  • Shang F, Huang H, Revesz K, Chen HC, Herz R, Pinter A. Characterization of monoclonal antibodies against the human immunodeficiency virus matrix protein, p17gag: identification of epitopes exposed at the surfaces of infected cells. J Virol. 1991 Sep;65(9):4798–4804. [PMC free article] [PubMed]
  • Sharer LR. Pathology of HIV-1 infection of the central nervous system. A review. J Neuropathol Exp Neurol. 1992 Jan;51(1):3–11. [PubMed]
  • Sharer LR, Cho ES, Epstein LG. Multinucleated giant cells and HTLV-III in AIDS encephalopathy. Hum Pathol. 1985 Aug;16(8):760–760. [PubMed]
  • Sharma DP, Anderson M, Zink MC, Adams RJ, Donnenberg AD, Clements JE, Narayan O. Pathogenesis of acute infection in rhesus macaques with a lymphocyte-tropic strain of simian immunodeficiency virus. J Infect Dis. 1992 Oct;166(4):738–746. [PubMed]
  • Sharma DP, Zink MC, Anderson M, Adams R, Clements JE, Joag SV, Narayan O. Derivation of neurotropic simian immunodeficiency virus from exclusively lymphocytetropic parental virus: pathogenesis of infection in macaques. J Virol. 1992 Jun;66(6):3550–3556. [PMC free article] [PubMed]
  • Sharpless NE, O'Brien WA, Verdin E, Kufta CV, Chen IS, Dubois-Dalcq M. Human immunodeficiency virus type 1 tropism for brain microglial cells is determined by a region of the env glycoprotein that also controls macrophage tropism. J Virol. 1992 Apr;66(4):2588–2593. [PMC free article] [PubMed]
  • Shaw GM, Hahn BH, Arya SK, Groopman JE, Gallo RC, Wong-Staal F. Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome. Science. 1984 Dec 7;226(4679):1165–1171. [PubMed]
  • Shaw GM, Harper ME, Hahn BH, Epstein LG, Gajdusek DC, Price RW, Navia BA, Petito CK, O'Hara CJ, Groopman JE, et al. HTLV-III infection in brains of children and adults with AIDS encephalopathy. Science. 1985 Jan 11;227(4683):177–182. [PubMed]
  • Gonda MA, Wong-Staal F, Gallo RC, Clements JE, Narayan O, Gilden RV. Sequence homology and morphologic similarity of HTLV-III and visna virus, a pathogenic lentivirus. Science. 1985 Jan 11;227(4683):173–177. [PubMed]
  • Shearer GM, Clerici M. Early T-helper cell defects in HIV infection. AIDS. 1991 Mar;5(3):245–253. [PubMed]
  • Sher A, Gazzinelli RT, Oswald IP, Clerici M, Kullberg M, Pearce EJ, Berzofsky JA, Mosmann TR, James SL, Morse HC., 3rd Role of T-cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection. Immunol Rev. 1992 Jun;127:183–204. [PubMed]
  • Shibata D, Brynes RK, Nathwani B, Kwok S, Sninsky J, Arnheim N. Human immunodeficiency viral DNA is readily found in lymph node biopsies from seropositive individuals. Analysis of fixed tissue using the polymerase chain reaction. Am J Pathol. 1989 Oct;135(4):697–702. [PMC free article] [PubMed]
  • Shibata R, Sakai H, Kiyomasu T, Ishimoto A, Hayami M, Adachi A. Generation and characterization of infectious chimeric clones between human immunodeficiency virus type 1 and simian immunodeficiency virus from an African green monkey. J Virol. 1990 Dec;64(12):5861–5868. [PMC free article] [PubMed]
  • Shibuya H, Irie K, Ninomiya-Tsuji J, Goebl M, Taniguchi T, Matsumoto K. New human gene encoding a positive modulator of HIV Tat-mediated transactivation. Nature. 1992 Jun 25;357(6380):700–702. [PubMed]
  • Shih CK, Rose JM, Hansen GL, Wu JC, Bacolla A, Griffin JA. Chimeric human immunodeficiency virus type 1/type 2 reverse transcriptases display reversed sensitivity to nonnucleoside analog inhibitors. Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9878–9882. [PMC free article] [PubMed]
  • Shioda T, Levy JA, Cheng-Mayer C. Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene. Nature. 1991 Jan 10;349(6305):167–169. [PubMed]
  • Shioda T, Levy JA, Cheng-Mayer C. Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell-line and macrophage tropism of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A. 1992 Oct 15;89(20):9434–9438. [PMC free article] [PubMed]
  • Shioda T, Shibuta H. Production of human immunodeficiency virus (HIV)-like particles from cells infected with recombinant vaccinia viruses carrying the gag gene of HIV. Virology. 1990 Mar;175(1):139–148. [PubMed]
  • Shirai A, Cosentino M, Leitman-Klinman SF, Klinman DM. Human immunodeficiency virus infection induces both polyclonal and virus-specific B cell activation. J Clin Invest. 1992 Feb;89(2):561–566. [PMC free article] [PubMed]
  • Shore SL, Cromeans TL, Romano TJ. Immune destruction of virus-infected cells early in the infectious cycle. Nature. 1976 Aug 19;262(5570):695–696. [PubMed]
  • Siddiqui A, Gaynor R, Srinivasan A, Mapoles J, Farr RW. trans-activation of viral enhancers including long terminal repeat of the human immunodeficiency virus by the hepatitis B virus X protein. Virology. 1989 Apr;169(2):479–484. [PubMed]
  • Siegal FP, Lopez C, Hammer GS, Brown AE, Kornfeld SJ, Gold J, Hassett J, Hirschman SZ, Cunningham-Rundles C, Adelsberg BR, et al. Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions. N Engl J Med. 1981 Dec 10;305(24):1439–1444. [PubMed]
  • Siegel JP, Djeu JY, Stocks NI, Masur H, Gelmann EP, Quinnan GV., Jr Sera from patients with the acquired immunodeficiency syndrome inhibit production of interleukin-2 by normal lymphocytes. J Clin Invest. 1985 Jun;75(6):1957–1964. [PMC free article] [PubMed]
  • Siliciano RF, Lawton T, Knall C, Karr RW, Berman P, Gregory T, Reinherz EL. Analysis of host-virus interactions in AIDS with anti-gp120 T cell clones: effect of HIV sequence variation and a mechanism for CD4+ cell depletion. Cell. 1988 Aug 12;54(4):561–575. [PubMed]
  • Simmonds P, Balfe P, Peutherer JF, Ludlam CA, Bishop JO, Brown AJ. Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers. J Virol. 1990 Feb;64(2):864–872. [PMC free article] [PubMed]
  • Simmonds P, Zhang LQ, McOmish F, Balfe P, Ludlam CA, Brown AJ. Discontinuous sequence change of human immunodeficiency virus (HIV) type 1 env sequences in plasma viral and lymphocyte-associated proviral populations in vivo: implications for models of HIV pathogenesis. J Virol. 1991 Nov;65(11):6266–6276. [PMC free article] [PubMed]
  • Sinangil F, Loyter A, Volsky DJ. Quantitative measurement of fusion between human immunodeficiency virus and cultured cells using membrane fluorescence dequenching. FEBS Lett. 1988 Oct 24;239(1):88–92. [PubMed]
  • Singh MK, Pauza CD. Extrachromosomal human immunodeficiency virus type 1 sequences are methylated in latently infected U937 cells. Virology. 1992 Jun;188(2):451–458. [PubMed]
  • Sioud M, Drlica K. Prevention of human immunodeficiency virus type 1 integrase expression in Escherichia coli by a ribozyme. Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):7303–7307. [PMC free article] [PubMed]
  • Sirianni MC, Soddu S, Malorni W, Arancia G, Aiuti F, Soddus S. Mechanism of defective natural killer cell activity in patients with AIDS is associated with defective distribution of tubulin. J Immunol. 1988 Apr 15;140(8):2565–2568. [PubMed]
  • Skinner MA, Langlois AJ, McDanal CB, McDougal JS, Bolognesi DP, Matthews TJ. Neutralizing antibodies to an immunodominant envelope sequence do not prevent gp120 binding to CD4. J Virol. 1988 Nov;62(11):4195–4200. [PMC free article] [PubMed]
  • Skolnik PR, Kosloff BR, Bechtel LJ, Huskins KR, Flynn T, Karthas N, McIntosh K, Hirsch MS. Absence of infectious HIV-1 in the urine of seropositive viremic subjects. J Infect Dis. 1989 Dec;160(6):1056–1060. [PubMed]
  • Skolnik PR, Kosloff BR, Hirsch MS. Bidirectional interactions between human immunodeficiency virus type 1 and cytomegalovirus. J Infect Dis. 1988 Mar;157(3):508–514. [PubMed]
  • Sodroski J, Goh WC, Rosen C, Campbell K, Haseltine WA. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity. Nature. 322(6078):470–474. [PubMed]
  • Sodroski J, Goh WC, Rosen C, Dayton A, Terwilliger E, Haseltine W. A second post-transcriptional trans-activator gene required for HTLV-III replication. Nature. 1986 May 22;321(6068):412–417. [PubMed]
  • Soeiro R, Rubinstein A, Rashbaum WK, Lyman WD. Maternofetal transmission of AIDS: frequency of human immunodeficiency virus type 1 nucleic acid sequences in human fetal DNA. J Infect Dis. 1992 Oct;166(4):699–703. [PubMed]
  • Somasundaran M, Robinson HL. A major mechanism of human immunodeficiency virus-induced cell killing does not involve cell fusion. J Virol. 1987 Oct;61(10):3114–3119. [PMC free article] [PubMed]
  • Sonigo P, Girard M, Dormont D. Design and trials of AIDS vaccines. Immunol Today. 1990 Dec;11(12):465–471. [PubMed]
  • Sönnerborg A, Johansson B, Strannegård O. Detection of HIV-1 DNA and infectious virus in cerebrospinal fluid. AIDS Res Hum Retroviruses. 1991 Apr;7(4):369–373. [PubMed]
  • Sönnerborg AB, Ehrnst AC, Bergdahl SK, Pehrson PO, Sköldenberg BR, Strannegård OO. HIV isolation from cerebrospinal fluid in relation to immunological deficiency and neurological symptoms. AIDS. 1988 Apr;2(2):89–93. [PubMed]
  • Spear GT, Carlson JR, Jennings MB, Takefman DM, Landay AL. Complement-mediated, antibody-dependent neutralizing titers of sera from asymptomatic and symptomatic HIV-infected individuals. AIDS. 1992 Sep;6(9):1047–1047. [PubMed]
  • Spear GT, Landay AL, Sullivan BL, Dittel B, Lint TF. Activation of complement on the surface of cells infected by human immunodeficiency virus. J Immunol. 1990 Feb 15;144(4):1490–1496. [PubMed]
  • Spear GT, Sullivan BL, Takefman DM, Landay AL, Lint TF. Human immunodeficiency virus (HIV)-infected cells and free virus directly activate the classical complement pathway in rabbit, mouse and guinea-pig sera; activation results in virus neutralization by virolysis. Immunology. 1991 Aug;73(4):377–382. [PMC free article] [PubMed]
  • Spector DH, Wade E, Wright DA, Koval V, Clark C, Jaquish D, Spector SA. Human immunodeficiency virus pseudotypes with expanded cellular and species tropism. J Virol. 1990 May;64(5):2298–2308. [PMC free article] [PubMed]
  • Spiegel H, Herbst H, Niedobitek G, Foss HD, Stein H. Follicular dendritic cells are a major reservoir for human immunodeficiency virus type 1 in lymphoid tissues facilitating infection of CD4+ T-helper cells. Am J Pathol. 1992 Jan;140(1):15–22. [PMC free article] [PubMed]
  • Sprecher S, Soumenkoff G, Puissant F, Degueldre M. Vertical transmission of HIV in 15-week fetus. Lancet. 1986 Aug 2;2(8501):288–289. [PubMed]
  • Stahl RE, Friedman-Kien A, Dubin R, Marmor M, Zolla-Pazner S. Immunologic abnormalities in homosexual men. Relationship to Kaposi's sarcoma. Am J Med. 1982 Aug;73(2):171–178. [PubMed]
  • Stahl-Hennig C, Voss G, Nick S, Petry H, Fuchs D, Wachter H, Coulibaly C, Lüke W, Hunsmann G. Immunization with tween-ether-treated SIV adsorbed onto aluminum hydroxide protects monkeys against experimental SIV infection. Virology. 1992 Feb;186(2):588–596. [PubMed]
  • Stahmer I, Zimmer JP, Ernst M, Fenner T, Finnern R, Schmitz H, Flad HD, Gerdes J. Isolation of normal human follicular dendritic cells and CD4-independent in vitro infection by human immunodeficiency virus (HIV-1). Eur J Immunol. 1991 Aug;21(8):1873–1878. [PubMed]
  • Stanley SK, Folks TM, Fauci AS. Induction of expression of human immunodeficiency virus in a chronically infected promonocytic cell line by ultraviolet irradiation. AIDS Res Hum Retroviruses. 1989 Aug;5(4):375–384. [PubMed]
  • Stanley SK, Kessler SW, Justement JS, Schnittman SM, Greenhouse JJ, Brown CC, Musongela L, Musey K, Kapita B, Fauci AS. CD34+ bone marrow cells are infected with HIV in a subset of seropositive individuals. J Immunol. 1992 Jul 15;149(2):689–697. [PubMed]
  • Starcich BR, Hahn BH, Shaw GM, McNeely PD, Modrow S, Wolf H, Parks ES, Parks WP, Josephs SF, Gallo RC, et al. Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS. Cell. 1986 Jun 6;45(5):637–648. [PubMed]
  • St Clair MH, Martin JL, Tudor-Williams G, Bach MC, Vavro CL, King DM, Kellam P, Kemp SD, Larder BA. Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase. Science. 1991 Sep 27;253(5027):1557–1559. [PubMed]
  • Steck FT, Rubin H. The mechanism of interference between an avian leukosis virus and Rous sarcoma virus. I. Establishment of interference. Virology. 1966 Aug;29(4):628–641. [PubMed]
  • Steffan AM, Lafon ME, Gendrault JL, Schweitzer C, Royer C, Jaeck D, Arnaud JP, Schmitt MP, Aubertin AM, Kirn A. Primary cultures of endothelial cells from the human liver sinusoid are permissive for human immunodeficiency virus type 1. Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1582–1586. [PMC free article] [PubMed]
  • Steffy KR, Kraus G, Looney DJ, Wong-Staal F. Role of the fusogenic peptide sequence in syncytium induction and infectivity of human immunodeficiency virus type 2. J Virol. 1992 Jul;66(7):4532–4535. [PMC free article] [PubMed]
  • Steimer KS, Klasse PJ, McKeating JA. HIV-1 neutralization directed to epitopes other than linear V3 determinants. AIDS. 1991;5 (Suppl 2):S135–S143. [PubMed]
  • Steimer KS, Scandella CJ, Skiles PV, Haigwood NL. Neutralization of divergent HIV-1 isolates by conformation-dependent human antibodies to Gp120. Science. 1991 Oct 4;254(5028):105–108. [PubMed]
  • Stein B, Krämer M, Rahmsdorf HJ, Ponta H, Herrlich P. UV-induced transcription from the human immunodeficiency virus type 1 (HIV-1) long terminal repeat and UV-induced secretion of an extracellular factor that induces HIV-1 transcription in nonirradiated cells. J Virol. 1989 Nov;63(11):4540–4544. [PMC free article] [PubMed]
  • Stein BS, Gowda SD, Lifson JD, Penhallow RC, Bensch KG, Engleman EG. pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane. Cell. 1987 Jun 5;49(5):659–668. [PubMed]
  • Steinberg HN, Crumpacker CS, Chatis PA. In vitro suppression of normal human bone marrow progenitor cells by human immunodeficiency virus. J Virol. 1991 Apr;65(4):1765–1769. [PMC free article] [PubMed]
  • Steuler H, Storch-Hagenlocher B, Wildemann B. Distinct populations of human immunodeficiency virus type 1 in blood and cerebrospinal fluid. AIDS Res Hum Retroviruses. 1992 Jan;8(1):53–59. [PubMed]
  • Stevenson M, Haggerty S, Lamonica C, Mann AM, Meier C, Wasiak A. Cloning and characterization of human immunodeficiency virus type 1 variants diminished in the ability to induce syncytium-independent cytolysis. J Virol. 1990 Aug;64(8):3792–3803. [PMC free article] [PubMed]
  • Stevenson M, Haggerty S, Lamonica CA, Meier CM, Welch SK, Wasiak AJ. Integration is not necessary for expression of human immunodeficiency virus type 1 protein products. J Virol. 1990 May;64(5):2421–2425. [PMC free article] [PubMed]
  • Stevenson M, Meier C, Mann AM, Chapman N, Wasiak A. Envelope glycoprotein of HIV induces interference and cytolysis resistance in CD4+ cells: mechanism for persistence in AIDS. Cell. 1988 May 6;53(3):483–496. [PubMed]
  • Stevenson M, Stanwick TL, Dempsey MP, Lamonica CA. HIV-1 replication is controlled at the level of T cell activation and proviral integration. EMBO J. 1990 May;9(5):1551–1560. [PMC free article] [PubMed]
  • Stevenson M, Zhang XH, Volsky DJ. Downregulation of cell surface molecules during noncytopathic infection of T cells with human immunodeficiency virus. J Virol. 1987 Dec;61(12):3741–3748. [PMC free article] [PubMed]
  • Stingl G, Rappersberger K, Tschachler E, Gartner S, Groh V, Mann DL, Wolff K, Popovic M. Langerhans cells in HIV-1 infection. J Am Acad Dermatol. 1990 Jun;22(6 Pt 2):1210–1217. [PubMed]
  • Stoneburner RL, Chiasson MA, Weisfuse IB, Thomas PA. The epidemic of AIDS and HIV-1 infection among heterosexuals in New York City. AIDS. 1990 Feb;4(2):99–106. [PubMed]
  • Stott EJ. Anti-cell antibody in macaques. Nature. 1991 Oct 3;353(6343):393–393. [PubMed]
  • Stricker RB, McHugh TM, Moody DJ, Morrow WJ, Stites DP, Shuman MA, Levy JA. An AIDS-related cytotoxic autoantibody reacts with a specific antigen on stimulated CD4+ T cells. Nature. 327(6124):710–713. [PubMed]
  • Su H, Boackle RJ. Interaction of the envelope glycoprotein of human immunodeficiency virus with C1q and fibronectin under conditions present in human saliva. Mol Immunol. 1991 Aug;28(8):811–817. [PubMed]
  • Sugiura K, Oyaizu N, Pahwa R, Kalyanaraman VS, Pahwa S. Effect of human immunodeficiency virus-1 envelope glycoprotein on in vitro hematopoiesis of umbilical cord blood. Blood. 1992 Sep 15;80(6):1463–1469. [PubMed]
  • Sun NC, Ho DD, Sun CR, Liou RS, Gordon W, Fung MS, Li XL, Ting RC, Lee TH, Chang NT, et al. Generation and characterization of monoclonal antibodies to the putative CD4-binding domain of human immunodeficiency virus type 1 gp120. J Virol. 1989 Sep;63(9):3579–3585. [PMC free article] [PubMed]
  • Sutjipto S, Pedersen NC, Miller CJ, Gardner MB, Hanson CV, Gettie A, Jennings M, Higgins J, Marx PA. Inactivated simian immunodeficiency virus vaccine failed to protect rhesus macaques from intravenous or genital mucosal infection but delayed disease in intravenously exposed animals. J Virol. 1990 May;64(5):2290–2297. [PMC free article] [PubMed]
  • Sweet RW, Truneh A, Hendrickson WA. CD4: its structure, role in immune function and AIDS pathogenesis, and potential as a pharmacological target. Curr Opin Biotechnol. 1991 Aug;2(4):622–633. [PubMed]
  • Swingler S, Easton A, Morris A. Cytokine augmentation of HIV-1 LTR-driven gene expression in neural cells. AIDS Res Hum Retroviruses. 1992 Apr;8(4):487–493. [PubMed]
  • Syu WJ, Huang JH, Essex M, Lee TH. The N-terminal region of the human immunodeficiency virus envelope glycoprotein gp120 contains potential binding sites for CD4. Proc Natl Acad Sci U S A. 1990 May;87(10):3695–3699. [PMC free article] [PubMed]
  • Szelc CM, Mitcheltree C, Roberts RL, Stiehm ER. Deficient polymorphonuclear cell and mononuclear cell antibody-dependent cellular cytotoxicity in pediatric and adult human immunodeficiency virus infection. J Infect Dis. 1992 Sep;166(3):486–493. [PubMed]
  • Takahashi H, Nakagawa Y, Pendleton CD, Houghten RA, Yokomuro K, Germain RN, Berzofsky JA. Induction of broadly cross-reactive cytotoxic T cells recognizing an HIV-1 envelope determinant. Science. 1992 Jan 17;255(5042):333–336. [PubMed]
  • Takahashi H, Takeshita T, Morein B, Putney S, Germain RN, Berzofsky JA. Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs. Nature. 1990 Apr 26;344(6269):873–875. [PubMed]
  • Takeda A, Robinson JE, Ho DD, Debouck C, Haigwood NL, Ennis FA. Distinction of human immunodeficiency virus type 1 neutralization and infection enhancement by human monoclonal antibodies to glycoprotein 120. J Clin Invest. 1992 Jun;89(6):1952–1957. [PMC free article] [PubMed]
  • Takeda A, Sweet RW, Ennis FA. Two receptors are required for antibody-dependent enhancement of human immunodeficiency virus type 1 infection: CD4 and Fc gamma R. J Virol. 1990 Nov;64(11):5605–5610. [PMC free article] [PubMed]
  • Takeda A, Tuazon CU, Ennis FA. Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry. Science. 1988 Oct 28;242(4878):580–583. [PubMed]
  • Takeuchi Y, Akutsu M, Murayama K, Shimizu N, Hoshino H. Host range mutant of human immunodeficiency virus type 1: modification of cell tropism by a single point mutation at the neutralization epitope in the env gene. J Virol. 1991 Apr;65(4):1710–1718. [PMC free article] [PubMed]
  • Takeuchi Y, Nagumo T, Hoshino H. Low fidelity of cell-free DNA synthesis by reverse transcriptase of human immunodeficiency virus. J Virol. 1988 Oct;62(10):3900–3902. [PMC free article] [PubMed]
  • Tang SB, Levy JA. Parameters involved in the cell fusion induced by HIV. AIDS. 1990 May;4(5):409–415. [PubMed]
  • Tang S, Poulin L, Levy JA. Lack of human immunodeficiency virus type 1 (HIV-1) replication and accumulation of viral DNA in HIV-1-infected T cells blocked in cell replication. J Gen Virol. 1992 Apr;73(Pt 4):933–939. [PubMed]
  • Tardieu M, Héry C, Peudenier S, Boespflug O, Montagnier L. Human immunodeficiency virus type 1-infected monocytic cells can destroy human neural cells after cell-to-cell adhesion. Ann Neurol. 1992 Jul;32(1):11–17. [PubMed]
  • Tateno M, Gonzalez-Scarano F, Levy JA. Human immunodeficiency virus can infect CD4-negative human fibroblastoid cells. Proc Natl Acad Sci U S A. 1989 Jun;86(11):4287–4290. [PMC free article] [PubMed]
  • Tateno M, Levy JA. MT-4 plaque formation can distinguish cytopathic subtypes of the human immunodeficiency virus (HIV). Virology. 1988 Nov;167(1):299–301. [PubMed]
  • Tenner-Rácz K, Rácz P, Dietrich M, Kern P. Altered follicular dendritic cells and virus-like particles in AIDS and AIDS-related lymphadenopathy. Lancet. 1985 Jan 12;1(8420):105–106. [PubMed]
  • Terai C, Kornbluth RS, Pauza CD, Richman DD, Carson DA. Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1. J Clin Invest. 1991 May;87(5):1710–1715. [PMC free article] [PubMed]
  • Tersmette M, de Goede RE, Al BJ, Winkel IN, Gruters RA, Cuypers HT, Huisman HG, Miedema F. Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. J Virol. 1988 Jun;62(6):2026–2032. [PMC free article] [PubMed]
  • Tersmette M, Gruters RA, de Wolf F, de Goede RE, Lange JM, Schellekens PT, Goudsmit J, Huisman HG, Miedema F. Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates. J Virol. 1989 May;63(5):2118–2125. [PMC free article] [PubMed]
  • Tersmette M, Lange JM, de Goede RE, de Wolf F, Eeftink-Schattenkerk JK, Schellekens PT, Coutinho RA, Huisman JG, Goudsmit J, Miedema F. Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality. Lancet. 1989 May 6;1(8645):983–985. [PubMed]
  • Tersmette M, van Dongen JJ, Clapham PR, de Goede RE, Wolvers-Tettero IL, Geurts van Kessel A, Huisman JG, Weiss RA, Miedema F. Human immunodeficiency virus infection studied in CD4-expressing human-murine T-cell hybrids. Virology. 1989 Feb;168(2):267–273. [PubMed]
  • Terwilliger E, Sodroski JG, Rosen CA, Haseltine WA. Effects of mutations within the 3' orf open reading frame region of human T-cell lymphotropic virus type III (HTLV-III/LAV) on replication and cytopathogenicity. J Virol. 1986 Nov;60(2):754–760. [PMC free article] [PubMed]
  • Terwilliger EF, Langhoff E, Gabuzda D, Zazopoulos E, Haseltine WA. Allelic variation in the effects of the nef gene on replication of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10971–10975. [PMC free article] [PubMed]
  • Thali M, Furman C, Helseth E, Repke H, Sodroski J. Lack of correlation between soluble CD4-induced shedding of the human immunodeficiency virus type 1 exterior envelope glycoprotein and subsequent membrane fusion events. J Virol. 1992 Sep;66(9):5516–5524. [PMC free article] [PubMed]
  • Thali M, Furman C, Ho DD, Robinson J, Tilley S, Pinter A, Sodroski J. Discontinuous, conserved neutralization epitopes overlapping the CD4-binding region of human immunodeficiency virus type 1 gp120 envelope glycoprotein. J Virol. 1992 Sep;66(9):5635–5641. [PMC free article] [PubMed]
  • Thiriart C, Goudsmit J, Schellekens P, Barin F, Zagury D, De Wilde M, Bruck C. Antibodies to soluble CD4 in HIV-1-infected individuals. AIDS. 1988 Oct;2(5):345–351. [PubMed]
  • Thiry L, Sprecher-Goldberger S, Jonckheer T, Levy J, Van de Perre P, Henrivaux P, Cogniaux-LeClerc J, Clumeck N. Isolation of AIDS virus from cell-free breast milk of three healthy virus carriers. Lancet. 1985 Oct 19;2(8460):891–892. [PubMed]
  • Tilley SA, Honnen WJ, Racho ME, Chou TC, Pinter A. Synergistic neutralization of HIV-1 by human monoclonal antibodies against the V3 loop and the CD4-binding site of gp120. AIDS Res Hum Retroviruses. 1992 Apr;8(4):461–467. [PubMed]
  • Tindall B, Barker S, Donovan B, Barnes T, Roberts J, Kronenberg C, Gold J, Penny R, Cooper D. Characterization of the acute clinical illness associated with human immunodeficiency virus infection. Arch Intern Med. 1988 Apr;148(4):945–949. [PubMed]
  • Tindall B, Carr A, Goldstein D, Penny R, Cooper DA. Administration of zidovudine during primary HIV-1 infection may be associated with a less vigorous immune response. AIDS. 1993 Jan;7(1):127–128. [PubMed]
  • Tindall B, Cooper DA. Primary HIV infection: host responses and intervention strategies. AIDS. 1991 Jan;5(1):1–14. [PubMed]
  • Tindall B, Evans L, Cunningham P, McQueen P, Hurren L, Vasak E, Mooney J, Cooper DA. Identification of HIV-1 in semen following primary HIV-1 infection. AIDS. 1992 Sep;6(9):949–952. [PubMed]
  • Tindall B, Gaines H, Imrie A, von Sydow MA, Evans L, Strannegard O, Tsang ML, Lindback S, Cooper DA. Zidovudine in the management of primary HIV-1 infection. AIDS. 1991 May;5(5):477–484. [PubMed]
  • Tong-Starkesen SE, Luciw PA, Peterlin BM. Signaling through T lymphocyte surface proteins, TCR/CD3 and CD28, activates the HIV-1 long terminal repeat. J Immunol. 1989 Jan 15;142(2):702–707. [PubMed]
  • Tornatore C, Nath A, Amemiya K, Major EO. Persistent human immunodeficiency virus type 1 infection in human fetal glial cells reactivated by T-cell factor(s) or by the cytokines tumor necrosis factor alpha and interleukin-1 beta. J Virol. 1991 Nov;65(11):6094–6100. [PMC free article] [PubMed]
  • Epidemiology, clinical features, and prognostic factors of paediatric HIV infection. Italian Multicentre Study. Lancet. 1988 Nov 5;2(8619):1043–1046. [PubMed]
  • Travis BM, Dykers TI, Hewgill D, Ledbetter J, Tsu TT, Hu SL, Lewis JB. Functional roles of the V3 hypervariable region of HIV-1 gp160 in the processing of gp160 and in the formation of syncytia in CD4+ cells. Virology. 1992 Jan;186(1):313–317. [PubMed]
  • Tremblay M, Meloche S, Sekaly RP, Wainberg MA. Complement receptor 2 mediates enhancement of human immunodeficiency virus 1 infection in Epstein-Barr virus-carrying B cells. J Exp Med. 1990 May 1;171(5):1791–1796. [PMC free article] [PubMed]
  • Tremblay M, Numazaki K, Li XG, Gornitsky M, Hiscott J, Wainberg MA. Resistance to infection by HIV-1 of peripheral blood mononuclear cells from HIV-1-infected patients is probably mediated by neutralizing antibodies. J Immunol. 1990 Nov 1;145(9):2896–2901. [PubMed]
  • Trono D. Partial reverse transcripts in virions from human immunodeficiency and murine leukemia viruses. J Virol. 1992 Aug;66(8):4893–4900. [PMC free article] [PubMed]
  • Trono D, Baltimore D. A human cell factor is essential for HIV-1 Rev action. EMBO J. 1990 Dec;9(12):4155–4160. [PMC free article] [PubMed]
  • Truneh A, Buck D, Cassatt DR, Juszczak R, Kassis S, Ryu SE, Healey D, Sweet R, Sattentau Q. A region in domain 1 of CD4 distinct from the primary gp120 binding site is involved in HIV infection and virus-mediated fusion. J Biol Chem. 1991 Mar 25;266(9):5942–5948. [PubMed]
  • Tschachler E, Groh V, Popovic M, Mann DL, Konrad K, Safai B, Eron L, diMarzo Veronese F, Wolff K, Stingl G. Epidermal Langerhans cells--a target for HTLV-III/LAV infection. J Invest Dermatol. 1987 Feb;88(2):233–237. [PubMed]
  • Tsubota H, Ringler DJ, Kannagi M, King NW, Solomon KR, MacKey JJ, Walsh DG, Letvin NL. CD8+CD4- lymphocyte lines can harbor the AIDS virus in vitro. J Immunol. 1989 Aug 1;143(3):858–863. [PubMed]
  • Tsujimoto H, Hasegawa A, Maki N, Fukasawa M, Miura T, Speidel S, Cooper RW, Moriyama EN, Gojobori T, Hayami M. Sequence of a novel simian immunodeficiency virus from a wild-caught African mandrill. Nature. 1989 Oct 12;341(6242):539–541. [PubMed]
  • Tsunetsugu-Yokota Y, Matsuda S, Maekawa M, Saito T, Takemori T, Takebe Y. Constitutive expression of the nef gene suppresses human immunodeficiency virus type 1 (HIV-1) replication in monocytic cell lines. Virology. 1992 Dec;191(2):960–963. [PubMed]
  • Turner S, Tizard R, DeMarinis J, Pepinsky RB, Zullo J, Schooley R, Fisher R. Resistance of primary isolates of human immunodeficiency virus type 1 to neutralization by soluble CD4 is not due to lower affinity with the viral envelope glycoprotein gp120. Proc Natl Acad Sci U S A. 1992 Feb 15;89(4):1335–1339. [PMC free article] [PubMed]
  • Tyler DS, Nastala CL, Stanley SD, Matthews TJ, Lyerly HK, Bolognesi DP, Weinhold KJ. GP120 specific cellular cytotoxicity in HIV-1 seropositive individuals. Evidence for circulating CD16+ effector cells armed in vivo with cytophilic antibody. J Immunol. 1989 Feb 15;142(4):1177–1182. [PubMed]
  • Tyler DS, Stanley SD, Nastala CA, Austin AA, Bartlett JA, Stine KC, Lyerly HK, Bolognesi DP, Weinhold KJ. Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection. Humoral and cellular defects. J Immunol. 1990 May 1;144(9):3375–3384. [PubMed]
  • Uehara T, Miyawaki T, Ohta K, Tamaru Y, Yokoi T, Nakamura S, Taniguchi N. Apoptotic cell death of primed CD45RO+ T lymphocytes in Epstein-Barr virus-induced infectious mononucleosis. Blood. 1992 Jul 15;80(2):452–458. [PubMed]
  • Ugen KE, Goedert JJ, Boyer J, Refaeli Y, Frank I, Williams WV, Willoughby A, Landesman S, Mendez H, Rubinstein A, et al. Vertical transmission of human immunodeficiency virus (HIV) infection. Reactivity of maternal sera with glycoprotein 120 and 41 peptides from HIV type 1. J Clin Invest. 1992 Jun;89(6):1923–1930. [PMC free article] [PubMed]
  • Vaishnav YN, Wong-Staal F. The biochemistry of AIDS. Annu Rev Biochem. 1991;60:577–630. [PubMed]
  • Valentin A, Albert J, Fenyö EM, Asjö B. HIV-1 infection of normal human macrophage cultures: implication for silent infection. Virology. 1990 Aug;177(2):790–794. [PubMed]
  • Valentin A, Lundin K, Patarroyo M, Asjö B. The leukocyte adhesion glycoprotein CD18 participates in HIV-1-induced syncytia formation in monocytoid and T cells. J Immunol. 1990 Feb 1;144(3):934–937. [PubMed]
  • Valentin A, Von Gegerfelt A, Matsuda S, Nilsson K, Asjö B. In vitro maturation of mononuclear phagocytes and susceptibility to HIV-1 infection. J Acquir Immune Defic Syndr. 1991;4(8):751–759. [PubMed]
  • Valeriano-Marcet J, Ravichandran L, Kerr LD. HIV associated systemic necrotizing vasculitis. J Rheumatol. 1990 Aug;17(8):1091–1093. [PubMed]
  • Valerie K, Delers A, Bruck C, Thiriart C, Rosenberg H, Debouck C, Rosenberg M. Activation of human immunodeficiency virus type 1 by DNA damage in human cells. Nature. 1988 May 5;333(6168):78–81. [PubMed]
  • Van de Perre P, Simonon A, Msellati P, Hitimana DG, Vaira D, Bazubagira A, Van Goethem C, Stevens AM, Karita E, Sondag-Thull D, et al. Postnatal transmission of human immunodeficiency virus type 1 from mother to infant. A prospective cohort study in Kigali, Rwanda. N Engl J Med. 1991 Aug 29;325(9):593–598. [PubMed]
  • van Noesel CJ, Gruters RA, Terpstra FG, Schellekens PT, van Lier RA, Miedema F. Functional and phenotypic evidence for a selective loss of memory T cells in asymptomatic human immunodeficiency virus-infected men. J Clin Invest. 1990 Jul;86(1):293–299. [PMC free article] [PubMed]
  • Van Voorhis BJ, Martinez A, Mayer K, Anderson DJ. Detection of human immunodeficiency virus type 1 in semen from seropositive men using culture and polymerase chain reaction deoxyribonucleic acid amplification techniques. Fertil Steril. 1991 Mar;55(3):588–594. [PubMed]
  • Vega MA, Guigó R, Smith TF. Autoimmune response in AIDS. Nature. 1990 May 3;345(6270):26–26. [PubMed]
  • Vella S, Giuliano M, Pezzotti P, Agresti MG, Tomino C, Floridia M, Greco D, Moroni M, Visco G, Milazzo F, et al. Survival of zidovudine-treated patients with AIDS compared with that of contemporary untreated patients. Italian Zidovudine Evaluation Group. JAMA. 1992 Mar 4;267(9):1232–1236. [PubMed]
  • Vendrell JP, Segondy M, Ducos J, Reynes J, Huguet MF, Nicolas JC, Serre A. Analysis of the spontaneous in vitro anti-HIV-1 antibody secretion by peripheral blood mononuclear cells in HIV-1 infection. Clin Exp Immunol. 1991 Feb;83(2):197–202. [PMC free article] [PubMed]
  • Villinger F, Powell JD, Jehuda-Cohen T, Neckelmann N, Vuchetich M, De B, Folks TM, McClure HM, Ansari AA. Detection of occult simian immunodeficiency virus SIVsmm infection in asymptomatic seronegative nonhuman primates and evidence for variation in SIV gag sequence between in vivo- and in vitro-propagated virus. J Virol. 1991 Apr;65(4):1855–1862. [PMC free article] [PubMed]
  • Viscidi RP, Mayur K, Lederman HM, Frankel AD. Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1. Science. 1989 Dec 22;246(4937):1606–1608. [PubMed]
  • Vittecoq D, Mattlinger B, Barre-Sinoussi F, Courouce AM, Rouzioux C, Doinel C, Bary M, Viard JP, Bach JF, Rouger P, et al. Passive immunotherapy in AIDS: a randomized trial of serial human immunodeficiency virus-positive transfusions of plasma rich in p24 antibodies versus transfusions of seronegative plasma. J Infect Dis. 1992 Feb;165(2):364–368. [PubMed]
  • Vlach J, Pitha PM. Herpes simplex virus type 1-mediated induction of human immunodeficiency virus type 1 provirus correlates with binding of nuclear proteins to the NF-kappa B enhancer and leader sequence. J Virol. 1992 Jun;66(6):3616–3623. [PMC free article] [PubMed]
  • Vogt MW, Witt DJ, Craven DE, Byington R, Crawford DF, Schooley RT, Hirsch MS. Isolation of HTLV-III/LAV from cervical secretions of women at risk for AIDS. Lancet. 1986 Mar 8;1(8480):525–527. [PubMed]
  • Vogt MW, Witt DJ, Craven DE, Byington R, Crawford DF, Hutchinson MS, Schooley RT, Hirsch MS. Isolation patterns of the human immunodeficiency virus from cervical secretions during the menstrual cycle of women at risk for the acquired immunodeficiency syndrome. Ann Intern Med. 1987 Mar;106(3):380–382. [PubMed]
  • Vogt PK. Phenotypic mixing in the avian tumor virus group. Virology. 1967 Aug;32(4):708–717. [PubMed]
  • Vogt PK, Ishizaki R. Patterns of viral interference in the avian leukosis and sarcoma complex. Virology. 1966 Nov;30(3):368–374. [PubMed]
  • Volberding PA, Lagakos SW, Koch MA, Pettinelli C, Myers MW, Booth DK, Balfour HH, Jr, Reichman RC, Bartlett JA, Hirsch MS, et al. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases. N Engl J Med. 1990 Apr 5;322(14):941–949. [PubMed]
  • von Briesen H, Andreesen R, Rübsamen-Waigmann H. Systematic classification of HIV biological subtypes on lymphocytes and monocytes/macrophages. Virology. 1990 Oct;178(2):597–602. [PubMed]
  • Von Gegerfelt A, Albert J, Morfeldt-Månson L, Broliden K, Fenyö EM. Isolate-specific neutralizing antibodies in patients with progressive HIV-1-related disease. Virology. 1991 Nov;185(1):162–168. [PubMed]
  • von Gegerfelt A, Chiodi F, Keys B, Norkrans G, Hagberg L, Fenyö EM, Broliden K. Lack of autologous neutralizing antibodies in the cerebrospinal fluid of HIV-1 infected individuals. AIDS Res Hum Retroviruses. 1992 Jun;8(6):1133–1138. [PubMed]
  • von Laer D, Hufert FT, Fenner TE, Schwander S, Dietrich M, Schmitz H, Kern P. CD34+ hematopoietic progenitor cells are not a major reservoir of the human immunodeficiency virus. Blood. 1990 Oct 1;76(7):1281–1286. [PubMed]
  • von Rüden T, Gilboa E. Inhibition of human T-cell leukemia virus type I replication in primary human T cells that express antisense RNA. J Virol. 1989 Feb;63(2):677–682. [PMC free article] [PubMed]
  • von Sydow M, Gaines H, Sönnerborg A, Forsgren M, Pehrson PO, Strannegård O. Antigen detection in primary HIV infection. Br Med J (Clin Res Ed) 1988 Jan 23;296(6617):238–240. [PMC free article] [PubMed]
  • Vyakarnam A, McKeating J, Meager A, Beverley PC. Tumour necrosis factors (alpha, beta) induced by HIV-1 in peripheral blood mononuclear cells potentiate virus replication. AIDS. 1990 Jan;4(1):21–27. [PubMed]
  • Wahl SM, Allen JB, Gartner S, Orenstein JM, Popovic M, Chenoweth DE, Arthur LO, Farrar WL, Wahl LM. HIV-1 and its envelope glycoprotein down-regulate chemotactic ligand receptors and chemotactic function of peripheral blood monocytes. J Immunol. 1989 May 15;142(10):3553–3559. [PubMed]
  • Wahl SM, Allen JB, McCartney-Francis N, Morganti-Kossmann MC, Kossmann T, Ellingsworth L, Mai UE, Mergenhagen SE, Orenstein JM. Macrophage- and astrocyte-derived transforming growth factor beta as a mediator of central nervous system dysfunction in acquired immune deficiency syndrome. J Exp Med. 1991 Apr 1;173(4):981–991. [PMC free article] [PubMed]
  • Wahren B, Morfeldt-Månsson L, Biberfeld G, Moberg L, Sönnerborg A, Ljungman P, Werner A, Kurth R, Gallo R, Bolognesi D. Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection. J Virol. 1987 Jun;61(6):2017–2023. [PMC free article] [PubMed]
  • Wain-Hobson S, Sonigo P, Danos O, Cole S, Alizon M. Nucleotide sequence of the AIDS virus, LAV. Cell. 1985 Jan;40(1):9–17. [PubMed]
  • Wain-Hobson S, Vartanian JP, Henry M, Chenciner N, Cheynier R, Delassus S, Martins LP, Sala M, Nugeyre MT, Guétard D, et al. LAV revisited: origins of the early HIV-1 isolates from Institut Pasteur. Science. 1991 May 17;252(5008):961–965. [PubMed]
  • Walker BD, Flexner C, Birch-Limberger K, Fisher L, Paradis TJ, Aldovini A, Young R, Moss B, Schooley RT. Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type 1. Proc Natl Acad Sci U S A. 1989 Dec;86(23):9514–9518. [PMC free article] [PubMed]
  • Walker BD, Flexner C, Paradis TJ, Fuller TC, Hirsch MS, Schooley RT, Moss B. HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals. Science. 1988 Apr 1;240(4848):64–66. [PubMed]
  • Walker CM, Erickson AL, Hsueh FC, Levy JA. Inhibition of human immunodeficiency virus replication in acutely infected CD4+ cells by CD8+ cells involves a noncytotoxic mechanism. J Virol. 1991 Nov;65(11):5921–5927. [PMC free article] [PubMed]
  • Walker CM, Levy JA. A diffusible lymphokine produced by CD8+ T lymphocytes suppresses HIV replication. Immunology. 1989 Apr;66(4):628–630. [PMC free article] [PubMed]
  • Walker CM, Moody DJ, Stites DP, Levy JA. CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Science. 1986 Dec 19;234(4783):1563–1566. [PubMed]
  • Walker CM, Moody DJ, Stites DP, Levy JA. CD8+ T lymphocyte control of HIV replication in cultured CD4+ cells varies among infected individuals. Cell Immunol. 1989 Apr 1;119(2):470–475. [PubMed]
  • Walker CM, Thomson-Honnebier GA, Hsueh FC, Erickson AL, Pan LZ, Levy JA. CD8+ T cells from HIV-1-infected individuals inhibit acute infection by human and primate immunodeficiency viruses. Cell Immunol. 1991 Oct 15;137(2):420–428. [PubMed]
  • Wang JH, Yan YW, Garrett TP, Liu JH, Rodgers DW, Garlick RL, Tarr GE, Husain Y, Reinherz EL, Harrison SC. Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains. Nature. 1990 Nov 29;348(6300):411–418. [PubMed]
  • Wang RY, Shih JW, Grandinetti T, Pierce PF, Hayes MM, Wear DJ, Alter HJ, Lo SC. High frequency of antibodies to Mycoplasma penetrans in HIV-infected patients. Lancet. 1992 Nov 28;340(8831):1312–1316. [PubMed]
  • Ward JW, Bush TJ, Perkins HA, Lieb LE, Allen JR, Goldfinger D, Samson SM, Pepkowitz SH, Fernando LP, Holland PV, et al. The natural history of transfusion-associated infection with human immunodeficiency virus. Factors influencing the rate of progression to disease. N Engl J Med. 1989 Oct 5;321(14):947–952. [PubMed]
  • Warren RQ, Anderson SA, Nkya WM, Shao JF, Hendrix CW, Melcher GP, Redfield RR, Kennedy RC. Examination of sera from human immunodeficiency virus type 1 (HIV-1)-infected individuals for antibodies reactive with peptides corresponding to the principal neutralizing determinant of HIV-1 gp120 and for in vitro neutralizing activity. J Virol. 1992 Sep;66(9):5210–5215. [PMC free article] [PubMed]
  • Watanabe M, Boyson JE, Lord CI, Letvin NL. Chimpanzees immunized with recombinant soluble CD4 develop anti-self CD4 antibody responses with anti-human immunodeficiency virus activity. Proc Natl Acad Sci U S A. 1992 Jun 1;89(11):5103–5107. [PMC free article] [PubMed]
  • Watanabe M, Chen ZW, Tsubota H, Lord CI, Levine CG, Letvin NL. Soluble human CD4 elicits an antibody response in rhesus monkeys that inhibits simian immunodeficiency virus replication. Proc Natl Acad Sci U S A. 1991 Jan 1;88(1):120–124. [PMC free article] [PubMed]
  • Watkins BA, Dorn HH, Kelly WB, Armstrong RC, Potts BJ, Michaels F, Kufta CV, Dubois-Dalcq M. Specific tropism of HIV-1 for microglial cells in primary human brain cultures. Science. 1990 Aug 3;249(4968):549–553. [PubMed]
  • Weber J, Clapham P, McKeating J, Stratton M, Robey E, Weiss R. Infection of brain cells by diverse human immunodeficiency virus isolates: role of CD4 as receptor. J Gen Virol. 1989 Oct;70(Pt 10):2653–2660. [PubMed]
  • Weber JN, Clapham PR, Weiss RA, Parker D, Roberts C, Duncan J, Weller I, Carne C, Tedder RS, Pinching AJ, et al. Human immunodeficiency virus infection in two cohorts of homosexual men: neutralising sera and association of anti-gag antibody with prognosis. Lancet. 1987 Jan 17;1(8525):119–122. [PubMed]
  • Webster A, Lee CA, Cook DG, Grundy JE, Emery VC, Kernoff PB, Griffiths PD. Cytomegalovirus infection and progression towards AIDS in haemophiliacs with human immunodeficiency virus infection. Lancet. 1989 Jul 8;2(8654):63–66. [PubMed]
  • Weiblen BJ, Lee FK, Cooper ER, Landesman SH, McIntosh K, Harris JA, Nesheim S, Mendez H, Pelton SI, Nahmias AJ, et al. Early diagnosis of HIV infection in infants by detection of IgA HIV antibodies. Lancet. 1990 Apr 28;335(8696):988–990. [PubMed]
  • Weimer R, Daniel V, Zimmermann R, Schimpf K, Opelz G. Autoantibodies against CD4 cells are associated with CD4 helper defects in human immunodeficiency virus-infected patients. Blood. 1991 Jan 1;77(1):133–140. [PubMed]
  • Weinberg JB, Matthews TJ, Cullen BR, Malim MH. Productive human immunodeficiency virus type 1 (HIV-1) infection of nonproliferating human monocytes. J Exp Med. 1991 Dec 1;174(6):1477–1482. [PMC free article] [PubMed]
  • Weinhold KJ, Lyerly HK, Matthews TJ, Tyler DS, Ahearne PM, Stine KC, Langlois AJ, Durack DT, Bolognesi DP. Cellular anti-GP120 cytolytic reactivities in HIV-1 seropositive individuals. Lancet. 1988 Apr 23;1(8591):902–905. [PubMed]
  • Weinhold KJ, Lyerly HK, Stanley SD, Austin AA, Matthews TJ, Bolognesi DP. HIV-1 GP120-mediated immune suppression and lymphocyte destruction in the absence of viral infection. J Immunol. 1989 May 1;142(9):3091–3097. [PubMed]
  • Weiss A, Wiskocil RL, Stobo JD. The role of T3 surface molecules in the activation of human T cells: a two-stimulus requirement for IL 2 production reflects events occurring at a pre-translational level. J Immunol. 1984 Jul;133(1):123–128. [PubMed]
  • Weiss CD, Levy JA, White JM. Oligomeric organization of gp120 on infectious human immunodeficiency virus type 1 particles. J Virol. 1990 Nov;64(11):5674–5677. [PMC free article] [PubMed]
  • Weiss RA. Receptor molecule blocks HIV. Nature. 1988 Jan 7;331(6151):15–15. [PubMed]
  • Weiss RA, Clapham PR, Weber JN, Dalgleish AG, Lasky LA, Berman PW. Variable and conserved neutralization antigens of human immunodeficiency virus. Nature. 1986 Dec 11;324(6097):572–575. [PubMed]
  • Weiss RA, Clapham PR, Weber JN, Whitby D, Tedder RS, O'Connor T, Chamaret S, Montagnier L. HIV-2 antisera cross-neutralize HIV-1. AIDS. 1988 Apr;2(2):95–100. [PubMed]
  • Weller SK, Joy AE, Temin HM. Correlation between cell killing and massive second-round superinfection by members of some subgroups of avian leukosis virus. J Virol. 1980 Jan;33(1):494–506. [PMC free article] [PubMed]
  • Wendler I, Bienzle U, Hunsmann G. Neutralizing antibodies and the course of HIV-induced disease. AIDS Res Hum Retroviruses. 1987 Summer;3(2):157–163. [PubMed]
  • Werner A, Winskowsky G, Kurth R. Soluble CD4 enhances simian immunodeficiency virus SIVagm infection. J Virol. 1990 Dec;64(12):6252–6256. [PMC free article] [PubMed]
  • Werner T, Ferroni S, Saermark T, Brack-Werner R, Banati RB, Mager R, Steinaa L, Kreutzberg GW, Erfle V. HIV-1 Nef protein exhibits structural and functional similarity to scorpion peptides interacting with K+ channels. AIDS. 1991 Nov;5(11):1301–1308. [PubMed]
  • Westermann J, Pabst R. Lymphocyte subsets in the blood: a diagnostic window on the lymphoid system? Immunol Today. 1990 Nov;11(11):406–410. [PubMed]
  • Westervelt P, Henkel T, Trowbridge DB, Orenstein J, Heuser J, Gendelman HE, Ratner L. Dual regulation of silent and productive infection in monocytes by distinct human immunodeficiency virus type 1 determinants. J Virol. 1992 Jun;66(6):3925–3931. [PMC free article] [PubMed]
  • Westervelt P, Trowbridge DB, Epstein LG, Blumberg BM, Li Y, Hahn BH, Shaw GM, Price RW, Ratner L. Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo. J Virol. 1992 Apr;66(4):2577–2582. [PMC free article] [PubMed]
  • Westmoreland D, St Jeor S, Rapp F. The development by cytomegalovirus-infected cells of binding affinity for normal human immunoglobulin. J Immunol. 1976 Jun;116(6):1566–1570. [PubMed]
  • White JM. Viral and cellular membrane fusion proteins. Annu Rev Physiol. 1990;52:675–697. [PubMed]
  • Wigdahl B, Guyton RA, Sarin PS. Human immunodeficiency virus infection of the developing human nervous system. Virology. 1987 Aug;159(2):440–445. [PubMed]
  • Wild C, Oas T, McDanal C, Bolognesi D, Matthews T. A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition. Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10537–10541. [PMC free article] [PubMed]
  • Wiley CA, Nelson JA. Role of human immunodeficiency virus and cytomegalovirus in AIDS encephalitis. Am J Pathol. 1988 Oct;133(1):73–81. [PMC free article] [PubMed]
  • Wiley CA, Schrier RD, Denaro FJ, Nelson JA, Lampert PW, Oldstone MB. Localization of cytomegalovirus proteins and genome during fulminant central nervous system infection in an AIDS patient. J Neuropathol Exp Neurol. 1986 Mar;45(2):127–139. [PubMed]
  • Wiley CA, Schrier RD, Nelson JA, Lampert PW, Oldstone MB. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci U S A. 1986 Sep;83(18):7089–7093. [PMC free article] [PubMed]
  • Wilks D, Walker L, O'Brien J, Habeshaw J, Dalgleish A. Differences in affinity of anti-CD4 monoclonal antibodies predict their effects on syncytium induction by human immunodeficiency virus. Immunology. 1990 Sep;71(1):10–15. [PMC free article] [PubMed]
  • Willey RL, Ross EK, Buckler-White AJ, Theodore TS, Martin MA. Functional interaction of constant and variable domains of human immunodeficiency virus type 1 gp120. J Virol. 1989 Sep;63(9):3595–3600. [PMC free article] [PubMed]
  • Willey RL, Rutledge RA, Dias S, Folks T, Theodore T, Buckler CE, Martin MA. Identification of conserved and divergent domains within the envelope gene of the acquired immunodeficiency syndrome retrovirus. Proc Natl Acad Sci U S A. 1986 Jul;83(14):5038–5042. [PMC free article] [PubMed]
  • Willey RL, Smith DH, Lasky LA, Theodore TS, Earl PL, Moss B, Capon DJ, Martin MA. In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. J Virol. 1988 Jan;62(1):139–147. [PMC free article] [PubMed]
  • Wilson C, Reitz MS, Jr, Aldrich K, Klasse PJ, Blomberg J, Gallo RC, Robert-Guroff M. The site of an immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 does not constitute the neutralization epitope. J Virol. 1990 Jul;64(7):3240–3248. [PMC free article] [PubMed]
  • Winkelstein W, Jr, Lyman DM, Padian N, Grant R, Samuel M, Wiley JA, Anderson RE, Lang W, Riggs J, Levy JA. Sexual practices and risk of infection by the human immunodeficiency virus. The San Francisco Men's Health Study. JAMA. 1987 Jan 16;257(3):321–325. [PubMed]
  • Wintsch J, Chaignat CL, Braun DG, Jeannet M, Stalder H, Abrignani S, Montagna D, Clavijo F, Moret P, Dayer JM, et al. Safety and immunogenicity of a genetically engineered human immunodeficiency virus vaccine. J Infect Dis. 1991 Feb;163(2):219–225. [PubMed]
  • Withrington RH, Cornes P, Harris JR, Seifert MH, Berrie E, Taylor-Robinson D, Jeffries DJ. Isolation of human immunodeficiency virus from synovial fluid of a patient with reactive arthritis. Br Med J (Clin Res Ed) 1987 Feb 21;294(6570):484–484. [PMC free article] [PubMed]
  • Wiviott LD, Walker CM, Levy JA. CD8+ lymphocytes suppress HIV production by autologous CD4+ cells without eliminating the infected cells from culture. Cell Immunol. 1990 Jul;128(2):628–634. [PubMed]
  • Wofsy CB, Cohen JB, Hauer LB, Padian NS, Michaelis BA, Evans LA, Levy JA. Isolation of AIDS-associated retrovirus from genital secretions of women with antibodies to the virus. Lancet. 1986 Mar 8;1(8480):527–529. [PubMed]
  • Wolber V, Rensland H, Brandmeier B, Sagemann M, Hoffmann R, Kalbitzer HR, Wittinghofer A. Expression, purification and biochemical characterisation of the human immunodeficiency virus 1 nef gene product. Eur J Biochem. 1992 May 1;205(3):1115–1121. [PubMed]
  • Wolff H, Anderson DJ. Immunohistologic characterization and quantitation of leukocyte subpopulations in human semen. Fertil Steril. 1988 Mar;49(3):497–504. [PubMed]
  • Wolff H, Anderson DJ. Potential human immunodeficiency virus-host cells in human semen. AIDS Res Hum Retroviruses. 1988 Feb;4(1):1–2. [PubMed]
  • Wolfs TF, Zwart G, Bakker M, Goudsmit J. HIV-1 genomic RNA diversification following sexual and parenteral virus transmission. Virology. 1992 Jul;189(1):103–110. [PubMed]
  • Wolfs TF, Zwart G, Bakker M, Valk M, Kuiken CL, Goudsmit J. Naturally occurring mutations within HIV-1 V3 genomic RNA lead to antigenic variation dependent on a single amino acid substitution. Virology. 1991 Nov;185(1):195–205. [PubMed]
  • Wolinsky SM, Rinaldo CR, Kwok S, Sninsky JJ, Gupta P, Imagawa D, Farzadegan H, Jacobson LP, Grovit KS, Lee MH, et al. Human immunodeficiency virus type 1 (HIV-1) infection a median of 18 months before a diagnostic western blot. Evidence from a cohort of homosexual men. Ann Intern Med. 1989 Dec 15;111(12):961–972. [PubMed]
  • Wolinsky SM, Wike CM, Korber BT, Hutto C, Parks WP, Rosenblum LL, Kunstman KJ, Furtado MR, Muñoz JL. Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants. Science. 1992 Feb 28;255(5048):1134–1137. [PubMed]
  • Wormser GP, Bittker S, Forseter G, Hewlett IK, Argani I, Joshi B, Epstein JS, Bucher D. Absence of infectious human immunodeficiency virus type 1 in "natural" eccrine sweat. J Infect Dis. 1992 Jan;165(1):155–158. [PubMed]
  • Wu F, Garcia J, Mitsuyasu R, Gaynor R. Alterations in binding characteristics of the human immunodeficiency virus enhancer factor. J Virol. 1988 Jan;62(1):218–225. [PMC free article] [PubMed]
  • Wu F, Garcia J, Sigman D, Gaynor R. tat regulates binding of the human immunodeficiency virus trans-activating region RNA loop-binding protein TRP-185. Genes Dev. 1991 Nov;5(11):2128–2140. [PubMed]
  • Wu JY, Gardner BH, Murphy CI, Seals JR, Kensil CR, Recchia J, Beltz GA, Newman GW, Newman MJ. Saponin adjuvant enhancement of antigen-specific immune responses to an experimental HIV-1 vaccine. J Immunol. 1992 Mar 1;148(5):1519–1525. [PubMed]
  • Yagita H, Nakata M, Kawasaki A, Shinkai Y, Okumura K. Role of perforin in lymphocyte-mediated cytolysis. Adv Immunol. 1992;51:215–242. [PubMed]
  • Yahi N, Baghdiguian S, Moreau H, Fantini J. Galactosyl ceramide (or a closely related molecule) is the receptor for human immunodeficiency virus type 1 on human colon epithelial HT29 cells. J Virol. 1992 Aug;66(8):4848–4854. [PMC free article] [PubMed]
  • Yamada M, Zurbriggen A, Oldstone MB, Fujinami RS. Common immunologic determinant between human immunodeficiency virus type 1 gp41 and astrocytes. J Virol. 1991 Mar;65(3):1370–1376. [PMC free article] [PubMed]
  • Yamamoto JK, Hohdatsu T, Olmsted RA, Pu R, Louie H, Zochlinski HA, Acevedo V, Johnson HM, Soulds GA, Gardner MB. Experimental vaccine protection against homologous and heterologous strains of feline immunodeficiency virus. J Virol. 1993 Jan;67(1):601–605. [PMC free article] [PubMed]
  • Yarchoan R, Mitsuya H, Broder S. Clinical and basic advances in the antiretroviral therapy of human immunodeficiency virus infection. Am J Med. 1989 Aug;87(2):191–200. [PubMed]
  • Yarchoan R, Perno CF, Thomas RV, Klecker RW, Allain JP, Wills RJ, McAtee N, Fischl MA, Dubinsky R, McNeely MC, et al. Phase I studies of 2',3'-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT). Lancet. 1988 Jan 16;1(8577):76–81. [PubMed]
  • Yarchoan R, Pluda JM, Perno CF, Mitsuya H, Broder S. Anti-retroviral therapy of human immunodeficiency virus infection: current strategies and challenges for the future. Blood. 1991 Aug 15;78(4):859–884. [PubMed]
  • Yarchoan R, Klecker RW, Weinhold KJ, Markham PD, Lyerly HK, Durack DT, Gelmann E, Lehrman SN, Blum RM, Barry DW, et al. Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex. Lancet. 1986 Mar 15;1(8481):575–580. [PubMed]
  • Yolken RH, Li S, Perman J, Viscidi R. Persistent diarrhea and fecal shedding of retroviral nucleic acids in children infected with human immunodeficiency virus. J Infect Dis. 1991 Jul;164(1):61–66. [PubMed]
  • York-Higgins D, Cheng-Mayer C, Bauer D, Levy JA, Dina D. Human immunodeficiency virus type 1 cellular host range, replication, and cytopathicity are linked to the envelope region of the viral genome. J Virol. 1990 Aug;64(8):4016–4020. [PMC free article] [PubMed]
  • Yu G, Felsted RL. Effect of myristoylation on p27 nef subcellular distribution and suppression of HIV-LTR transcription. Virology. 1992 Mar;187(1):46–55. [PubMed]
  • Yu X, Yuan X, Matsuda Z, Lee TH, Essex M. The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions. J Virol. 1992 Aug;66(8):4966–4971. [PMC free article] [PubMed]
  • Yuille MA, Hugunin M, John P, Peer L, Sacks LV, Poiesz BJ, Tomar RH, Silverstone AE. HIV-1 infection abolishes CD4 biosynthesis but not CD4 mRNA. J Acquir Immune Defic Syndr. 1988;1(2):131–137. [PubMed]
  • Zachar V, Spire B, Hirsch I, Chermann JC, Ebbesen P. Human transformed trophoblast-derived cells lacking CD4 receptor exhibit restricted permissiveness for human immunodeficiency virus type 1. J Virol. 1991 Apr;65(4):2102–2107. [PMC free article] [PubMed]
  • Zack JA, Haislip AM, Krogstad P, Chen IS. Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle. J Virol. 1992 Mar;66(3):1717–1725. [PMC free article] [PubMed]
  • Zack JA, Arrigo SJ, Weitsman SR, Go AS, Haislip A, Chen IS. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell. 1990 Apr 20;61(2):213–222. [PubMed]
  • Zack JA, Cann AJ, Lugo JP, Chen IS. HIV-1 production from infected peripheral blood T cells after HTLV-I induced mitogenic stimulation. Science. 1988 May 20;240(4855):1026–1029. [PubMed]
  • Zaghouani H, Goldstein D, Shah H, Anderson S, Lacroix M, Dionne G, Kennedy R, Bona C. Induction of antibodies to the envelope protein of the human immunodeficiency virus by immunization with monoclonal anti-idiotypes. Proc Natl Acad Sci U S A. 1991 Jul 1;88(13):5645–5649. [PMC free article] [PubMed]
  • Zagury D, Bernard J, Cheynier R, Desportes I, Leonard R, Fouchard M, Reveil B, Ittele D, Lurhuma Z, Mbayo K, et al. A group specific anamnestic immune reaction against HIV-1 induced by a candidate vaccine against AIDS. Nature. 1988 Apr 21;332(6166):728–731. [PubMed]
  • Zagury D, Bernard J, Leibowitch J, Safai B, Groopman JE, Feldman M, Sarngadharan MG, Gallo RC. HTLV-III in cells cultured from semen of two patients with AIDS. Science. 1984 Oct 26;226(4673):449–451. [PubMed]
  • Zagury D, Bernard J, Leonard R, Cheynier R, Feldman M, Sarin PS, Gallo RC. Long-term cultures of HTLV-III--infected T cells: a model of cytopathology of T-cell depletion in AIDS. Science. 1986 Feb 21;231(4740):850–853. [PubMed]
  • Zambruno G, Mori L, Marconi A, Mongiardo N, De Rienzo B, Bertazzoni U, Giannetti A. Detection of HIV-1 in epidermal Langerhans cells of HIV-infected patients using the polymerase chain reaction. J Invest Dermatol. 1991 Jun;96(6):979–982. [PubMed]
  • Zarling JM, Ledbetter JA, Sias J, Fultz P, Eichberg J, Gjerset G, Moran PA. HIV-infected humans, but not chimpanzees, have circulating cytotoxic T lymphocytes that lyse uninfected CD4+ cells. J Immunol. 1990 Apr 15;144(8):2992–2998. [PubMed]
  • Zauli G, Re MC, Visani G, Furlini G, La Placa M. Inhibitory effect of HIV-1 envelope glycoproteins gp120 and gp160 on the in vitro growth of enriched (CD34+) hematopoietic progenitor cells. Arch Virol. 1992;122(3-4):271–280. [PubMed]
  • Zazopoulos E, Haseltine WA. Mutational analysis of the human immunodeficiency virus type 1 Eli Nef function. Proc Natl Acad Sci U S A. 1992 Jul 15;89(14):6634–6638. [PMC free article] [PubMed]
  • Zeballos RS, Cavalcante N, Freire CA, Hernandez HJ, Longo IM, Peixinho ZF, Moura NC, Mendes NF. Delayed hypersensitivity skin tests in prognosis of human immunodeficiency virus infection. J Clin Lab Anal. 1992;6(3):119–122. [PubMed]
  • Zeira M, Byrn RA, Groopman JE. Inhibition of serum-enhanced HIV-1 infection of U937 monocytoid cells by recombinant soluble CD4 and anti-CD4 monoclonal antibody. AIDS Res Hum Retroviruses. 1990 May;6(5):629–639. [PubMed]
  • Zhang LQ, Simmonds P, Ludlam CA, Brown AJ. Detection, quantification and sequencing of HIV-1 from the plasma of seropositive individuals and from factor VIII concentrates. AIDS. 1991 Jun;5(6):675–681. [PubMed]
  • Zhou EM, Lohman KL, Kennedy RC. Administration of noninternal image monoclonal anti-idiotypic antibodies induces idiotype-restricted responses specific for human immunodeficiency virus envelope glycoprotein epitopes. Virology. 1990 Jan;174(1):9–17. [PubMed]
  • Zhu ZH, Chen SS, Huang AS. Phenotypic mixing between human immunodeficiency virus and vesicular stomatitis virus or herpes simplex virus. J Acquir Immune Defic Syndr. 1990;3(3):215–219. [PubMed]
  • Ziegler JB, Cooper DA, Johnson RO, Gold J. Postnatal transmission of AIDS-associated retrovirus from mother to infant. Lancet. 1985 Apr 20;1(8434):896–898. [PubMed]
  • Ziegler JL, Stites DP. Hypothesis: AIDS is an autoimmune disease directed at the immune system and triggered by a lymphotropic retrovirus. Clin Immunol Immunopathol. 1986 Dec;41(3):305–313. [PubMed]
  • Ziza JM, Brun-Vezinet F, Venet A, Rouzioux CH, Traversat J, Israel-Biet B, Barre-Sinoussi F, Chermann JC, Godeau P. Lymphadenopathy-associated virus isolated from bronchoalveolar lavage fluid in AIDS-related complex with lymphoid interstitial pneumonitis. N Engl J Med. 1985 Jul 18;313(3):183–183. [PubMed]
  • Zolla-Pazner S, Gorny MK. Passive immunization for the prevention and treatment of HIV infection. AIDS. 1992 Nov;6(11):1235–1247. [PubMed]
  • Zucker-Franklin D, Cao YZ. Megakaryocytes of human immunodeficiency virus-infected individuals express viral RNA. Proc Natl Acad Sci U S A. 1989 Jul;86(14):5595–5599. [PMC free article] [PubMed]
  • Zwart G, Langedijk H, van der Hoek L, de Jong JJ, Wolfs TF, Ramautarsing C, Bakker M, de Ronde A, Goudsmit J. Immunodominance and antigenic variation of the principal neutralization domain of HIV-1. Virology. 1991 Apr;181(2):481–489. [PubMed]

Articles from Microbiological Reviews are provided here courtesy of American Society for Microbiology (ASM)

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • Cited in Books
    Cited in Books
    PubMed Central articles cited in books
  • MedGen
    MedGen
    Related information in MedGen
  • PubMed
    PubMed
    PubMed citations for these articles
  • Substance
    Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...